
<html lang="en"     class="pb-page"  data-request-id="31260d50-815c-448a-8d91-d1aa21e7916d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.5b00354;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-15"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes" /></meta><meta name="dc.Creator" content="Anna M.  Knapinska" /></meta><meta name="dc.Creator" content="Daniela  Dreymuller" /></meta><meta name="dc.Creator" content="Andreas  Ludwig" /></meta><meta name="dc.Creator" content="Lyndsay  Smith" /></meta><meta name="dc.Creator" content="Vladislav  Golubkov" /></meta><meta name="dc.Creator" content="Anjum  Sohail" /></meta><meta name="dc.Creator" content="Rafael  Fridman" /></meta><meta name="dc.Creator" content="Marc  Giulianotti" /></meta><meta name="dc.Creator" content="Travis M.  LaVoi" /></meta><meta name="dc.Creator" content="Richard A.  Houghten" /></meta><meta name="dc.Creator" content="Gregg B.  Fields" /></meta><meta name="dc.Creator" content="Dmitriy  Minond" /></meta><meta name="dc.Description" content="ADAM17 is implicated in several debilitating diseases. However, drug discovery efforts targeting ADAM17 have failed due to the utilization of zinc-binding inhibitors. We previously reported discove..." /></meta><meta name="Description" content="ADAM17 is implicated in several debilitating diseases. However, drug discovery efforts targeting ADAM17 have failed due to the utilization of zinc-binding inhibitors. We previously reported discove..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 4, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00354" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00354" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00354" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00354" /></link>
        
    
    

<title>SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00354" /></meta><meta property="og:title" content="SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0006.jpeg" /></meta><meta property="og:description" content="ADAM17 is implicated in several debilitating diseases. However, drug discovery efforts targeting ADAM17 have failed due to the utilization of zinc-binding inhibitors. We previously reported discovery of highly selective nonzinc-binding exosite-targeting inhibitors of ADAM17 that exhibited not only enzyme isoform selectivity but synthetic substrate selectivity as well (J. Biol. Chem. 2013, 288, 22871). As a result of SAR studies presented herein, we obtained several highly selective ADAM17 inhibitors, six of which were further characterized in biochemical and cell-based assays. Lead compounds exhibited low cellular toxicity and high potency and selectivity for ADAM17. In addition, several of the leads inhibited ADAM17 in a substrate-selective manner, which has not been previously documented for inhibitors of the ADAM family. These findings suggest that targeting exosites of ADAM17 can be used to obtain highly desirable substrate-selective inhibitors. Additionally, current inhibitors can be used as probes of biological activity of ADAM17 in various in vitro and, potentially, in vivo systems." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00354"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00354">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00354&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00354&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00354&amp;href=/doi/10.1021/acs.jmedchem.5b00354" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 5808-5824</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00310" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00427" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of <u class="uu">A</u><u class="uu">D</u>isintegrin <u class="uu">A</u>nd <u class="uu">M</u>etalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna+M.++Knapinska">Anna M. Knapinska</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Dreymuller">Daniela Dreymuller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Ludwig">Andreas Ludwig</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lyndsay++Smith">Lyndsay Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vladislav++Golubkov">Vladislav Golubkov</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anjum++Sohail">Anjum Sohail</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rafael++Fridman">Rafael Fridman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Giulianotti">Marc Giulianotti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Travis+M.++LaVoi">Travis M. LaVoi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+A.++Houghten">Richard A. Houghten</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregg+B.++Fields">Gregg B. Fields</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dmitriy++Minond">Dmitriy Minond</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Torrey Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Wayne State University, 8200 Scott Hall, 540 East Canfield Avenue, Detroit, Michigan 48201, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">â¥</span> <span class="aff-text">Florida Atlantic University, 5353 Parkside Drive, Jupiter, Florida 33458, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">â¥</span> <span class="aff-text">Institute of Pharmacology and Toxicology, RWTH Aachen University, Wendlingweg 2, 52074 Aachen, Germany</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">The Scripps Research Institute/Scripps Florida, 130 Scripps Way, Jupiter, Florida 33458, United States</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">â</span> <span class="aff-text">Department of Chemistry, Center for Drug Discovery and Innovation, University of South Florida, Tampa, Florida 33612, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 772-345-4705. Fax: 772-345-3649. E-mail: <a href="/cdn-cgi/l/email-protection#492d24202726272d093d3920243a67263b2e"><span class="__cf_email__" data-cfemail="1470797d7a7b7a705460647d79673a7b6673">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00354&amp;href=/doi/10.1021%2Facs.jmedchem.5b00354" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 5808â5824</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 20, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 March 2015</li><li><span class="item_label"><b>Published</b> online</span>4 August 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00354" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00354</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5808%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnna%2BM.%2BKnapinska%252C%2BDaniela%2BDreymuller%252C%2BAndreas%2BLudwig%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D15%26contentID%3Dacs.jmedchem.5b00354%26title%3DSAR%2BStudies%2Bof%2BExosite-Binding%2BSubstrate-Selective%2BInhibitors%2Bof%2BA%2BDisintegrin%2BAnd%2BMetalloprotease%2B17%2B%2528ADAM17%2529%2Band%2BApplication%2Bas%2BSelective%2Bin%2BVitro%2BProbes%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5824%26publicationDate%3DAugust%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00354"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">875</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00354" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;M. Knapinska&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Dreymuller&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Ludwig&quot;},{&quot;first_name&quot;:&quot;Lyndsay&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Vladislav&quot;,&quot;last_name&quot;:&quot;Golubkov&quot;},{&quot;first_name&quot;:&quot;Anjum&quot;,&quot;last_name&quot;:&quot;Sohail&quot;},{&quot;first_name&quot;:&quot;Rafael&quot;,&quot;last_name&quot;:&quot;Fridman&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Giulianotti&quot;},{&quot;first_name&quot;:&quot;Travis&quot;,&quot;last_name&quot;:&quot;M. LaVoi&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;A. Houghten&quot;},{&quot;first_name&quot;:&quot;Gregg&quot;,&quot;last_name&quot;:&quot;B. Fields&quot;},{&quot;first_name&quot;:&quot;Dmitriy&quot;,&quot;last_name&quot;:&quot;Minond&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;5808-5824&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00354&quot;},&quot;abstract&quot;:&quot;ADAM17 is implicated in several debilitating diseases. However, drug discovery efforts targeting ADAM17 have failed due to the utilization of zinc-binding inhibitors. We previously reported discovery of highly selective nonzinc-binding exosite-targeting inhibitors of ADAM17 that exhibited not only enzyme isoform selectivity but synthetic substrate selectivity as well ( J. Biol. Chem. 2013, 288, 22871 ). As a result of SAR studies presented herein, we obtained several highly selective ADAM17 inhibitors, six of which were further characterized in biochemical and cell-based assays. Lead compounds exhibited low cellular toxicity and high potency and selectivity for ADAM17. In addition, several of the leads inhibited ADAM17 in a substrate-selective manner, which has not been previously documented for inhibitors of the ADAM family. These findings suggest that targeting exosites of ADAM17 can be used to obtain highly desirable substrate-selective inhibitors. Additionally, current inhibitors can be used as probes of &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00354&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00354" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00354&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00354" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00354&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00354" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00354&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00354&amp;href=/doi/10.1021/acs.jmedchem.5b00354" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00354" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00354" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00354%26sid%3Dliteratum%253Aachs%26pmid%3D26192023%26genre%3Darticle%26aulast%3DKnapinska%26date%3D2015%26atitle%3DSAR%2BStudies%2Bof%2BExosite-Binding%2BSubstrate-Selective%2BInhibitors%2Bof%2BA%2BDisintegrin%2BAnd%2BMetalloprotease%2B17%2B%2528ADAM17%2529%2Band%2BApplication%2Bas%2BSelective%2Bin%2BVitro%2BProbes%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D15%26spage%3D5808%26epage%3D5824%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/jmcmar.2015.58.issue-15/20150813/jmcmar.2015.58.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">ADAM17 is implicated in several debilitating diseases. However, drug discovery efforts targeting ADAM17 have failed due to the utilization of zinc-binding inhibitors. We previously reported discovery of highly selective nonzinc-binding exosite-targeting inhibitors of ADAM17 that exhibited not only enzyme isoform selectivity but synthetic substrate selectivity as well ( <cite>J. Biol. Chem.</cite> <span class="NLM_year">2013</span>, <em>288</em>, 22871). As a result of SAR studies presented herein, we obtained several highly selective ADAM17 inhibitors, six of which were further characterized in biochemical and cell-based assays. Lead compounds exhibited low cellular toxicity and high potency and selectivity for ADAM17. In addition, several of the leads inhibited ADAM17 in a substrate-selective manner, which has not been previously documented for inhibitors of the ADAM family. These findings suggest that targeting exosites of ADAM17 can be used to obtain highly desirable substrate-selective inhibitors. Additionally, current inhibitors can be used as probes of biological activity of ADAM17 in various in vitro and, potentially, in vivo systems.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">ADAM17 is a prototypical member of <u class="uu">a</u><u class="uu">d</u>isintegrin <u class="uu">a</u>nd <u class="uu">m</u>etalloproteinase family of metzincin proteases<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> implicated in several aggressive forms of cancer,<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> rheumatoid arthritis,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and Alzheimerâs disease.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Not surprisingly, multiple pharmaceutical companies attempted to develop inhibitors of ADAM17 as potential drug candidates for the above-mentioned therapeutic indications. From 2001 to 2009, more than a hundred ADAM17 inhibitors were patented.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Even though some of these molecules inhibit ADAM17 with subnanomolar potency and several of them reached clinical trials,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> they ultimately failed as drugs. It is believed that the main reason for these failures was the zinc-binding mechanism of action leading to a broad-spectrum inhibition of many zinc-dependent metalloproteases leading to in vivo side effects most frequently manifesting as a musculoskeletal syndrome (MSS).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Additionally, many of the zinc-binding moieties, such as hydroxamates, are metabolically unstable, which limits their bioavailability.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> There are several comprehensive reviews available on collagenase inhibitors,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> TACE inhibitors,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> metzincin inhibitors,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and metalloenzyme inhibitors<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> that address the drawbacks of zinc-binding inhibitors.</div><div class="NLM_p">To circumvent the problems of zinc-binding inhibitors of ADAM17 and metzincins in general, several groups, including ours, pursued discovery and development of inhibitors that act via a nonzinc-binding mechanism and target secondary substrate binding sites (also known as exosites).<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13-16)</a> For example, Aventis discovered a pyrimidine dicarboxamide that had low nanomolar potency for MMP-13 and no activity against other MMPs when tested at 100 Î¼M.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Pfizer reported discovery of highly selective nanomolar range MMP-13 inhibitors based on pyrimidinedione and quinazolinone scaffolds acting via binding to the S<sub>1</sub>â² exosite.<a onclick="showRef(event, 'ref14 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref17">(14, 17)</a> Similarly, Alantos Pharmaceuticals identified a new class of highly selective nonzinc-binding MMP-13 inhibitors.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Most recently, Takeda Pharmaceutical Company reported yet another nonzinc-binding inhibitor of MMP-13 that acts via binding to the S<sub>1</sub>â² site.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The lead from the Takeda series, compound <b>26c</b>, exhibited subnanomolar activity against MMP-13 and good oral bioavailability. Our group reported the discovery of a MMP-13 exosite inhibitor that binds to two different exosites.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> Several of these inhibitors were efficacious in in vivo models of arthritis without causing MSS,<a onclick="showRef(event, 'ref14 ref15 ref22'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref22">(14, 15, 22)</a> suggesting that nonzinc-binding inhibition can indeed overcome the drawbacks of zinc-binding inhibitors of metzincins.</div><div class="NLM_p">In addition to potentially being drug candidates, selective inhibitors of ADAM17 could represent extremely useful tools for dissecting the highly complex role of ADAM17 in various diseases and normal processes. Such probes have become the staple of chemical biology for studying cellular processes.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The development of exosite inhibitors of ADAM17 and ADAM in general have been hampered by the lack of knowledge about exosites in the structures of ADAM. However, development of an ADAM17-selective low nanomolar inhibitory antibody<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> was reported in 2011. This antibody was shown to work via binding across the catalytic and noncatalytic domains of ADAM17, thereby obstructing access of the substrate to the catalytic cleft of ADAM17.</div><div class="NLM_p last">Our group has previously reported the discovery of the first small molecule exosite-binding selective inhibitor of ADAM17.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In the present study. we report results of structureâactivity relationship studies and cellular characterization of this novel class of ADAM17 inhibitors that could potentially be used as probes for the biological activity of ADAM17.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61818" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61818" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> SAR Studies</h3><div class="NLM_p">We previously conducted initial exploration of structureâactivity relationship of pyrrolidine diketopiperazine analogues using <i>S</i>-4-hydroxybenzyl and <i>S</i>-propyl in the R1 position.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In both cases, we tried <i>S</i>- and <i>R</i>-hydroxybenzyl and <i>S</i>-2-naphthylmethyl in position R2, <i>S</i>- and <i>R</i>-hydroxybenzyl in position R3, and 2-phenylbutyl, 2-adamantan-1-yl-ethyl, and cyclopentyl-methyl in position R4. Analogues with <i>S</i>-propyl in R1 position did not produce highly potent compounds (best compound IC<sub>50</sub> value 12 Î¼M) but were selective for ADAM17 as compared to ADAM10. In the present study, we expanded the SAR of the R1 <i>S</i>-propyl analogues in order to determine whether greater activity can be achieved without loss of selectivity. Thus, compounds <b>1</b>â<b>7</b> have <i>S</i>-propyl in the R1 position, R-hydroxybenzyl in position R2, and <i>S</i>-hydroxybenzyl in position R3, whereas residues in position R4 are varied (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). All compounds of this series produced complete inhibition at 100 Î¼M, with IC<sub>50</sub> values ranging from 94 to 5.9 Î¼M. Two out of three three best compounds (<b>2</b> and <b>6</b>, IC<sub>50</sub> = 10 Â± 1.3 and 5.9 Â± 0.9 Î¼M, respectively) contained 4-adamantan-1-yl-methyl and 2-adamantan-1-yl-ethyl in the R4 position, respectively. From our previous study, the best compound reported by us (compound <b>15</b> in ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a> and compound <b>17</b> in present work) had 2-adamantan-1-yl-ethyl moiety in the R4 position. Overall, when 2-adamantan-1-yl-ethyl was present in position R4, it produced the greatest inhibition without loss of selectivity regardless of which functionalities were present in positions R1â3. On the basis of this consideration, the next series of analogues all have <i>S</i>-propyl in the R1 position, <i>R</i>-hydroxybenzyl in R2, and 2-adamantan-1-yl-ethyl in R4, while position R3 is varied to produce compounds <b>8</b>â<b>11</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The functionalities used in position R3 were selective in the positional scan study during the deconvolution stage as described previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Stereoisomers with <i>S</i>- and <i>R</i>-hydroxybenzyl in position R3, compounds <b>6</b> and <b>8</b>, exhibited similar IC<sub>50</sub> values (IC<sub>50</sub> = 5.9 Â± 0.9 and 5.4 Â± 0.5 Î¼M for <b>6</b> and <b>8</b>, respectively). <i>R</i>- and <i>S</i>-5-Naphthalen-2-ylmethyl (compounds <b>9</b> and <b>10</b>) were also equipotent (IC<sub>50</sub> = 7.9 Â± 0.8 and 10 Â± 0.8 Î¼M for <b>10</b> and <b>9</b>, respectively). Finally, compound <b>11</b> with <i>S</i>-butyl in R3 had IC<sub>50</sub> of 6.5 Â± 0.9 Î¼M. These results suggested that the potency of compounds of this scaffold is largely determined by the presence of 2-adamantan-1-yl-ethyl in R4. To confirm this hypothesis, we introduced <i>R</i>-6-naphthalen-2-ylmethyl in position R1. Activity of <i>R</i>-6-naphthalen-2-ylmethyl was greater than <i>S</i>-propyl based on the positional scan.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Additionally, positions R4 and R2 were fixed with 2-adamantan-1-yl-ethyl and <i>S</i>-4-hydroxybenzyl, respectively, while R3 was varied (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Introduction of <i>R</i>-6-naphthalen-2-ylmethyl in position R1 resulted in 2â3-fold loss of potency (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, IC<sub>50</sub> compound <b>8</b> = 5.4 Â± 0.5 Î¼M versus 15 Â± 1.2 Î¼M for compound <b>13</b>; 5.9 Â± 0.9 Î¼M for <b>6</b> and 8.1 Â± 0.9 Î¼M for compound <b>12</b>) when hydroxybenzyl was present in position R3. When 5-naphthalen-2-ylmethyl was present in R3, introduction of <i>R</i>-6-naphthalen-2-ylmethyl into R1 did not have a significant effect (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, IC<sub>50</sub> compound <b>9</b> = 10 Â± 0.8 Î¼M versus 8.4 Â± 1.0 Î¼M for <b>14</b>; 7.9 Â± 0.8 Î¼M for <b>10</b> versus 5.7 Â± 1.0 Î¼M for <b>15</b>). Similarly, the presence of <i>S</i>-5-butyl in R3 resulted in comparable IC<sub>50</sub> values whether R1 contained either <i>S</i>-propyl or <i>R</i>-6-naphthalen-2-ylmethyl (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, IC<sub>50</sub> compound <b>11</b> = 6.5 Â± 0.9 Î¼M versus 5.7 Â± 0.8 for <b>16</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Study Results of Individual Compounds Synthesized Based on Kinetic Studies of Mixture Samples<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0002.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">Positions R1-3 are fixed, R4 is scanned. IC<sub>50</sub> values reported as a mean of three experiments Â± standard deviation.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Study Results of Individual Compounds Synthesized Based on Positional Scan of Mixture Samples<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0003.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">R3 is scanned, and R1, R2, and R4 are fixed. IC<sub>50</sub> values data reported as a mean of three experiments Â± standard deviation.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Study Results of Individual Compounds Synthesized Based on Positional Scan of Mixture Samples<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0004.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>Table a</sup><p class="last">R3 is scanned, and R1, R2, and R4 are fixed. IC<sub>50</sub> values data reported as a mean of three experiments Â± standard deviation.</p></div></div><div></div></div><div class="NLM_p">As a result of the structureâactivity relationship study, several compounds with low micromolar IC<sub>50</sub> values were identified. We chose compounds exhibiting the greatest potency for ADAM17 containing 2-adamantan-1-yl-ethyl in R4 (<b>20</b>, <b>16</b>, and <b>17</b> described in ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>) to be tested against an extended panel of zinc metalloproteinases. Additionally, we chose the most potent compounds without 2-adamantan-1-yl-ethyl (<b>18</b>, <b>19,</b> and <b>21</b>) for comparison in selectivity testing and cell-based studies.</div><div class="NLM_p">Compounds <b>21</b>, <b>19</b>, <b>20</b>, and <b>16</b> exhibited the best selectivity profile, inhibiting only ADAM17 and sparing five other metzincins. Compound <b>17</b> exhibited limited inhibition of MMP-2, MMP-9, and MMP-14/MT1-MMP (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) at 100 Î¼M, most likely due to nonspecific binding. This biochemical inhibition profile suggested that compounds of this series could potentially be used as selective in vitro and in vivo probes of ADAM17.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of Selectivity Testing of Novel ADAM17 Inhibitors against a Panel Zinc of Metalloproteases<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0005.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>Table a</sup><p class="last">All results are IC<sub>50</sub>, Î¼M (%inhibition at 100 Î¼M). No parentheses indicates 0% inhibition at 100 Î¼M. NT: not tested.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cell-Based Studies: Cell Toxicity and Cell Surface Targets</h3><div class="NLM_p">Before testing the ADAM17 inhibitors for abrogation of shedding of cell surface proteins that are generally considered to be physiologically relevant substrates of ADAM17, the compounds were tested for toxicity in cell viability assays. All six leads were tested with healthy and lung cancer cell lines (CHO-K1 and A549, respectively). Additionally, <b>18</b>, <b>17</b>, and <b>20</b> were tested with liver and breast cancer cell lines (HEPG2 and MDA-MB-231, respectively). CHO-K1 and A549 cells were viable for 72 h in the presence of up to 33 Î¼M of lead compounds (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). <b>18</b>, <b>17</b>, and <b>20</b> did not inhibit viability of HEPG2 and MDA-MB-231 cells for 72 h up to 33 Î¼M (data not shown). These results suggested that the lead compounds could be utilized as probes of ADAM17 activity in cell-based assays without compromising the health of the cellular system under investigation.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Results of cell viability assay with ADAM17 inhibitors. (A) Viability assay with CHO-K1 cells. (B) Viability assay with A549 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">ADAM17 has been implicated as either the main or, in some cases, the only protease responsible for the cleavage of more than 70 cell surface proteins.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> To assess activity of the lead compounds against ADAM17 in a cell-based setting, several cell lines and cell surface proteins were examined.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Cytokines</h3><div class="NLM_p">The ability of compounds to protect of TNFÎ± from shedding by ADAM17 was assessed. TNFÎ± is a canonical substrate of ADAM17.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> The present ADAM17 inhibitors were discovered using substrate based on the TNFÎ± cleavage sequence;<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> therefore, we were interested to see whether TNFÎ± shedding would be inhibited in a cell-based assay. We tested compounds at 25 Î¼M and used Marimastat (a broad spectrum metzincin inhibitor) at 10 Î¼M as a control. Five out of six test compounds and Marimastat inhibited approximately 30â50% of TNFÎ± cleavage in THP1 cells (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). To assess the potency of this inhibition, we performed a doseâresponse study with compounds <b>17</b> and <b>19</b>, whereby they exhibited â¼100 and 28 Î¼M IC<sub>50</sub> values, respectively (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Results of TNFÎ± shedding assay in THP-1 cells with ADAM17 inhibitors. (A) Single point assay. One-way analysis of variance (ANOVA) was used followed by Dunnett posthoc test. The data shown are the mean Â± SEM, <i>n</i> = 5. *****<i>p</i> < 0.0001; ***<i>p</i> < 0.001, **<i>p</i> < 0.01, *<i>p</i> < 0.05. (B) Doseâresponse assay with compounds <b>17</b> and <b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">PMA - or LPS-induced production of chemokine IL-8 by epithelial cells of human airway (NCI-H292) or human trachel smooth muscle cells (HTSMC) was reported to be mediated by ADAM17âs cleavage of TGFÎ± and subsequent transactivation of ErB/EGFR<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and was inhibited by ADAM17 siRNA. In human tracheal smooth muscle cells (HTSMC), IL-8 was shed in response to LPS, acid, and IL-1 stimulation<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and was decreased as a result of ADAM17 shRNA application. Thus, IL-8 production by these cells can be used as read out for TGFÎ± shedding. We tested compounds <b>18</b>, <b>17</b>, <b>20</b>, and <b>16</b> for inhibition of LPS- and IL-1-stimulated IL-8 release from HTSMCs. Ten Î¼M of compounds <b>18</b>, <b>17</b>, <b>20</b>, and <b>16</b> inhibited 18â62% of LPS-stimulated IL-8 shedding (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Interestingly, none of the tested compounds were able to inhibit IL-1-mediated production of IL-8 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). It is known that IL-1 stimulates production of IL-8 via inducing cleavage of neuregulins, which can be cleaved by multiple proteases of which ADAM17 is the critical sheddase in the cell system that was used here.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> Lack of inhibition of IL-1-induced IL-8 release in combination with inhibition of LPS-induced IL-8 release suggests that our lead compounds target TGFÎ± cleavage by ADAM17 but not cleavage of neuregulins. Our compounds may have significant utility for dissecting of complex proteolytic pathways where ADAM17 is implicated in a substrate-specific manner.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of ADAM17 inhibitors on cytokine shedding in HTMS cells. (A) LPS-stimulated IL-8 shedding inhibition assay. (B) IL-1-stimulated IL-8 shedding inhibition assay. (C) Fractalkine constitutive shedding inhibition assay. One-way analysis of variance (ANOVA) was used followed by Dunnett posthoc test. The data shown are the mean Â± SEM, <i>n</i> = 3 from three independent experiments. *****<i>p</i> value <0.0001, ***<i>p</i> value <0.001, **<i>p</i> value <0.01, *<i>p</i> value <0.05. GI: control ADAM10 selective inhibitor GI254023X.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To test for selectivity of compounds, we conducted assays for inhibition of shedding of fractalkine/CX3CL1 and CXCL16 using HTSMC. Fractalkine/CX3CL1 is shed both constitutively and in response to PMA stimulation. ADAM17 was shown to be responsible for PMA-induced cleavage,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> whereas constitutive shedding is ascribed to ADAM10.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> None of the lead compounds were able to abrogate constitutive ADAM10-mediated release of fractalkine/CX3CL1 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C), suggesting that the compounds are selective for ADAM17. Additionally, compounds <b>18</b>, <b>17</b>, <b>20</b>, and <b>16</b> did not inhibit the shedding of CXCL16 ascribed to ADAM10,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> further suggesting their selectivity for ADAM17 in HTSMC (data not shown).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Receptors</h3><div class="NLM_p">Shedding of discoidin domain receptor 1 (DDR1) in HCC1806 breast cancer cells is mediated by cell surface-bound metalloproteases.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Membrane type 1 matrix metalloprotease (MT1-MMP, also known as MMP-14) was determined to be one of the enzymes responsible for the constitutive cleavage of DDR1. However, MT1-MMP knockdown or inhibition by pharmacological agents did not result in the abrogation of DDR1 shedding. These data suggested the existence of a compensatory mechanism whereby another metalloprotease cleaves DDR1 in the event of MT1-MMP inhibition. Because ADAM10 and ADAM17 mRNAs were detected in HCC1806 cells,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> the hypothesis of ADAM proteases involvement in DDR1 cleavage was formed and it was decided to investigate whether shedding of DDR1 ectodomain could be affected by the application of ADAM17 selective inhibitors. Compound <b>17</b> was tested using 10, 20, and 40 Î¼M concentrations. DDR1 shedding was inhibited in a dose-dependent manner (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), however, even at the highest tested dosage (40 Î¼M), soluble DDR1 was detectable. This suggests that both ADAM17 and MT1-MMP have to be inhibited to completely abrogate the shedding of DDR1. Additionally, compound <b>17</b> did not inhibit ADAM10 in the in vitro assay (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), suggesting that this enzyme does not appear to be involved in constitutive shedding of DDR1 despite the presence of its mRNA in HCC1806 cells.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Results of DDR1 release assay in HCC1806 breast cancer cells with compound <b>17</b>. One, untreated control; <b>2</b>, 10 Î¼M compound <b>17</b>; 3, 20 Î¼M compound <b>17</b>, 4â40 Î¼M compound <b>17</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another cell surface protein with importance in cancer progression that is cleaved by MT1-MMP and ADAM17 is protein tyrosine kinase 7 (PTK7). PTK7 proteolysis controls cell migration in early embryogenesis and regulates cancer cell directional motility, invasion, and metastasis.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39">(35-39)</a> The full-length PTK7 efficiently inhibits cell invasion and down-regulates myosin light chain (MLC) phosphorylation, a downstream event in the Wnt/PCP pathway.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Proteolysis of PTK7 reverses the inhibitory signal of the full-length PTK7 and subsequently promotes cell invasion<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and metastasis.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Thus, PTK7 proteolysis by MT1-MMP and ADAM17 is a proteolytic master switch that turns on the motility of cells. We tested lead compounds (<b>18</b>, <b>17</b>, <b>19</b>, and <b>16</b>) at 25, 50, and 100 Î¼M concentrations using a human fibrosarcoma cell line that expressed a PTK7 mutant uncleavable by MT1-MMP (HT1080-L622D) and colorectal cancer cells (SW480) expressing wild-type PTK7 endogenously (wtPTK7). Compound <b>17</b> inhibited shedding of L622D-PTK7 and wtPTK-7 at 50 and 100 Î¼M (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A) when both HT1080-L622D and SW480 cells were stimulated with PMA. <b>18</b>, <b>19</b>, and <b>16</b> did not exhibit inhibition of L622D-PTK7 and wtPTK-7 up to 100 Î¼M (data not shown).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound <b>17</b> on PTK7 shedding and invasion. (A) PTK7 shedding assay in HT1080 (fibrosarcoma) and SW480 (colorectal cancer) cells. (B) Invasion assay in HT1080 cells. sPTK7: soluble PTK7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A dual inhibitor of ADAM10 and ADAM17, INCB3619 (ADAM17 IC<sub>50</sub> = 14 nM, ADAM10 IC<sub>50</sub> = 22 nM, MT1-MMP IC<sub>50</sub> = 772 nM)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> was able to inhibit both shedding of PTK7 and invasion of HT1080 cells.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> On the basis of this evidence, we hypothesized that selective inhibition of ADAM17 should result in a decrease of invasiveness of HT1080 cells. Indeed, we observed a dose-dependent inhibition of invasion of HT1080 cells in a Transwell assay (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Growth Factors</h3><div class="NLM_p">ADAM10 and ADAM17 are believed to be the main sheddases of EGFR ligands.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Moreover, the expression of ADAM17 was shown to be up-regulated in lung cancer,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> where it has been shown to shed heregulin<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> leading to activation of EGFR/ERK/Akt pathways and resulting in cancer cell proliferation,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> resistance to EGFR-based therapies,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and poor prognosis.<a onclick="showRef(event, 'ref40 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref42">(40, 42)</a> On the basis of these considerations, we were interested to see whether exosite inhibition of ADAM17 can be an effective tool to study the role of ADAM17 in lung cancer. We used A549 nonsmall cell lung cancer cells, which were shown to have high expression levels of heregulin<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> to determine the ability of our lead compounds to inhibit its shedding. Heregulin is specifically cleaved by ADAM17<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and therefore represents a suitable end point in determining cellular efficacy of ADAM17 inhibitors. Interestingly, despite very similar IC<sub>50</sub> values for ADAM17 inhibition in the biochemical assay (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), only compound <b>17</b> completely inhibited shedding of heregulin in the cell-based assay (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A, all leads tested at 40 Î¼M). To assess enzyme selectivity of compound <b>17</b>, we tested its ability to inhibit shedding of another EGFR ligand, betacellulin, which is cleaved exclusively by ADAM10.<a onclick="showRef(event, 'ref41 ref45'); return false;" href="javascript:void(0);" class="ref ref41 ref45">(41, 45)</a> Marimastat and compounds <b>21</b>, <b>18</b>, and <b>16</b> were also tested. None of tested selective ADAM17 inhibitors affected the shedding of betacellulin from A549 cell surface at 40 Î¼M, whereas Marimastat exhibited almost complete inhibition at 10 Î¼M. This suggests that <b>17</b> selectively inhibits ADAM17 not only in biochemical but in a cell-based environment and could be a useful tool to study the role of ADAM17 in cells.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of ADAM17 inhibitors on growth factors shedding in A549 cells. (A) Effect on shedding of heregulin. M-stat: marimastat. (B) Effect on shedding of betacellulin. One-way analysis of variance (ANOVA) was used followed by Dunnett posthoc test. The data shown are the mean Â± SEM, <i>n</i> = 3. ***<i>p</i> <0.001. (C) Effect on shedding of TGFÎ±. One-way analysis of variance (ANOVA) was used followed by Dunnett posthoc test. The data shown are the mean Â± SEM, <i>n</i> = 3. ***<i>p</i> <0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We previously reported that <b>17</b> was able to preferentially inhibit ADAM17 hydrolysis of a glycosylated synthetic substrate based on the TNFÎ± sequence (<b>15</b> in ref <a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">46</a>). ADAM17 is known to be able to cleave more than 70 cell surface proteins,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> creating concern that indiscriminate inhibition of all ADAM17-mediated shedding could have unpredictable side effects. In turn, inhibitors that can selectively inhibit hydrolysis of certain substrates or a subset of substrates could be of interest for drug discovery. To assess whether <b>17</b> inhibits heregulin with some degree of selectivity, we tested it for the inhibition of shedding of TGFÎ±, another EGFR ligand with importance in lung cancer. Indeed, <b>17</b> did not affect shedding of TGFÎ± in A549 cells up to 100 Î¼M, whereas 10 Î¼M Marimastat decreased soluble TGFÎ± in the supernatant of A549 cells to the level of non-PMA-treated control (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Synergy Studies</h3><div class="NLM_p">It was shown that ADAM17 inhibition by broad spectrum metalloprotease inhibitor INCB3619 led to abrogation of heregulin shedding in A549 cells, which potentiated the activity of the EGFR tyrosine kinase inhibitor gefitinib.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> As mentioned above, <b>17</b> inhibited shedding of heregulin in A549 cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A); therefore, we used it to test for synergy with gefitinib. Then 40 Î¼M compound <b>17</b> potentiated gefitinib activity against A549 cells in the viability assay (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The IC<sub>50</sub> value for gefitinib inhibition of A549 cell growth was 8.4 Î¼M, but in the presence of 40 Î¼M compound <b>17</b> the IC<sub>50</sub> value decreased 4-fold (1.9 Î¼M). For comparison, 10 Î¼M INCB3619 shifted gefitinibâs IC<sub>50</sub> value from â¼8 to â¼1 Î¼M in A549 cells.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Because <b>17</b> exhibited no intrinsic activity against A549 cell in viability assay (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), the improvement of gefitinibâs potency can be ascribed to the synergy between <b>17</b> and gefitinib. For comparison, compound <b>17</b> did not potentiate the activity of two other FDA-approved lung cancer drugs etoposide or doxorubicin (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B,C). Etoposide and doxorubicin act via topoisomerase inhibition, distinct from the inhibition of EGFR tyrosine kinase activity of gefitinib.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0014.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Results of synergy studies of compound <b>17</b> with FDA-approved lung cancer drugs. (A) Synergy study with gefitinib. (B) Synergy study with etoposide. (C) Synergy study with doxorubicin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Despite the large number of ADAM17 inhibitors developed by various academic and industrial entities, there is a paucity of ADAM17 inhibitors that work by binding to so-called exosites. Therefore, there is limited understanding of the biological and biochemical effects of inhibition by such molecules. Indeed, what can be expected from molecules that bind to an exosite rather to an active site of ADAM17 or any other enzyme? For example, the anti-BACE1 exosite-binding antibody inhibited hydrolysis of a longer APP-based synthetic substrate 10-fold more potently than a shorter version of the same substrate,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> suggesting that exosite-based inhibition can lead to substrate selectivity. Substrate-selective inhibition is much more rare than enzyme-selective inhibition but has been demonstrated for different classes of enzymes. In the case of COX-2 substrate-selective inhibitors, binding to an allosteric subunit results in noncompetitive inhibition of endocannabinoid oxygenation, but no inhibition of arachidonic acid oxygenation was observed.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Substrate-selective inhibition of protein kinase PDK1 was also achieved as a result of binding of small molecule to an allosteric site.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">To our knowledge, substrate-selective inhibition of ADAM17 has not been reported so far. While metzincin isoform selectivity was addressed in many studies, the possibility of substrate selectivity of metzincin inhibitors still remains largely unexplored. It is now understood that some metzincins should not be inhibited in certain disease scenarios (i.e., MMP-8 and MMP-14 in skin and breast cancer<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51-53)</a>). However, it is much less known about whether hydrolysis of any of the cognate substrates should be spared from inhibition. As demonstrated in the case of Î³-secretase inhibitor discovery for Alzheimerâs disease, inhibition of Î³-secretase abrogated release of Î²-amyloid but also prevented a cleavage of Notch leading to toxicity (reviewed in ref <a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">54</a>). It is well-known that metzincins have broad substrate repertoires, therefore, it is possible that total abrogation of activity of a target enzyme might be unwanted.</div><div class="NLM_p">Our data suggest that exosite inhibition of ADAM17 can lead to a substrate-selective inhibition (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Data presented herein demonstrate that compound <b>17</b> inhibits ADAM17 selectively in cell-based assays, which in turn suggests that it can be used as a probe of ADAM17 activity in in vitro and, potentially, in vivo, systems. In addition to enzyme selectivity, compound <b>17</b> also exhibited unusual substrate selectivity by sparing ADAM17-mediated cleavage of TGFÎ±. For comparison, both Marimastat (a broad spectrum ADAM and MMP zinc-binding inhibitor) and INCB84298 (a moderately ADAM17-selective zinc-binding inhibitor) inhibited shedding of each tested EGFR ligand (heregulin, TGFÎ±, HB-EGF, amphiregulin, and EGF) in A549 cells almost equipotently.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Even though limited enzyme selectivity might be achieved by targeting the zinc of the ADAM17 active site, the zinc-binding inhibitors cannot selectively inhibit proteolysis of subset of ADAM17 substrates. Further studies characterizing the substrate inhibition profile of exosite inhibitor <b>17</b> are needed to determine which substrates of ADAM17 are protected from shedding and what is the underlying mechanism of this unusual substrate selectivity. One possibility is that different ADAM17 substrates interact with different exosites or sets of exosites in ADAM17, while compound <b>17</b> potentially interacts with just one exosite and, therefore, cannot inhibit binding of substrates that interact with exosites different from the one that compound <b>17</b> binds to. This possible explanation is consistent with the fact that ADAM17-selective exosite-binding antibody D1(A12)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> inhibits shedding of all tested ADAM17 substrates (i.e., TNFÎ±, TGFÎ±, amphiregulin, HB-EGF-AP, and TNFR1a) while sparing ADAM10. D1(A12) interacts with a significantly greater surface area of ADAM17 as compared to <b>17</b> bridging catalytic and noncatalytic domains and, therefore, potentially interacting with many more exosites than <b>17</b>. The limited exosite interaction is possibly due to the fact that inhibitors of the <b>17</b> chemotype were discovered using a TNFÎ±-based glycosylated substrate, creating a bias toward inhibition of TNFÎ± (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) over other ADAM17 substrates (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, TNFÎ± versus TGFÎ±, heregulin). It will be interesting to see whether a similar bias toward inhibiting certain other ADAM17 substrates can be achieved by using HTS substrates derived from different cognate substrates of these adamalysins or other metzincins. Conversely, this ability to âprogramâ or bias discovery toward substrate-selective inhibitors can be highly desirable for drug discovery for enzymes with complex substrate repertoires.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Summary of Cell-Based Testing of Novel ADAM17 Inhibitors for Suppression of Shedding of Cell-Surface Proteins<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">target ID</th><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center">[C] tested (Î¼M)</th><th class="colsep0 rowsep0" align="center"><b>16</b></th><th class="colsep0 rowsep0" align="center"><b>17</b></th><th class="colsep0 rowsep0" align="center"><b>18</b></th><th class="colsep0 rowsep0" align="center"><b>19</b></th><th class="colsep0 rowsep0" align="center"><b>20</b></th><th class="colsep0 rowsep0" align="center"><b>21</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNFÎ±</td><td class="colsep0 rowsep0" align="left">THP1</td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">57</td><td class="colsep0 rowsep0" align="center">43</td><td class="colsep0 rowsep0" align="center">36</td><td class="colsep0 rowsep0" align="center">60</td><td class="colsep0 rowsep0" align="center">44</td><td class="colsep0 rowsep0" align="center">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PTK7</td><td class="colsep0 rowsep0" align="left">HT1080</td><td class="colsep0 rowsep0" align="center">25â100</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">25â50</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PTK7</td><td class="colsep0 rowsep0" align="left">SW480</td><td class="colsep0 rowsep0" align="center">25â100</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0â82</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DDR1</td><td class="colsep0 rowsep0" align="left">HCC1806</td><td class="colsep0 rowsep0" align="center">10â40</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">59â81</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IL-8</td><td class="colsep0 rowsep0" align="left">HTSMC</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">62</td><td class="colsep0 rowsep0" align="center">36</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">62</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FKN</td><td class="colsep0 rowsep0" align="left">HTSMC</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CXCL16</td><td class="colsep0 rowsep0" align="left">HTSMC</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Heregulin</td><td class="colsep0 rowsep0" align="left">A549</td><td class="colsep0 rowsep0" align="center">40</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">28</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TGFÎ±</td><td class="colsep0 rowsep0" align="left">A549</td><td class="colsep0 rowsep0" align="center">40</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BTC</td><td class="colsep0 rowsep0" align="left">A549</td><td class="colsep0 rowsep0" align="center">40</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Notch<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">SKMEL-28</td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Neprilysin<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></td><td class="colsep0 rowsep0" align="left">Ea.hy926</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">62</td><td class="colsep0 rowsep0" align="center">38</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Data reported as inhibition, %. NT: not tested.</p></div><div class="footnote" id="t5fn1"><sup>b</sup><p class="last">Personal communication from Dr. Kaushik (Kansas University Medical Center).</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05057" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05057" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The findings presented herein suggest that targeting exosites of ADAM17 can be used to obtain highly desirable enzyme isoform and substrate-selective inhibitors. Additionally, current inhibitors can be used as probes of the biological activity of ADAM17 in various in vitro and, potentially, in vivo systems.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Synthesis Procedure for Pyrrolidine-bis-diketopiperazine</h3><div class="NLM_p">All compounds were synthesized via solid-phase methodology (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) on 4-methylbenzhydrylamine hydrochloride resin (MBHA) (1.1 mmol/g, 100â200 mesh) using the âtea-bagâ approach<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> as previously described elsewhere.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Boc-amino acids were coupled utilizing standard coupling procedures (6 equiv) with hydroxybenzotriazole hydrate (HOBt, 6 equiv) and <i>N</i>,<i>N</i>â²-diisopropylcarbodiimide (DIC, 6 equiv) in dimethylformamide (DMF, 0.1 M) for 120 min. Boc protecting groups were removed with 55% trifluoroacetic acid (TFA)/45% dichloromethane (DCM) (1Ã, 30 min) and subsequently neutralized with 5% diisopropylethylamine (DIEA)/95% DCM (3Ã, 2 min). Carboxylic acids (10 equiv) were coupled utilizing standard coupling procedures with HOBt (10 equiv) and DIC (10 equiv) in DMF (0.1 M) for 120 min. Completion of all couplings was monitored with a ninhydrin test. Compounds were reduced to polyamines (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) using a 40Ã excess of borane (1.0 M in tetrahydrofuran (THF)) over each amide bond in a glass vessel under nitrogen at 65 Â°C for 72 h. The solution was then poured off, the reaction was quenched with methanol (MeOH), and the bags were washed with THF (1Ã, 1 min) and MeOH (4Ã, 1 min) and allowed to air-dry. Once dry, the bags were treated with piperidine overnight at 65 Â°C in a glass vessel. The solution was poured off, and the bags were washed with DMF (2Ã, 1 min), DCM (2Ã, 1 min), MeOH (1Ã, 1 min), DMF (2Ã, 1 min), DCM (2Ã, 1 min), and MeOH (1Ã, 1 min) and allowed to air-dry. Completion of reduction was checked by cleaving a control sample and analyzing using LCMS. As previously reported by our group and others, the reduction of polyamides with borane is free of racemization (refs <a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">1â3</a>). Diketopiperazine cyclization (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) was performed under anhydrous conditions (<22% humidity). The dry bags were washed with anhydrous DMF (2Ã, 1 min), then added to a solution of 1,1â²-oxalyldiimidazole (5-fold excess for each cyclization site) in anhydrous DMF (0.1 M) and shaken at room temperature overnight. The solution was poured off, and the bags were rinsed with DMF (3Ã, 1 min) and DCM (3Ã, 1 min). Completion of cyclization was checked by cleaving a control sample and analyzing by LCMS. The compounds were then cleaved from the resin with hydrofluoric acid (HF) in the presence of anisole in an ice bath at 0 Â°C for 90 min (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and extracted using 95% acetic acid (AcOH)/5% H<sub>2</sub>O (2Ã, 5 mL). Final crude products were purified using HPLC as described below. All chirality was generated from the corresponding amino acids. Under the reaction conditions described, no epimerization was observed, and for those compounds with multiple chiral centers, a single diastereomer was obtained</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis Procedure for Leads of Pyrrollidine-bis-diketopiperazine Series Used in Present Studies</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Compound Purification and Characterization</h3><div class="NLM_p">The final compounds were purified using preparative HPLC with a dual pump Shimadzu LC-20AB system equipped with a Luna C18 preparative column (21.5 mm Ã 150 mm, 5 Î¼m) at Î» = 214 nm, with a mobile phase of (A) H<sub>2</sub>O (+0.1% formic acid)/(B) acetonitrile (ACN) (+0.1% formic acid) at a flow rate of 13 mL/min; gradients varied by compound based on hydrophobicity. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded in DMSO-<i>d</i><sub>6</sub> on a Bruker Ascend 400 MHz spectrometer at 400.14 and 100.62 MHz, respectively, and MALDI-TOF mass spectra were recorded using an Applied Biosystems Voyager DE-PRO Biospectrometry workstation. The purities of synthesized compounds were confirmed to be greater than 95% by liquid chromatography and mass spectrometry on a Shimadzu LCMS-2010 instrument with ESI Mass Spec and SPD-20A liquid chromatograph with a mobile phase of (A) H<sub>2</sub>O (+0.1% formic acid)/(B) ACN (+0.1% formic acid) (5â95% over 6 min with a 4 min rinse).</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>S</i>)-4-((4-(<i>tert</i>-Butyl)cyclohexyl)methyl)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-5-(4-hydroxybenzyl)piperazine-2,3-dione (<b>1</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>1</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and 4-(<i>tert</i>-butyl)cyclohexanecarboxylic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.5 (br s, 1 H) 7.6 (br s, 1 H) 7.0â7.1 (m, 1 H) 6.9 (br s, 1 H) 6.7 (br s, 1 H) 6.5 (br s, 1 H) 6.3 (br s, 1 H) 3.6 (d, <i>J</i> = 12.5 Hz, 1 H) 3.5 (br s, 1 H) 3.3 (br s, 19H) 3.2 (br s, 1 H) 2.9 (br s, 1 H) 2.7â2.8 (m, 1 H) 2.7 (br s, 13 H) 2.3 (br s, 4 H) 2.1 (br s, 1 H) 1.9 (br s, 1 H) 1.8 (br s, 1 H) 1.7 (br s, 1 H) 1.5 (br s, 1 H) 1.4 (d, <i>J</i> = 12.3 Hz, 1 H) 1.3 (br s, 1 H) 1.2 (br s, 1 H) 0.9 (br s, 1 H) 0.7â0.9 (m, 2 H). <i>m</i>/<i>z</i> calcd C<sub>43</sub>H<sub>61</sub>N<sub>5</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 744.46; found (MS ESI), 744.35. Purity LCMS: 95.5% (254 nm, peak height).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>S</i>)-4-((3<i>S</i>,5<i>S</i>,7<i>S</i>)-Adamantan-1-ylmethyl)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-5-(4-hydroxybenzyl)piperazine-2,3-dione (<b>2</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>2</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and 1-adamantanecarboxylic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.5 (br s, 1 H) 7.3 (d, <i>J</i> = <i>J</i> = 6.8 Hz, 1 H) 7.1 (br s, 1 H) 7.0 (br s, 1 H) 6.9 (br s, 1 H) 6.7 (br s, 1 H) 6.5 (br s, 1 H) 6.3 (br s, 1 H) 3.6 (br s, 3 H) 3.3 (br s, 18 H) 3.1 (br s, 2 H) 2.8 (d, <i>J</i> = 11.7 Hz, 2 H) 2.7 (br s, 9 H) 2.3 (br s, 5 H) 2.0 (br s, 1 H) 1.9 (br s, 1 H) 1.6 (br s, 1 H) 1.5 (br s, 2 H) 1.3 (br s, 1 H) 1.2 (br s, 1 H) 0.9 (br s, 1 H). <i>m</i>/<i>z</i> calcd C<sub>43</sub>H<sub>57</sub>N<sub>5</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 740.43; found (MS ESI), 740.40. Purity LCMS: 95.1% (254 nm, peak height).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>S</i>)-4-(Cyclohexylmethyl)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-5-(4-hydroxybenzyl)piperazine-2,3-dione (<b>3</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>3</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-Tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and cyclohexanecarboxylic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.4 (br s, 1 H) 7.6â7.7 (m, 2 H) 7.3 (d, <i>J</i> = 5.8 Hz, 1 H) 7.1 (br s, 1 H) 7.0 (br s, 1 H) 6.9 (br s, 1 H) 6.6 (br s, 1 H) 6.5 (br s, 1 H) 4.8 (br s, 1 H) 3.8 (br s, 2 H) 3.6 (br s, 3 H) 3.3 (br s, 13 H) 3.0 (br s, 3 H) 2.8 (d, <i>J</i> = 11.7 Hz, 2 H) 2.7 (br s, 6 H) 2.2â2.5 (m, 3 H) 2.0 (br s, 1 H) 1.8 (br s, 1 H) 1.7 (br s, 2 H) 1.5 (br s, 2 H) 1.2 (br s, 1 H) 1.1 (d, <i>J</i> = 16.9 Hz, 1 H) 0.9 (br s, 1 H) 0.8 (br s, 1 H). <i>m</i>/<i>z</i> calcd C<sub>39</sub>H<sub>53</sub>N<sub>5</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 688.40; found (MS ESI), 688.20. Purity LCMS: 96.1% (254 nm, peak height).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>S</i>)-4-(Cyclobutylmethyl)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-5-(4-hydroxybenzyl)piperazine-2,3-dione (<b>4</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>4</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and cyclobutanecarboxylic acid (R<sub>4</sub>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): 8.5(br s, 1 H) 6.9â7.0 (m, 5 H) 6.6â6.7 (m, 4 H) 3.6 (d, <i>J</i> = 12.47 Hz, 1 H) 3.3 (br s, 13 H) 2.8 (d, <i>J</i> = 10.86 Hz, 2 H) 2.7 (br s, 8 H) 2.3 (br s, 4 H) 1.9 (br s, 1 H) 1.8 (br s, 1 H) 1.7 (br s, 2 H) 1.6 (d, <i>J</i> = 11.30 Hz, 4 H) 1.3 (br s, 1 H) 1.2 (br s, 1 H) 0.9 (br s, 1 H). <i>m</i>/<i>z</i> calcd C<sub>37</sub>H<sub>49</sub>N<sub>5</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 660.37; found (MS ESI), 660.30. Purity LCMS: 97.3% (254 nm, peak height).</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (5<i>S</i>)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-Dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-5-(4-hydroxybenzyl)-4-(2-phenylbutyl)piperazine-2,3-dione (<b>5</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>5</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-Tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and 2-phenylbutanoic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.5 (br s, 1 H) 7.6 (br s, 1 H) 6.9 (br s, 1 H) 6.7â6.8 (m, 1 H) 6.5 (br s, 1 H) 6.3 (br s, 1 H) 3.3 (br s, 17 H) 2.8 (br s, 2 H) 2.7 (br s, 9 H) 2.3 (br s, 1 H) 2.1â2.2 (m, 1 H) 2.1 (br s, 1 H) 2.0 (br s, 1 H) 1.9 (br s, 1 H) 1.8 (br s, 1 H) 1.7 (br s, 2 H) 1.5 (br s, 2 H) 1.5â1.6 (m, 3 H) 1.3 (br s, 1 H) 1.2 (br s, 1 H) 0.9 (br s, 1 H) 0.7 (br s, 1 H). <i>m</i>/<i>z</i> calcd C<sub>44</sub>H<sub>59</sub>N<sub>5</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 724.40; found (MS ESI), 724.30. Purity LCMS: 97.0% (254 nm, peak height).</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-4-(2-((3<i>S</i>,5<i>S</i>,7<i>S</i>)-Adamantan-1-yl)ethyl)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-5-(4-hydroxybenzyl)piperazine-2,3-dione (<b>6</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>6</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.5 (br s, 1 H) 7.0 (br s, 1 H) 6.9 (br s, 1 H) 6.7 (br s, 1 H) 6.5 (br s, 1 H) 6.3 (br s, 1 H) 3.4 (br s, 22 H) 2.8 (br s, 2 H) 2.7 (br s, 14 H) 2.3 (br s, 3 H) 2.1 (br s, 1 H) 2.0 (br s, 1 H) 1.9 (br s, 1 H) 1.8 (br s, 1 H) 1.7 (br s, 1 H) 1.6 (br s, 1 H) 1.4 (br s, 1 H) 1.3 (br s, 1 H) 1.2 (br s, 1 H) 0.9 (br s, 1 H). <i>m</i>/<i>z</i> calcd C<sub>44</sub>H<sub>59</sub>N<sub>5</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 754.45; found, (MS ESI), 754.30. Purity LCMS: 99.3% (254 nm, peak height).</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-4-(Cyclopentylmethyl)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-5-(4-hydroxybenzyl)piperazine-2,3-dione (<b>7</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>7</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and cyclopentylcarboxylic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.4 (br s, 1 H) 7.00 (br s, 1 H) 6.9 (d, <i>J</i> = 6.28 Hz, 2 H) 6.7â6.8 (m, 1 H) 6.5 (br s, 1 H) 3.6 (br s, 3 H) 3.3 (br s, 25 H) 2.8 (br s, 2 H) 2.7 (br s, 13 H) 2.3 (br s, 3 H) 1.4â1.6 (m, 1 H) 1.3 (br s, 1 H) 1.2 (br s, 1 H) 0.9 (br s, 1 H). <i>m</i>/<i>z</i> calcd C<sub>38</sub>H<sub>51</sub>N<sub>5</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 674.38; found (MS ESI), 674.25. Purity LCMS: 95.8% (254 nm, peak height).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>R</i>)-4-(2-((3<i>R</i>,5<i>R</i>,7<i>R</i>)-Adamantan-1-yl)ethyl)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-5-(4-hydroxybenzyl)piperazine-2,3-dione (<b>8</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>8</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">d</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.4 (br s, 1 H) 7.3 (d, <i>J</i> = 5.8 Hz, 1 H) 6.9â7.0 (m, 1 H) 6.9 (br s, 1 H) 6.6â6.7 (m, 3 H) 6.5 (br s, 1 H) 3.8 (d, <i>J</i> = 10.64 Hz, 1 H) 3.5â3.7 (m, 3 H) 3.4â3.5 (m, 3 H) 3.3 (br s, 7 H) 3.1â3.3 (m, 3 H) 3.0 (br s, 2 H) 2.7â2.9 (m, 4 H) 2.3â2.5 (m, 2 H) 2.2 (d, <i>J</i> = 7.8 Hz, 1 H) 1.8â2.0 (m, 3 H) 1.8 (br s, 1 H) 1.7 (d, <i>J</i> = 11.74 Hz, 4 H) 1.8 (d, <i>J</i> = 11.00 Hz, 4 H) 1.4 (br s, 5 H) 1.3 (br s, 1 H) 1.1â1.3 (m, 2 H) 0.8â1.0 (m, 3 H). <i>m</i>/<i>z</i> calcd C<sub>44</sub>H<sub>59</sub>N<sub>5</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 754.45; found (MS ESI), 754.30. Purity LCMS: 96.3% (254 nm, peak height).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>S</i>)-4-(2-((3<i>S</i>,5<i>S</i>,7<i>S</i>)-Adamantan-1-yl)ethyl)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-5-(naphthalen-2-ylmethyl)piperazine-2,3-dione (<b>9</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>9</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-Ala(2-naphthyl)-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.4 (br s, 1 H) 7.8â8.0 (m, 2 H) 7.7 (br s, 1 H) 7.5 (br s, 1 H) 7.4 (br s, 1 H) 6.9 (d, <i>J</i> = 6.4 Hz, 2 H) 6.6 (d, <i>J</i> = 7.5 Hz, 2 H) 6.5 (br s, 1 H) 4.0 (br s, 1 H) 3.8 (d, <i>J</i> = 12.8 Hz, 1 H) 3.5 (d, <i>J</i> = 13.4 Hz, 4 H) 3.3 (br s, 6 H) 3.0â3.2 (m, 3 H) 2.9 (d, <i>J</i> = 14.1 Hz, 2 H) 2.8 (br s, 2 H) 2.7 (d, <i>J</i> = 12.8 Hz, 4 H) 2.2â2.5 (m, 3 H) 1.9 (br s, 1 H) 1.8 (br s, 3 H) 1.7â1.8 (m, 2 H) 1.6 (d, <i>J</i> = 11.9 Hz, 3 H) 1.4â1.5 (m, 4 H) 1.3 (br s, 4 H) 1.0â1.2 (m, 4 H) 0.7â1.0 (m, 2 H). <i>m</i>/<i>z</i> calcd C<sub>48</sub>H<sub>61</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 788.47; found (MS ESI), 788.30. Purity LCMS: 98.9% (254 nm, peak height).</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>R</i>)-4-(2-((3<i>R</i>,5<i>R</i>,7<i>R</i>)-Adamantan-1-yl)ethyl)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-5-(naphthalen-2-ylmethyl)piperazine-2,3-dione (<b>10</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>10</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">d</span>-Ala(2-naphthyl)-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.4 (br s, 1 H) 7.7â7.9 (m, 2 H) 7.6 (br s, 1 H) 7.5 (br s, 1 H) 7.3 (d, <i>J</i> = 5.75 Hz, 1 H) 7.0 (br s, 1 H) 6.7 (d, <i>J</i> = 7.0 Hz, 1 H) 3.9 (br s, 1 H) 3.8 (d, <i>J</i> = 9.0 Hz, 1 H) 3.6 (d, <i>J</i> = 14.9 Hz, 4 H) 3.4 (br s, 9 H) 3.2 (br s, 3 H) 3.0 (br s, 2 H) 2.9 (br s, 2 H) 2.8 (d, <i>J</i> = 11.9 Hz, 2 H) 2.7 (br s, 3 H) 2.4 (br s, 2 H) 2.2 (d, <i>J</i> = 6.7 Hz, 1 H) 2.1 (br s, 1 H) 1.9 (br s, 1 H) 1.8 (br s, 3 H) 1.7 (br s, 2 H) 1.5â1.6 (m, 3 H) 1.4â1.5 (m, 3 H) 1.3 (br s, 5 H) 1.2 (br s, 1 H) 1.1 (br s, 1 H) 0.9 (br s, 2 H). <i>m</i>/<i>z</i> calcd C<sub>48</sub>H<sub>61</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 788.47; found (MS ESI), 788.35. Purity LCMS: 98.3% (254 nm, peak height).</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>S</i>)-4-(2-((3<i>S</i>,5<i>S</i>,7<i>S</i>)-adamantan-1-yl)ethyl)-5-butyl-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)piperazine-2,3-dione (<b>11</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>11</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-Z)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-norleucine-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 9.2 (br s, 1 H) 8.4 (br s, 1 H) 6.9 (d, <i>J</i> = 7.3 Hz, 1 H) 6.6 (d, <i>J</i> = 7.3 Hz, 1 H) 3.1 (br s, 1 H) 3.8 (d, <i>J</i> = 12.8 Hz, 1 H) 3.5â3.7 (m, 3 H) 3.3 (br s, 12 H) 3.2 (d, <i>J</i> = 10.9 Hz, 1 H) 2.9 (d, <i>J</i> = 11.6 Hz, 2 H) 2.8 (br s, 1 H) 2.8 (br s, 1 H) 2.7 (br s, 3 H) 2.4 (br s, 1 H) 2.3 (d, <i>J</i> = 7.8 Hz, 1 H) 1.9 (br s, 3 H) 1.7â1.9 (m, 1 H) 1.5â1.7 (m, 6 H) 1.5 (br s, 6 H) 1.4 (br s, 5 H) 1.3 (br s, 6 H) 0.9 (d, <i>J</i> = 8.6 Hz, 2 H). <i>m</i>/<i>z</i> calcd C<sub>41</sub>H<sub>61</sub>N<sub>6</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 704.47; found (MS ESI), 704.35. Purity LCMS: 99.8% (254 nm, peak height).</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-4-(2-((3<i>S</i>,5<i>S</i>,7<i>S</i>)-Adamantan-1-yl)ethyl)-5-(4-hydroxybenzyl)-1-((<i>S</i>)-1-(4-hydroxyphenyl)-3-((<i>S</i>)-2-(((<i>R</i>)-6-(naphthalen-2-ylmethyl)-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)piperazine-2,3-dione (<b>12</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>12</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">d</span>-Ala(2-naphthyl)-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>).). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/30, 40/65. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.5 (br s, 1 H) 7.9â7.9 (m, 3 H) 7.6â7.7 (d, <i>J</i> = 6.5 Hz, 1 H) 7.5 (br s, 2 H) 7.0 (d, <i>J</i> = 7.4 Hz, 1 H) 6.9 (d, <i>J</i> = 7.3 Hz, 2 H) 6.6â6.7 (m, 1 H) 6.5 (br s, 1 H) 3.8 (br s, 4 H) 3.7 (br s, 1 H) 3.4 (br s, 19 H) 23.0 (d, <i>J</i> = 11.5 Hz, 3 H) 2.8 (br s, 2 H) 2.7 (br s, 8 H) 2.3 (br s, 2 H) 1.9 (br s, 1 H) 1.6 (br s, 1 H) 1.6 (br s, 1 H) 1.4 (br s, 1 H) 1.2 (br s, 2 H) 1.0 (br s, 2 H). <i>m</i>/<i>z</i> calcd C<sub>52</sub>H<sub>61</sub>N<sub>5</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 852.46; found (MS ESI), 852.25. Purity LCMS: 95.1% (254 nm, peak height).</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>R</i>)-4-(2-((3<i>R</i>,5<i>R</i>,7<i>R</i>)-Adamantan-1-yl)ethyl)-5-(4-hydroxybenzyl)-1-((<i>S</i>)-1-(4-hydroxyphenyl)-3-((<i>S</i>)-2-(((<i>R</i>)-6-(naphthalen-2-ylmethyl)-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)piperazine-2,3-dione (<b>13</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>13</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">d</span>-Ala(2-naphthyl)-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">d</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>).). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/30, 40/65. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.6 (br s, 1 H) 7.8â7.9 (m, 3 H) 7.6 (d, <i>J</i> = 7.6 Hz, 1 H) 7.6 (br s, 2 H) 7.0 (d, <i>J</i> = 7.5 Hz, 1 H) 6.9 (d, <i>J</i> = 7.3 Hz, 2 H) 6.5â6.7 (m, 3 H) 3.8 (br s, 1 H) 3.7 (br s, 1 H) 3.4â3.6 (m, 4 H) 3.2â3.4 (m, 3 H) 3.2 (br s, 2 H) 2.9â3.1 (m, 3 H) 2.8 (br s, 1 H) 2.5â2.7 (m, 5 H) 2.3â2.5 (m, 3 H) 2.2 (br s, 1 H) 2.4 (br s, 1 H) 1.9 (br s, 3 H) 1.6 (br s, 5 H) 1.6 (d, <i>J</i> = 11.0 Hz, 4 H) 1.4 (br s, 5 H) 1.3 (br s, 1 H) 1.2 (br s, 2 H) 1.0 (br s, 1 H). <i>m</i>/<i>z</i> calcd C<sub>52</sub>H<sub>61</sub>N<sub>5</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 852.46; found (MS ESI), 852.35. Purity LCMS: 96.6% (254 nm, peak height).</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-4-(2-((3<i>S</i>,5<i>S</i>,7<i>S</i>)-Adamantan-1-yl)ethyl)-1-((<i>S</i>)-1-(4-hydroxyphenyl)-3-((<i>S</i>)-2-(((<i>R</i>)-6-(naphthalen-2-ylmethyl)-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)-5-(naphthalen-2-ylmethyl)piperazine-2,3-dione (<b>14</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>14</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">d</span>-Ala(2-naphthyl)-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-Ala(2-naphthyl)-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>).). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/30, 40/65. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.0 (br s, 1 H) 7.9â8.1 (m, 2 H) 7.8 (d, <i>J</i> = 13.0 Hz, 1 H) 7.6â7.7 (m, 2 H) 7.5â7.6 (m, 2 H) 7.4â7.5 (m, 2 H) 7.4 (br s, 1 H) 6.9â7.1 (m, 1 H) 6.7â6.8 (m, 1 H) 6.6 (d, <i>J</i> = 7.5 Hz, 2 H) 4.1 (br s, 1 H) 3.4â3.7 (m, 5 H) 3.3 (br s, 8 H) 3.1â3.3 (m, 3 H) 3.0â3.1 (m, 2 H) 2.9 (br s, 1 H) 2.8 (br s, 1 H) 2.6 (br s, 4 H) 2.4 (d, <i>J</i> = 8.4 Hz, 2 H) 2.2 (br s, 1 H) 2.1 (d, <i>J</i> = 11.3 Hz, 1 H) 1.2 (br s, 1 H) 1.99 (br s, 2 H) 1.7â1.8 (m, 2 H) 1.6 (d, <i>J</i> = 11.4 Hz, 3 H) 1.5 (d, <i>J</i> = 11.1 Hz, 3 H) 1.3 (br s, 4 H) 1.3 (d, <i>J</i> = 14.6 Hz, 1 H) 1.2 (br s, 1 H). <i>m</i>/<i>z</i> calcd C<sub>56</sub>H<sub>63</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 886.48; found (MS ESI), 886.40. Purity LCMS: 99.8% (254 nm, peak height).</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>R</i>)-4-(2-((3<i>R</i>,5<i>R</i>,7<i>R</i>)-Adamantan-1-yl)ethyl)-1-((<i>S</i>)-1-(4-hydroxyphenyl)-3-((<i>S</i>)-2-(((<i>R</i>)-6-(naphthalen-2-ylmethyl)-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)-5-(naphthalen-2-ylmethyl)piperazine-2,3-dione (<b>15</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>15</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">d</span>-Ala(2-naphthyl)-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">d</span>-Ala(2-naphthyl)-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>).). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/30, 40/65. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ ppm 8.6 (br s, 1 H) 7.8â7.9 (m, 6 H) 7.5â7.6 (m, 2 H) 7.5 (br s, 2 H) 7.4 (br s, 1 H) 7.3 (d, <i>J</i> = 8.2 Hz, 1 H) 7.0 (d, <i>J</i> = 6.7 Hz, 2 H) 6.7 (d, <i>J</i> = 7.2 Hz, 2 H) 4.0 (br s, 1 H) 3.8 (br s, 1 H) 3.5â3.7 (m, 1 H) 3.5 (d, <i>J</i> = 12.0 Hz, 3 H) 3.3 (d, <i>J</i> = 12.2 Hz, 3 H) 3.2 (br s, 2 H) 2.8â3.1 (m, 3 H) 2.8 (br s, 3 H) 2.7 (br s, 2 H) 2.6 (d, <i>J</i> = 14.31 Hz, 3 H) 2.4â2.5 (m, 1 H) 2.1â2.4 (m, 1 H) 1.8 (br s, 3 H) 1.9 (br s, 1 H) 1.5â1.7 (m, 5 H) 1.4â1.5 (m, 5 H) 1.3 (br s, 5 H) 1.2 (d, <i>J</i> = 11.7 Hz, 1 H) 1.1 (br s, 1 H). <i>m</i>/<i>z</i> calcd C<sub>56</sub>H<sub>63</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 886.48; found (MS ESI), 886.30. Purity LCMS: 99.6% (254 nm, peak height).</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-4-(2-(Adamantan-1-yl)ethyl)-5-butyl-1-((<i>S</i>)-1-(4-hydroxyphenyl)-3-((<i>S</i>)-2-(((<i>R</i>)-6-(naphthalen-2-ylmethyl)-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)piperazine-2,3-dione (<b>16</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>16</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">d</span>-Ala(2-naphthyl)-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-Z)-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-norleucine-OH (R<sub>3</sub>), and 1-adamantaneacetic Acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/30, 40/65. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 8.56 (d, <i>J</i> = 5.01 Hz, 1 H) 7.8â8.0 (m, 3 H) 7.5â7.6 (m, 2 H) 7.0 (m, <i>J</i> = 8.1 Hz, 2 H) 6.6 (m, <i>J</i> = 8.1 Hz, 2 H) 3.8 (br s, 1 H) 3.6â3.8 (m, 3 H) 3.5 (d, <i>J</i> = 10.4 Hz, 3 H) 3.2â3.5 (m, 8 H) 2.9â3.2 (m, 4 H) 2.7â2.9 (m, 4 H) 2.7 (d, <i>J</i> = 6.5 Hz, 1 H) 2.6 (d, <i>J</i> = 11.6 Hz, 1 H) 2.2â2.5 (m, 2 H) 1.9â2.1 (m, 3 H) 1.5â1.8 (m, 10H) 1.5 (br s, 5 H) 1.3 (br s, 5 H) 0.9 (br s, 3 H) <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 158.3, 157.9, 1557.5, 156.4, 156.1, 135.7, 133.6, 132.4, 129.9, 128.7, 128.5, 128.3, 128.2, 127.9, 126.7, 126.2, 115.5, 56.1, 54.8, 53.7, 42.1, 41.5, 40.7, 40.5, 37.0, 34.7, 32.0, 30.8, 28.4, 23.4, 22.5, 14.3. <i>m</i>/<i>z</i> calcd C<sub>49</sub>H<sub>63</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 802.49; found (MS ESI), 802.3. Purity LCMS: 99% (254 nm, peak height)</div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (5<i>R</i>)-4-(2-((1<i>R</i>,3<i>R</i>)-Adamantan-1-yl)ethyl)-5-(4-hydroxybenzyl)-1-((2<i>R</i>)-1-(2-(((<i>R</i>)-6-(4-hydroxybenzyl)-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-(naphthalen-2-yl)propan-2-yl)piperazine-2,3-dione. (<b>17</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>17</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">d</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">d</span>-2-naphthylalanine-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">d</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 8.5 (br s, 2 H) 7.8â7.9 (m, 5 H) 7.4â7.5 (m, 5 H) 7.2 (d, <i>J</i> = 8.1 Hz, 2H) 7.0 (br s, 2H) 6.9 (d, <i>J</i> = 7.2 Hz, 4 H) 6.7 (d, <i>J</i> = 6.5 Hz, 7H) 3.9 (d, <i>J</i> = 13.6 Hz, 2 H) 3.8 (br s, 2 H) 3.7 (br s, 2 H) 3.5 (s, 3 H) 3.5 (s, 2 H) 3.4 (br s, 3 H) 3.3 (br s, 2 H) 3.2 (br s, 3 H) 3.0 (t, <i>J</i> = 14.6 Hz, 4 H) 2.9 (d, <i>J</i> = 13.1 Hz, 3 H) 2.7â2.9 (m, 7 H) 2.3â2.5 (m, 3 H) 2.3 (d, <i>J</i> = 8.19 Hz, 2 H) 1.8 (br s, 7 H) 1.6â1.8 (m 10 H) 1.4â1.6 (m, 6 H) 1.3 (br s, 10 H) 1.2 (br s, 2 H) 1.1 (br s, 2 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 158.4, 157.9, 157.1, 156.8, 156.4, 133.5, 132.2, 130.7, 130.4, 128.3, 127.9, 127.7, 127.7, 127.1, 126.5, 125.9, 116.0, 115.9, 64.2, 58.7, 56.3, 54.8, 53.6, 41.9, 41.1, 40.7, 40.5, 37.0, 35.9, 34.7, 31.8, 28.3, 27.8, 23.3. <i>m</i>/<i>z</i> calcd C<sub>44</sub>H<sub>65</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 744.51; found (MS ESI), 744.25. Purity LCMS: 98% (254 nm, peak height).</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>S</i>)-1((<i>R</i>)-1((<i>S</i>)-2-(((<i>S</i>)-6-Benzyl-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-cyclohexylpropan-2-yl)-5-(4-hydroxybenzyl)-4-phenethylpiperazine-2,3-dione (<b>18</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>18</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-phenylalanine-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">d</span>-cyclohexylalanine-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-<i>Z</i>)-OH (R<sub>3</sub>), and phenylacetic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 0.80â1.05 (m, 2 H) 1.08â1.20 (m, 3 H) 1.24 (br s, 2 H) 1.50â1.71 (m, 6 H) 1.78â1.96 (m, 2 H) 1.97â2.13 (m, 2 H) 2.55â2.65 (m, 2 H) 2.67â2.88 (m, 6 H) 2.90â3.04 (m, 3 H) 3.11 (d, <i>J</i> = 12.96 Hz, 1 H) 3.19â3.32 (m, 2 H) 3.37 (br s, 1 H) 3.52 (dd, <i>J</i> = 13.08, 3.30 Hz, 2 H) 3.65 (d, <i>J</i> = 10.03 Hz, 2 H) 3.70â3.94 (m, 2 H) 6.73 (m, <i>J</i> = 8.07 Hz, 2 H) 7.01 (m, <i>J</i> = 8.07 Hz, 2 H) 7.15â7.31 (m, 9 H) 8.50 (d, <i>J</i> = 5.01 Hz, 1 H) <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 22.74 (s, 1 C) 26.13 (s, 1 C) 26.30 (s, 1 C) 26.56 (s, 1 C) 29.54 (s, 1 C) 32.83 (s, 1 C) 33.55 (s, 1 C) 33.63 (s, 1 C) 34.51 (s, 1 C) 37.14 (s, 1 C) 37.51 (s, 1 C) 39.40 (s, 1 C) 39.61 (s, 1 C) 39.82 (s, 1 C) 40.03 (s, 1 C) 40.23 (s, 1 C) 40.45 (s, 1 C) 40.66 (s, 1 C) 48.41 (s, 1 C) 55.86 (s, 1 C) 58.51 (s, 1 C) 62.76 (s, 1 C) 115.89 (s, 1 C) 126.79 (s, 1 C) 127.11 (s, 1 C) 127.76 (s, 1 C) 128.81 (s, 1 C) 128.98 (s, 1 C) 129.13 (s, 1 C) 129.77 (s, 1 C) 130.35 (s, 1 C) 137.72 (s, 1 C) 139.29 (s, 1 C) 156.65 (s, 1 C) 156.72 (s, 1 C) 157.34 (s, 1 C) 157.80 (s, 1 C) 157.95 (s, 1 C). <i>m</i>/<i>z</i> calcd C<sub>44</sub>H<sub>55</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 734.42; found, 734.15 (MALDI), 734.15 (MS ESI) Purity LCMS: 99.0% (254 nm, peak height).</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>S</i>)-5-Benzyl-1-((<i>R</i>)-1-cyclohexyl-3-((<i>S</i>)-2-(((<i>S</i>)-2,3-dioxo-6-propylpiperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)-4-phenethylpiperazine-2,3-dione. (<b>19</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>19</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-norvaline-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">d</span>-cyclohexylalanine-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-phenylalanine-OH (R<sub>3</sub>), and phenylacetic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 8.4 (br s, 1 H) 7.3 (br s, 2 H) 7.3 (br s, 3 H) 7.2 (s, 2 H) 7.2 (s, 3 H) 3.7 (br s, 3 H) 3.4â3.7 (m, 2 H) 3.2 (d, <i>J</i> = 11.86 Hz, 2 H) 3.0 (br s, 1 H) 2.9 (br s, 1 H) 2.8 (br s, 1 H) 2.7 (br s, 3 H) 2.6 (br s, 2 H) 2.1 (br s, 2 H) 1.9 (br s, 2 H) 1.6 (br s, 5 H) 1.6 (br s, 4 H) 1.3 (br s, 4 H) 1.2 (br s, 4 H) 1.0 (br s, 1 H) 0.8â1.0 (m, 4 H) 0.8 (br s, 1 H) <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 158.0, 157.4, 156.8, 139.3, 137.9, 129.4, 129.1, 128.8, 127.2, 126.7, 62.9, 56.8, 55.6, 53.9, 51.2, 48.3, 41.0, 40.7, 38.0, 37.7, 34.5, 33.7, 33.6, 32.8, 29.6, 26.6, 26.3, 26.1, 22.9, 19.4, 14.2. <i>m</i>/<i>z</i> calcd C<sub>40</sub>H<sub>55</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 670.43; found (MS ESI), 670.20. Purity LCMS: 99% (254 nm, peak height).</div></div><div id="sec5_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)-4-(2-(Adamantan-1yl)ethyl)-1-((<i>S</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-6-benzyl-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-phenylpropan-2-yl)-5-(4-hydroxybenzyl)piperazine-2,3-dione (<b>20</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>20</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-phenylalanine-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-phenylalanine-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine(2-Br-Z)-OH (R<sub>3</sub>), and 1-adamantaneacetic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/30, 40/65. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 8.54 (d, <i>J</i> = 5.13 Hz, 1 H) 7.09â7.34 (m, 6 H) 7.02 (d, <i>J</i> = 6.97 Hz, 3 H) 6.76 (d, <i>J</i> = 8.07 Hz, 2 H) 3.88 (d, <i>J</i> = 10.51 Hz, 1 H) 3.66â3.83 (m, 2 H) 3.42â3.63 (m, 4 H) 3.29â3.42 (m, 7 H) 3.22 (d, <i>J</i> = 12.10 Hz, 2 H) 3.12 (br s, 1 H) 2.75â3.02 (m, 6 H) 2.61 (br s, 2 H) 2.38 (d, <i>J</i> = 7.46 Hz, 2 H) 2.25 (q, <i>J</i> = 8.15 Hz, 1 H) 1.86â2.02 (m, 3 H) 1.74â1.86 (m, 1 H) 1.61â1.73 (m, 4 H) 1.48â1.60 (m, 3 H) 1.38 (br s, 5 H) 1.06â1.32 (m, 2 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 176.94 (s, 1 C) 176.50 (s, 1 C) 174.17 (s, 1 C) 165.03 (s, 1 C) 158.36 (s, 1 C) 157.84 (s, 1 C) 156.77 (s, 1 C) 156.40 (s, 1 C) 144.44 (s, 1 C) 138.69 (s, 1 C) 137.91 (s, 1 C) 137.20 (s, 1 C) 130.46 (s, 1 C) 129.78 (s, 1 C) 129.08 (s, 1 C) 128.79 (s, 1 C) 128.72 (s, 1 C) 127.73 (s, 1 C) 127.20 (s, 1 C) 126.74 (s, 1 C) 115.97 (s, 1 C) 114.23 (s, 1 C) 63.97 (s, 1 C) 58.48 (s, 1 C) 56.35 (s, 1 C) 54.85 (s, 1 C) 41.96 (s, 1 C) 41.13 (s, 1 C) 40.66 (s, 1 C) 40.45 (s, 1 C) 40.23 (s, 1 C) 40.03 (s, 1 C) 39.82 (s, 1 C) 39.61 (s, 1 C) 39.40 (s, 1 C) 36.98 (s, 1 C) 36.89 (s, 1 C) 31.86 (s, 1 C) 28.37 (s, 1 C) 23.36 (s, 1 C). <i>m</i>/<i>z</i> calcd C<sub>48</sub>H<sub>59</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 786.46; found, 787.0037 (MALDI), 786.15 (MS ESI). Purity LCMS: 98.0% (254 nm, peak height).</div></div><div id="sec5_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>S</i>)-5-Benzyl-1-((<i>R</i>)-1-((<i>S</i>)-2-(((<i>S</i>)-6-benzyl-2,3-dioxopiperazin-1-yl)methyl)pyrrolidin-1-yl)-3-cyclohexylpropan-2-yl)-4-phenethylpiperazine-2,3-dione (<b>21</b>)</h4><div class="NLM_p last">Using general scheme (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) for the synthesis of bis-cyclic diketopiperazines, compound <b>21</b> was synthesized using the following reagents: Boc-<span class="smallcaps smallerCapital">l</span>-phenylalanine-OH (R<sub>1</sub>), Boc-<span class="smallcaps smallerCapital">d</span>-cyclohexylalanine-OH (R<sub>2</sub>), Boc-<span class="smallcaps smallerCapital">l</span>-phenylalanine-OH (R<sub>3</sub>), and phenylacetic acid (R<sub>4</sub>). The final crude product was purified using HPLC as described above, with a gradient of (B) 0/5, 2/5, 4/20, 40/55. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 8.5 (br s, 2 H) 7.4 (d, <i>J</i> = 7.1 Hz, 4 H) 7.2â7.3 (m, 17 H) 7.2 (d, <i>J</i> = 7.2 Hz, 6 H) 3.7â3.9 (m, 5 H) 3.7 (d, <i>J</i> = 9.4 Hz, 2 H) 3.5 (d, <i>J</i> = 12.7 Hz, 3 H) 3.3 (d, <i>J</i> = 12.6 Hz, 4 H) 3.1 (d, <i>J</i> = 12.8 Hz, 2 H) 2.9â3.0 (m, 7 H) 2.7â2.9 (m, 11 H) 2.6 (br s, 4 H) 2.0â2.2 (m, 4 H) 1.9 (d, <i>J</i> = 11.74 Hz, 4 H) 1.5â1.7 (m, 12 H) 1.2 (br s, 5 H) 1.2 (br s, 6 H) 0.8â1.1 (m, 4 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 158.0, 157.8, 157.3, 156.8, 139.2, 137.9, 137.7, 129.8, 129.4, 129.1, 129.0, 128.8, 127.3, 127.1, 126.8, 62.8, 58.5, 55.6, 53.8, 51.2, 48.4, 40.7, 40.5, 37.9, 37.8, 37.5, 34.5, 33.6, 33.5, 32.8, 29.6, 26.6, 26.3, 26.1, 22.8; <i>m</i>/<i>z</i> calcd C<sub>44</sub>H<sub>55</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 718.43; found (MS ESI), 718.20. Purity LCMS: 98.0% (254 nm, peak height).</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> SAR Studies</h3><div class="NLM_p last">Test compounds<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(-57, 58)</a> were solubilized in 3% DMSO/H<sub>2</sub>O and added to polypropylene 384-well plates (Greiner catalogue no. 781280). ADAM10 and 17 glycosylated substrate assays followed the same general protocol. Then 5 Î¼L of 3Ã enzyme solution (30 nM) in assay buffer (10 mM Hepes, 0.001% Brij-35, pH 7.5) were added to solid bottom white 384 low volume plates (Nunc catalogue no. 264706). Test compounds and pharmacological assay control were prepared as 10-point, 1:3 serial dilutions starting at 300 Î¼M, then added to the cells (5 Î¼L per well) using the Biomek NX<sup>P</sup>. After 30 min incubation at RT the reactions were started by addition of 5 Î¼L of 3Ã solutions of substrate (30 Î¼M). Fluorescence was measured every 30 min for 2 h using the multimode microplate reader Synergy H4 (Biotek Instruments, Winooski, VT) using Î»<sub>excitation</sub> = 360 nm and Î»<sub>emission</sub> = 460 nm. Rates of hydrolysis were obtained from plots of fluorescence versus time, and inhibition was calculated using rates obtained from wells containing substrates only (100% inhibition) and substrates with enzyme (0% inhibition). Three parameters were calculated on a per-plate basis, (a) the signal-to-background ratio (S/B), (b) the coefficient for variation [CV; CV = (standard deviation/mean) Ã 100)] for all compound test wells, and (c) the <i>Z</i>â²-factor.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The IC<sub>50</sub> value of the pharmacological control ((<i>N</i>-hydroxy-1-(4-methoxyphenyl)sulfonyl-4-(4-biphenylcarbonyl)piperazine-2-carboxamide, Calbiochem catalogue no. 444252) was also calculated to ascertain the assay robustness.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> MMP assays</h3><div class="NLM_p last">MMP assays followed the same general protocol. First 5 Î¼L of 3Ãenzyme solution (3 nM for MMP-8 and -14, 6 nM for MMP-2 and -9) in TCB assay buffer (50 mM Tricine, 50 mM NaCl, 10 mM CaCl<sub>2</sub>, 0.005% Brij-35, pH 7.5) were added to solid bottom white 384 low volume plates (Nunc catalogue no. 264706). Test compounds and pharmacological assay control (marimastat) were prepared as 10-point, 1:3 serial dilutions starting at 300 Î¼M, then added to the cells (5 Î¼L per well) using the Biomek NX<sup>P</sup>. After 30 min incubation at RT, the reactions were started by addition of 5 Î¼L of 3Ã solutions of Mca-KLPGL-Dnp-AR substrate (30 Î¼M, R&D Systems catalogue no. ES010). Fluorescence was measured after 1 h incubation at RT using the multimode microplate reader Synergy H4 (Biotek Instruments, Winooski, VT) using Î»<sub>excitation</sub> = 324 nm and Î»<sub>emission</sub> = 393 nm. Inhibition was calculated using RFU values obtained from wells containing substrate only (100% inhibition) and substrates with enzyme (0% inhibition). Three parameters were calculated on a per-plate basis: (a) the signal-to-background ratio (S/B), (b) the coefficient for variation [CV; CV = (standard deviation/mean) Ã 100)] for all compound test wells, and (c) the <i>Z</i>â²-factor.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The IC<sub>50</sub> value of the pharmacological control marimastat ((2<i>S</i>,3<i>R</i>)-<i>N</i>4-[(1<i>S</i>)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-<i>N</i>1,2-dihydroxy-3-(2-methylpropyl)butanediamide, Tocris catalogue no. 2631) was also calculated to ascertain the assay robustness.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> CellTiter Glo Cell Viability Assay</h3><div class="NLM_p last">Compounds were solubilized in 3% DMSO/H<sub>2</sub>O and added to polypropylene 384-well plates (Greiner catalogue no. 781280). Then 1250 of CHO-K1, HEPG2, MDA-MB-438, M14, or A549 cells were plated in 384-well plates in 5 Î¼L of serum-free media (EMEM for HEPG2, DMEM/F12 for MDA-MB-438, F12 for CHO-K1 and A549). Test compounds and gefitinib (pharmacological assay control) were prepared as 10-point, 1:3 serial dilutions starting at 300 Î¼M, then added to the cells (5 Î¼L per well) using the Biomek NX<sup>P</sup>. Plates were incubated for 72 h at 37 Â°C, 5% CO<sub>2</sub>, and 95% RH. After incubation, 5 Î¼L of CellTiter-Glo (Promega catalogue no. G7570) were added to each well and incubated for 15 min at room temperature. Luminescence was recorded using a Biotek Synergy H4 multimode microplate reader. Viability was expressed as a percentage relative to wells containing cells treated with 100 Î¼M gefitinib (0%) and wells containing cells treated with 1% DMSO only (100%). Three parameters were calculated on a per-plate basis: (a) the signal-to-background ratio (S/B), (b) the coefficient for variation [CV; CV = (standard deviation/mean) Ã 100)] for all compound test wells, and (c) the <i>Z</i>â²-factor (18). The IC<sub>50</sub> value of the pharmacological control (gefitinib, LC Laboratories no. G-4408) was also calculated to ascertain the assay robustness.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Synergy Studies</h3><div class="NLM_p last">First, 1250 of A549 cells were plated in 384-well plates in 5 Î¼L of serum-free F12 media. Next, compound <b>17</b> was added in 5 Î¼L of serum-free F12 media such that its final concentration in the assay was 40 Î¼M and incubated for 1 h at 37 Â°C, 5% CO<sub>2</sub> and 95% RH. Gefitinib, etoposide, and doxorubicin were prepared as 10-point, 1:3 serial dilutions starting at 300 Î¼M, then added to the cells (5 Î¼L per well) using the Biomek NX<sup>P</sup>. Plates were incubated for 72 h at 37 Â°C, 5% CO<sub>2</sub> and 95% RH. After incubation, 5 Î¼L of CellTiter-Glo (Promega catalogue no. G7570) were added to each well and incubated for 15 min at room temperature. Luminescence was recorded using a Biotek Synergy H4 multimode microplate reader. Viability was expressed as a percentage relative to wells containing cells treated with 100 Î¼M gefitinib (0%) and wells containing cells treated with 1% DMSO only (100%). Three parameters were calculated on a per-plate basis: (a) the signal-to-background ratio (S/B), (b) the coefficient for variation [CV; CV = (standard deviation/mean) Ã 100)] for all compound test wells, and (c) the <i>Z</i>â²-factor (18). The IC<sub>50</sub> value of the pharmacological control (gefitinib, LC Laboratories no. G-4408) was also calculated to ascertain the assay robustness.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Inhibition of TNFÎ± Shedding</h3><div class="NLM_p last">THP-1 cells were cultured in RPMI 1640 (ATCC) medium supplemented with 10% fetal bovine serum (FBS, Thermo Scientific HyClone, Logan, UT, USA), 50 U/mL penicillin, and 50 Î¼g/mL streptomycin (Invitrogen, CA), and 0.05 mM 2-mercaptoethanol (Invitrogen). The cell cultures were maintained in a 37 Â°C incubator with 5% CO<sub>2</sub> and under a humidified atmosphere. Protocol described in<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> was followed. Briefly, THP-1 cells were dispensed at 3000 cells/4 Î¼L/well in 384-well white solid bottom plates, followed by an addition of 4 Î¼L compound in 3% DMSO solution or 3% DMSO only. After 1 h incubation, 1 Î¼L LPS in assay medium at 5 Î¼g/mL LPS (final concentration of 1 Î¼g/mL) was dispensed into the assay plates and plates were incubated overnight at 37 Â°C with 5% CO<sub>2</sub> and under a humidified atmosphere. 1.5 Î¼L of the mixture containing acceptor beads conjugated with anti-TNFÎ± antibody was added into each well The assay plates were incubated in the dark at RT for 1 h, followed by the addition of 1.5 Î¼L of donor bead coated with streptavidin which captures the biotinylated anti-TNFÎ± antibody. After the assay plates were incubated in the dark at RT for another 1 h, the assay plates were read in the AlphaScreen mode using Biotek Synergy H4 multimode microplate reader (Biotek Inc., VT).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Inhibition of DDR1 Shedding</h3><div class="NLM_p last">Briefly, HCC1806 cells, seeded in 6-well plates, were treated overnight without (control) or with various concentrations of inhibitor <b>17</b> in serum-free media. Then 400 Î¼L/well of conditioned media was collected, TCA precipitated, and the resultant pellets were resolved by reducing 12% SDS-PAGE gel followed by immunoblot analyses. The blot was probed with N-terminal DDR1 antibody (R&D Systems no. AF2396).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Inhibition of PTK7 Shedding</h3><div class="NLM_p last">Cells were grown to reach a 60â90% confluence in wells of a 12-well tissue culture plate (BD Biosciences). Cells were washed with and then transferred to fresh serum-free DMEM (0.5 mL/well). PMA (50 ng/mL) and the inhibitors were added to the cells at the indicated concentrations, and incubation was continued for an additional 16 h. The medium aliquots were then withdrawn and centrifuged to remove cell debris. The supernatant was concentrated until dryness using a Speed-Vac. To remove salt, the pellet was washed using acetone, dissolved in 1% SDS, and centrifuged to remove insoluble material (14000<i>g</i>, 10 min). The supernatant aliquots were separated by SDS-gel electrophoresis in 4â12% NuPAGE gels (Invitrogen). The shed PTK7 was detected by Western blotting with a goat polyclonal PTK7 antibody.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Western Blot Densitometry</h3><div class="NLM_p">The immunoblots were scanned and digitized. Pixel density of the protein bands was quantified using the ImageJ software. Inhibition of shedding (%) with compound was calculated.</div><div class="NLM_p last">Inhibition is demonstrated as a percentage relative to the density of protein bands of untreated samples containing no compound (0%) and the density of background intensity (no protein band, complete inhibition, 100%).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Inhibition of Shedding of Cytokines</h3><div class="NLM_p last">Tracheal smooth muscle cells (HTSMC, Promocell no. C-12565) were grown to 70% confluency in 24 well-plates. Cells were starved with growth factor free medium (smooth muscle cell basal medium, C-22262, PromoCell, Germany) supplemented with 0.5% FBS and 1% penicillin/streptavidin 24 h before stimulation. Cells were washed twice to remove growth factors and preincubated with 10 Î¼m inhibitor or DMSO (0.1%) or 10 Î¼M of GI254023X<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> as inhibition control for 30 min. Supernatant was removed, and cells were washed once and then stimulated with or without 100 ng/mL LPS or 10 ng/mL of IL-1 in the absence or presence of inhibitors. Release of cytokines was measured 4 and 24 h after stimulation using ELISA kits for IL-8, FKN, and CXCL16 (R&D Systems, D8000C, DX310, and DCX160, respectively).Percent inhibition was calculated as a percentage relative to the untreated control samples containing no compound (0%).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Inhibition of Heregulin Shedding</h3><div class="NLM_p last">Briefly, A549 cells were cultured in T175 flasks in F12K media supplemented by 10% FBS. For assay, cells were passaged and seeded at 5 Ã 10<sup>6</sup> A549 cells in T175 flasks in 20 mL of serum-free F12K media. All test and control inhibitors were added and incubated for 1 h, after which PMA was added at 500 ng/mL final concentration to stimulate heregulin shedding. All leads were tested at 40 Î¼M, and marimastat was tested at 5 Î¼M. A549 cells were incubated with PMA for 1 h, after which supernatant was collected and concentrated using Amicon Ultra-15. Cells were harvested and lysed using mammalian protein extraction buffer (GE Healthcare no. 28-9412-79). Protein concentration was determined in both supernatants and lysates using NanoDrop (ThermoFisher), and all samples were run on SDS-PAGE using recombinant Heregulin (R&D Systems no. 5898-NR) as a control. Gels were transferred and probed by Heregulin mAb (R&D Systems no. MAB377). Lysates were probed for actin to control for protein concentration.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Inhibition of TGFÎ± and Betacellulin Shedding</h3><div class="NLM_p last">A549 cells were cultured in T175 flasks in F12K media supplemented by 10% FBS. For assay, cells were passaged and seeded at 1.3 Ã 10<sup>4</sup> in 24-well plates in serum-free F12K media. All test and control inhibitors were added and incubated for 1 h, after which PMA was added at 500 ng/mL final concentration to stimulate TGFÎ± shedding. In the case of betacellulin, PMA was not added because betacellulin is cleaved constitutively. All leads were tested at 40 Î¼M, and marimastat was tested at 10 Î¼M. A549 cells were incubated with PMA for 1 h, after which supernatant was collected and concentrated using Amicons. TGFÎ± and betacellulin were detected in supernatant by ELISA (R&D Systems catalogue nos. DTGA00 and DY261, respectively).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Invasion Studies</h3><div class="NLM_p last">Invasion assay protocol has been extensively published.<a onclick="showRef(event, 'ref35 ref36 ref62'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref62">(35, 36, 62)</a> Briefly, we used 6.5 mm, 24-well Transwell plates with the 8 Î¼m pore size membranes. The membrane was coated with Matrigel. Cells (1 Ã 10<sup>5</sup>/well) were seeded in the serum-free media (0.1 mL) into the upper chamber. The 10% serum-containing media (0.6 mL) was added to the lower chamber as a chemoattractant. Serum-free media in both upper and lower chambers was used as a negative control. Compound <b>17</b> was added to both chambers. Cells were allowed to invade for 5â24 h. The cells on the upper membrane surface were removed with a cotton swab. The cells that migrated onto the membraneâs lower surface were stained for 10 min using 0.2% crystal violet in 20% methanol/water solution (0.3 mL). The dye was extracted using 1% SDS (0.25 mL). The OD<sub>570Â nm</sub> values were measured using a plate reader.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Statistics</h3><div class="NLM_p last">One-way analysis of variance (ANOVA) was used followed by Dunnett posthoc test.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00354">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Molecular formula strings (CSV). The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00354" class="ext-link">10.1021/acs.jmedchem.5b00354</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00354/suppl_file/jm5b00354_si_001.csv">jm5b00354_si_001.csv (2.67 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00354" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84633" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84633" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dmitriy Minond</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a0c4cdc9cecfcec4e0d4d0c9cdd38ecfd2c7"><span class="__cf_email__" data-cfemail="a0c4cdc9cecfcec4e0d4d0c9cdd38ecfd2c7">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna M. Knapinska</span> - <span class="hlFld-Affiliation affiliation">Florida
Atlantic University, 5353 Parkside Drive, Jupiter, Florida 33458, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Dreymuller</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacology and Toxicology, RWTH Aachen
University, Wendlingweg
2, 52074 Aachen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Ludwig</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacology and Toxicology, RWTH Aachen
University, Wendlingweg
2, 52074 Aachen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lyndsay Smith</span> - <span class="hlFld-Affiliation affiliation">Florida
Atlantic University, 5353 Parkside Drive, Jupiter, Florida 33458, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vladislav Golubkov</span> - <span class="hlFld-Affiliation affiliation">Sanford-Burnham
Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anjum Sohail</span> - <span class="hlFld-Affiliation affiliation">Wayne
State University, 8200
Scott Hall, 540 East Canfield Avenue, Detroit, Michigan 48201, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rafael Fridman</span> - <span class="hlFld-Affiliation affiliation">Wayne
State University, 8200
Scott Hall, 540 East Canfield Avenue, Detroit, Michigan 48201, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Giulianotti</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Center for Drug Discovery and Innovation, University of South Florida, Tampa, Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Travis M. LaVoi</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard A. Houghten</span> - <span class="hlFld-Affiliation affiliation">Torrey
Pines Institute for Molecular Studies, 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregg B. Fields</span> - <span class="hlFld-Affiliation affiliation">Florida
Atlantic University, 5353 Parkside Drive, Jupiter, Florida 33458, United
States</span>;Â 
    <span class="hlFld-Affiliation affiliation">The Scripps
Research Institute/Scripps Florida, 130 Scripps Way, Jupiter, Florida 33458, United
States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written by D.M. and edited by G.B.F. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2279e4212-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the James and Esther King Biomedical Research Program (2KN05 to D.M.), the National Institutes of Health (DA033985-01 to D.M., CA098799 to G.B.F., and DA031370 to R.A.H.), and by the State of Florida, Executive Office of the Governorâs Office of Tourism, Trade, and Economic Development. We thank Angela Morales for her technical help.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> Abbreviations Used</h2><tr><td class="NLM_term">ADAM</td><td class="NLM_def"><p class="first last">a disintegrin and metalloprotease</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloprotease</p></td></tr><tr><td class="NLM_term">TACE</td><td class="NLM_def"><p class="first last">TNFÎ± converting enzyme</p></td></tr><tr><td class="NLM_term">DDR1</td><td class="NLM_def"><p class="first last">discoidin domain receptor 1</p></td></tr><tr><td class="NLM_term">PTK7</td><td class="NLM_def"><p class="first last">protein tyrosine kinase 7</p></td></tr><tr><td class="NLM_term">PMA</td><td class="NLM_def"><p class="first last">phorbol myristoic acid</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 63 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Edwards, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handsley, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, C. J.</span><span> </span><span class="NLM_article-title"><i>The ADAM metalloproteinases</i></span> <span class="citation_source-journal">Mol. Aspects Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">258</span><span class="NLM_x">â</span> <span class="NLM_lpage">89</span><span class="refDoi">Â DOI: 10.1016/j.mam.2008.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.mam.2008.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=18762209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ShsLnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=258-89&issue=5&author=D.+R.+Edwardsauthor=M.+M.+Handsleyauthor=C.+J.+Pennington&title=The+ADAM+metalloproteinases&doi=10.1016%2Fj.mam.2008.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The ADAM metalloproteinases</span></div><div class="casAuthors">Edwards, Dylan R.; Handsley, Madeleine M.; Pennington, Caroline J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">258-289</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ADAMs (a disintegrin and metalloproteinase) are a fascinating family of transmembrane and secreted proteins with important roles in regulating cell phenotype via their effects on cell adhesion, migration, proteolysis and signalling.  Though all ADAMs contain metalloproteinase domains, in humans only 13 of the 21 genes in the family encode functional proteases, indicating that at least for the other eight members, protein-protein interactions are crit. aspects of their biol. functions.  The functional ADAM metalloproteinases are involved in "ectodomain shedding" of diverse growth factors, cytokines, receptors and adhesion mols.  The archetypal activity is shown by ADAM-17 (tumor necrosis factor-Î± convertase, TACE), which is the principal protease involved in the activation of pro-TNF-Î±, but whose sheddase functions cover a broad range of cell surface mols.  In particular, ADAM-17 is required for generation of the active forms of Epidermal Growth Factor Receptor (EGFR) ligands, and its function is essential for the development of epithelial tissues.  Several other ADAMs have important sheddase functions in particular tissue contexts.  Another major family member, ADAM-10, is a principal player in signalling via the Notch and Eph/ephrin pathways.  For a growing no. of substrates, foremost among them being Notch, cleavage by ADAM sheddases is essential for their subsequent "regulated intramembrane proteolysis" (RIP), which generates cleaved intracellular domains that translocate to the nucleus and regulate gene transcription.  Several ADAMs play roles in spermatogenesis and sperm function, potentially by effecting maturation of sperm and their adhesion and migration in the uterus.  Other non-catalytic ADAMs function in the CNS via effects on guidance mechanisms.  The ADAM family are thus fundamental to many control processes in development and homeostasis, and unsurprisingly they are also linked to pathol. states when their functions are dysregulated, including cancer, cardiovascular disease, asthma, Alzheimer's disease.  This review will provide an overview of current knowledge of the human ADAMs, discussing their structure, function, regulation and disease involvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5y6VHfdnkV7Vg90H21EOLACvtfcHk0lgDTPhf7IcSKA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ShsLnM&md5=f2a2ba7a28bfeedd908526c5e0fb20ac</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2008.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2008.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DD.%2BR.%26aulast%3DHandsley%26aufirst%3DM.%2BM.%26aulast%3DPennington%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520ADAM%2520metalloproteinases%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2008%26volume%3D29%26issue%3D5%26spage%3D258%26epage%3D89%26doi%3D10.1016%2Fj.mam.2008.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Moss, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sklair-Tavron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, R.</span><span> </span><span class="NLM_article-title"><i>Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis</i></span> <span class="citation_source-journal">Nat. Clin. Pract. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">300</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1038/ncprheum0797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2Fncprheum0797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=18414459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFyktrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=300-9&issue=6&author=M.+L.+Mossauthor=L.+Sklair-Tavronauthor=R.+Nudelman&title=Drug+insight%3A+tumor+necrosis+factor-converting+enzyme+as+a+pharmaceutical+target+for+rheumatoid+arthritis&doi=10.1038%2Fncprheum0797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis</span></div><div class="casAuthors">Moss, Marcia L.; Sklair-Tavron, Liora; Nudelman, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Rheumatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">300-309</span>CODEN:
                <span class="NLM_cas:coden">NCPRCF</span>;
        ISSN:<span class="NLM_cas:issn">1745-8382</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Drugs that inhibit tumor necrosis factor (TNF) provide considerable benefit in treatment of rheumatoid arthritis (RA); however, there is an unmet medical need for alternative therapies with higher clin. benefit and lower safety risk and cost.  The potential to treat RA by targeting TNF-converting enzyme, which promotes the release of sol. TNF from its membrane-bound precursor, is outlined in this Review.  The success of agents that inhibit tumor necrosis factor (TNF), such as infliximab, adalimumab and etanercept, has led to a desire for orally available small mols. that have a better safety profile and are less costly to produce than current agents.  One target for anti-TNF therapy that is currently under investigation is TNF-converting enzyme, which promotes the release of sol. TNF from its membrane-bound precursor.  Inhibitors of this enzyme with drug-like properties have been made and tested in the clinic.  These inhibitors include TMI-005 and BMS-561392, both of which have entered into phase II clin. trials.  This article summarizes preclin. and clin. findings regarding the use of inhibitors of TNF-converting enzyme for the treatment of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSuKdTCwfevLVg90H21EOLACvtfcHk0liCtNI6egpMyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFyktrg%253D&md5=010f075b0cfb6379a47a5aabbcc2ac0b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fncprheum0797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncprheum0797%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DM.%2BL.%26aulast%3DSklair-Tavron%26aufirst%3DL.%26aulast%3DNudelman%26aufirst%3DR.%26atitle%3DDrug%2520insight%253A%2520tumor%2520necrosis%2520factor-converting%2520enzyme%2520as%2520a%2520pharmaceutical%2520target%2520for%2520rheumatoid%2520arthritis%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Rheumatol.%26date%3D2008%26volume%3D4%26issue%3D6%26spage%3D300%26epage%3D9%26doi%3D10.1038%2Fncprheum0797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kataoka, H.</span><span> </span><span class="NLM_article-title"><i>EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments</i></span> <span class="citation_source-journal">J. Dermatol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">148</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span><span class="refDoi">Â DOI: 10.1016/j.jdermsci.2009.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.jdermsci.2009.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=19896805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlt77L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2009&pages=148-53&issue=3&author=H.+Kataoka&title=EGFR+ligands+and+their+signaling+scissors%2C+ADAMs%2C+as+new+molecular+targets+for+anticancer+treatments&doi=10.1016%2Fj.jdermsci.2009.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments</span></div><div class="casAuthors">Kataoka, Hiromi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-153</span>CODEN:
                <span class="NLM_cas:coden">JDSCEI</span>;
        ISSN:<span class="NLM_cas:issn">0923-1811</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Members of the human epidermal growth factor receptor (HER) family of receptor tyrosine kinases and their ligands (EGFR ligands) are known to play crucial roles in the regulation of cell proliferation and differentiation, and in the survival of many types of cancer.  HER family members are activated in cancer cells and are now considered to be useful mol. targets for cancer therapy.  Recently, several new drugs, including monoclonal antibodies and small-mol. inhibitors that target HER members, have been developed and clin. used to treat solid tumors.  Members of a disintegrin and metalloproteinase (ADAM) family are thought to mediate the shedding of EGFR ligands and this event is crit. for the prodn. of sol. functional EGFR ligands.  In melanoma cells, UV irradn. activates some ADAM members and induces melanoma cell growth through EGFR ligand shedding by activated ADAMs.  These findings suggest that ADAM inhibitors are also candidate anticancer drugs acting via the blockade of HER family signaling pathways.  After shedding of EGFR ligands by ADAMs, the carboxy-terminal fragments (CTFs) of EGFR ligands in the cytoplasm are translocated to the nucleus and induce cell proliferation by binding and exporting repressors and activating cyclin A and c-Myc.  Based on these findings, the present mol. targeting therapy against HER members, EGFR and HER2, may not be sufficient, while ADAMs and nuclear translocation of the CTF of EGFR ligands are potential targets for the treatment of cancer, particularly malignancies that are dependent on the EGF family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7c8NW9kenQLVg90H21EOLACvtfcHk0liCtNI6egpMyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlt77L&md5=7a2fc57ff061bac8416e7c1087817d01</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jdermsci.2009.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdermsci.2009.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DKataoka%26aufirst%3DH.%26atitle%3DEGFR%2520ligands%2520and%2520their%2520signaling%2520scissors%252C%2520ADAMs%252C%2520as%2520new%2520molecular%2520targets%2520for%2520anticancer%2520treatments%26jtitle%3DJ.%2520Dermatol.%2520Sci.%26date%3D2009%26volume%3D56%26issue%3D3%26spage%3D148%26epage%3D53%26doi%3D10.1016%2Fj.jdermsci.2009.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Asai, M.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase</i></span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">231</span><span class="NLM_x">â</span> <span class="NLM_lpage">5</span><span class="refDoi">Â DOI: 10.1016/S0006-291X(02)02999-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2FS0006-291X%2802%2902999-6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2003&pages=231-5&issue=1&author=M.+Asai&title=Putative+function+of+ADAM9%2C+ADAM10%2C+and+ADAM17+as+APP+alpha-secretase&doi=10.1016%2FS0006-291X%2802%2902999-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2802%2902999-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252802%252902999-6%26sid%3Dliteratum%253Aachs%26aulast%3DAsai%26aufirst%3DM.%26atitle%3DPutative%2520function%2520of%2520ADAM9%252C%2520ADAM10%252C%2520and%2520ADAM17%2520as%2520APP%2520alpha-secretase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D301%26issue%3D1%26spage%3D231%26epage%3D5%26doi%3D10.1016%2FS0006-291X%2802%2902999-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Murumkar, P. R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Novel TACE inhibitors in drug discovery: a review of patented compounds</i></span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">31</span><span class="NLM_x">â</span> <span class="NLM_lpage">57</span><span class="refDoi">Â DOI: 10.1517/13543770903465157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1517%2F13543770903465157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=20021284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SmsbvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=31-57&issue=1&author=P.+R.+Murumkar&title=Novel+TACE+inhibitors+in+drug+discovery%3A+a+review+of+patented+compounds&doi=10.1517%2F13543770903465157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Novel TACE inhibitors in drug discovery: a review of patented compounds</span></div><div class="casAuthors">Murumkar, Prashant R.; Das Gupta, Shirshendu; Chandani, Sneha R.; Giridhar, Rajani; Yadav, Mange Ram</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-57</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  TNF-Î± converting enzyme (TACE), a pro-inflammatory cytokine, catalyzes the formation of TNF-Î± from membrane bound TNF-Î± precursor protein.  TNF-Î± is believed to play pathophysiol. roles in inflammation, anorexia, cachexia, septic shock, viral replication and so on.  TNF-Î± is a key player in inflammation and joint damage in rheumatoid arthritis.  While a variety of TACE inhibitors have been reported in the literature, a vast majority of these compds. are peptidic and peptide-like compds. that are expected to have bioavailability and pharmacokinetic problems, common to such compds., limiting their clin. effectiveness.  Low mol. mass, long acting, orally bioavailable inhibitors of TACE are, therefore, highly desirable for the treatment of potential chronic diseases mentioned above.  A review of patented compds. as TACE inhibitors in drug discovery is given.  A selection of interesting patents recorded from 2001 to 2009 is presented.  Various novel TACE inhibitors developed by different companies have been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGron3ywSCYrb7Vg90H21EOLACvtfcHk0liCtNI6egpMyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SmsbvO&md5=2bb922b5dad96f3f721e861d6f2c7bf4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543770903465157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903465157%26sid%3Dliteratum%253Aachs%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26atitle%3DNovel%2520TACE%2520inhibitors%2520in%2520drug%2520discovery%253A%2520a%2520review%2520of%2520patented%2520compounds%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D31%26epage%3D57%26doi%3D10.1517%2F13543770903465157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Renkiewicz, R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats</i></span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1742</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1002/art.11030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1002%2Fart.11030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=12794843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlSgu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=1742-9&issue=6&author=R.+Renkiewicz&title=Broad-spectrum+matrix+metalloproteinase+inhibitor+marimastat-induced+musculoskeletal+side+effects+in+rats&doi=10.1002%2Fart.11030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats</span></div><div class="casAuthors">Renkiewicz, Richard; Qiu, Luping; Lesch, Charles; Sun, Xin; Devalaraja, Radhika; Cody, Theresa; Kaldjian, Eric; Welgus, Howard; Baragi, Vijaykumar</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1742-1749</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The aim was to characterize the clin. and histopathol. changes in a rat model of broad-spectrum matrix metalloproteinase (MMP)-induced musculoskeletal syndrome (MSS), and to facilitate research into the causes and treatments of MSS in humans.  Male Lewis rats weighing 150-180 gm were administered 10-30 mg of the broad-spectrum MMP inhibitor marimastat over a 2-wk period via surgically implanted s.c. osmotic pumps.  The animals were monitored and scored for the onset and severity of MSS, using clin. and histol. parameters.  Marimastat-treated rats exhibited various clin. signs, including compromised ability to rest on their hind feet, high-stepping gait, reluctance or inability to move, and hind paw swelling.  Histol., marimastat-treated rat joints were characterized by soft tissue and bone changes, such as increased epiphyseal growth plate, synovial hyperplasia, and increased cellularity in the joint capsule and extracapsular ligaments.  The severity of MSS, as judged by clin. criteria (2 blinded observers using 3 clin. parameters), paw vol., and histol. score, was nearly identical.  The obsd. changes were indistinguishable from those reported for primate models and mimic MSS in humans.  This simple and sensitive model of MSS is an attractive alternative for studying the pathol. of MSS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp15ajNWrmIbLVg90H21EOLACvtfcHk0ljxj107-rbc3A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlSgu7c%253D&md5=83cf556e52d5873e969cf526347bfe92</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fart.11030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.11030%26sid%3Dliteratum%253Aachs%26aulast%3DRenkiewicz%26aufirst%3DR.%26atitle%3DBroad-spectrum%2520matrix%2520metalloproteinase%2520inhibitor%2520marimastat-induced%2520musculoskeletal%2520side%2520effects%2520in%2520rats%26jtitle%3DArthritis%2520Rheum.%26date%3D2003%26volume%3D48%26issue%3D6%26spage%3D1742%26epage%3D9%26doi%3D10.1002%2Fart.11030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Murumkar, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giridhar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, M. R.</span><span> </span><span class="NLM_article-title"><i>Novel methods and strategies in the discovery of TACE inhibitors</i></span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">157</span><span class="NLM_x">â</span> <span class="NLM_lpage">81</span><span class="refDoi">Â DOI: 10.1517/17460441.2013.744745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1517%2F17460441.2013.744745" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=157-81&issue=2&author=P.+R.+Murumkarauthor=R.+Giridharauthor=M.+R.+Yadav&title=Novel+methods+and+strategies+in+the+discovery+of+TACE+inhibitors&doi=10.1517%2F17460441.2013.744745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.744745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.744745%26sid%3Dliteratum%253Aachs%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DGiridhar%26aufirst%3DR.%26aulast%3DYadav%26aufirst%3DM.%2BR.%26atitle%3DNovel%2520methods%2520and%2520strategies%2520in%2520the%2520discovery%2520of%2520TACE%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26issue%3D2%26spage%3D157%26epage%3D81%26doi%3D10.1517%2F17460441.2013.744745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Yadav, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murumkar, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambre, V. P.</span><span> </span><span class="NLM_article-title"><i>Advances in studies on collagenase inhibitors</i></span> <span class="citation_source-journal">EXS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">â</span> <span class="NLM_lpage">135</span><span class="refDoi">Â DOI: 10.1007/978-3-0348-0364-9_4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1007%2F978-3-0348-0364-9_4" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2012&pages=83-135&author=M.+R.+Yadavauthor=P.+R.+Murumkarauthor=V.+P.+Zambre&title=Advances+in+studies+on+collagenase+inhibitors&doi=10.1007%2F978-3-0348-0364-9_4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2F978-3-0348-0364-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-0348-0364-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DM.%2BR.%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DZambre%26aufirst%3DV.%2BP.%26atitle%3DAdvances%2520in%2520studies%2520on%2520collagenase%2520inhibitors%26jtitle%3DEXS%26date%3D2012%26volume%3D103%26spage%3D83%26epage%3D135%26doi%3D10.1007%2F978-3-0348-0364-9_4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">DasGupta, S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Current perspective of TACE inhibitors: a review</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">444</span><span class="NLM_x">â</span> <span class="NLM_lpage">59</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2008.11.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bmc.2008.11.067" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=444-59&issue=2&author=S.+DasGupta&title=Current+perspective+of+TACE+inhibitors%3A+a+review&doi=10.1016%2Fj.bmc.2008.11.067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.11.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.11.067%26sid%3Dliteratum%253Aachs%26aulast%3DDasGupta%26aufirst%3DS.%26atitle%3DCurrent%2520perspective%2520of%2520TACE%2520inhibitors%253A%2520a%2520review%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D2%26spage%3D444%26epage%3D59%26doi%3D10.1016%2Fj.bmc.2008.11.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Georgiadis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiotakis, A.</span><span> </span><span class="NLM_article-title"><i>Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">8781</span><span class="NLM_x">â</span> <span class="NLM_lpage">94</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2008.08.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bmc.2008.08.058" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8781-94&issue=19&author=D.+Georgiadisauthor=A.+Yiotakis&title=Specific+targeting+of+metzincin+family+members+with+small-molecule+inhibitors%3A+progress+toward+a+multifarious+challenge&doi=10.1016%2Fj.bmc.2008.08.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.08.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.08.058%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DYiotakis%26aufirst%3DA.%26atitle%3DSpecific%2520targeting%2520of%2520metzincin%2520family%2520members%2520with%2520small-molecule%2520inhibitors%253A%2520progress%2520toward%2520a%2520multifarious%2520challenge%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26issue%3D19%26spage%3D8781%26epage%3D94%26doi%3D10.1016%2Fj.bmc.2008.08.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Fisher, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title"><i>Recent advances in MMP inhibitor design</i></span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">115</span><span class="NLM_x">â</span> <span class="NLM_lpage">36</span><span class="refDoi">Â DOI: 10.1007/s10555-006-7894-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1007%2Fs10555-006-7894-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=16680577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=115-36&issue=1&author=J.+F.+Fisherauthor=S.+Mobashery&title=Recent+advances+in+MMP+inhibitor+design&doi=10.1007%2Fs10555-006-7894-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in MMP inhibitor design</span></div><div class="casAuthors">Fisher, Jed F.; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-136</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The search for an MMP inhibitor with anticancer efficacy is a nearly three-decade endeavor.  This inhibitor is yet to be found.  The reasons for this failure include shortcomings in the chem. of these compds. (including broad MMP sub-type selectivity, metabolic lability, and toxicity) as well as the emerging, and arguably extraordinary, complexity of MMP cell (and cancer) biol.  Together these suggest that the successful anticancer inhibitor must possess MMP selectivity against the MMP subtype whose involvement is crit., yet highly temporally (with respect to metastatic progression) and mechanistically (with respect to matrix degrdn.) regulated.  This review summarizes the progression of chem. structure and mechanistic thinking toward these objectives, with emphasis on the disappointment, the perseverance, and the resilient optimism that such an inhibitor is there to be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgy2dldRRXLVg90H21EOLACvtfcHk0ljxj107-rbc3A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D&md5=ceed8438ad533dac294e22102e5ba8bf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10555-006-7894-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-006-7894-9%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520MMP%2520inhibitor%2520design%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2006%26volume%3D25%26issue%3D1%26spage%3D115%26epage%3D36%26doi%3D10.1007%2Fs10555-006-7894-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Yiotakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dive, V.</span><span> </span><span class="NLM_article-title"><i>Synthetic active site-directed inhibitors of metzincins: achievement and perspectives</i></span> <span class="citation_source-journal">Mol. Aspects Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span><span class="NLM_x">â</span> <span class="NLM_lpage">38</span><span class="refDoi">Â DOI: 10.1016/j.mam.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.mam.2008.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=18657570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ShsLnP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=329-38&issue=5&author=A.+Yiotakisauthor=V.+Dive&title=Synthetic+active+site-directed+inhibitors+of+metzincins%3A+achievement+and+perspectives&doi=10.1016%2Fj.mam.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic active site-directed inhibitors of metzincins: Achievement and perspectives</span></div><div class="casAuthors">Yiotakis, Athanasios; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">329-338</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The involvement of many zinc metalloproteinases belonging to the metzincin family with a variety of pathol. states raises the possibility of therapeutic intervention using synthetic inhibitors with appropriate selectivity.  Knowledge of the catalytic domain 3D-structures for various members of the metzincin family has been successfully exploited by chemists to develop potent synthetic inhibitors.  However, despite intense efforts, very few highly selective inhibitors of metzincins have been discovered up to now.  A survey of the literature suggests that the over-exploitation of the hydroxamate function as a zinc-binding group to develop inhibitors might be responsible for this situation.  The use of alternative zinc-binding groups has led to more selective inhibitors, but the most encouraging results have been obtained for MMP-13 with compds. that do not incorporate zinc-binding groups in their structure.  This new family of inhibitors exploits the presence of a deep S 1 ' cavity in the protease active site, a specific trait shared by many members of the metzincin family.  However, to be successfully transposed to the metzincin members, this strategy will not only be able to exploit the structural detail of these S 1 ' cavities, but probably also subtle difference in their dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGory6HknHN-obVg90H21EOLACvtfcHk0li5V5TfRi4kbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ShsLnP&md5=44bb1c612fad4769f3bdea1de9ba4792</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYiotakis%26aufirst%3DA.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DSynthetic%2520active%2520site-directed%2520inhibitors%2520of%2520metzincins%253A%2520achievement%2520and%2520perspectives%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2008%26volume%3D29%26issue%3D5%26spage%3D329%26epage%3D38%26doi%3D10.1016%2Fj.mam.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Engel, C. K.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Structural basis for the highly selective inhibition of MMP-13</i></span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">181</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1016/j.chembiol.2004.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.chembiol.2004.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=15734645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslCmsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=181-9&issue=2&author=C.+K.+Engel&title=Structural+basis+for+the+highly+selective+inhibition+of+MMP-13&doi=10.1016%2Fj.chembiol.2004.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Highly Selective Inhibition of MMP-13</span></div><div class="casAuthors">Engel, Christian K.; Pirard, Bernard; Schimanski, Sandra; Kirsch, Reinhard; Habermann, Joerg; Klingler, Otmar; Schlotte, Volkhard; Weithmann, Klaus Ulrich; Wendt, K. Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-189</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Inhibitors for matrix metalloproteinases (MMPs) are under investigation for the treatment of cancer, arthritis, and cardiovascular disease.  Here, the authors report a class of highly selective MMP-13 inhibitors (pyrimidine dicarboxamides) that exhibit no detectable activity against other MMPs.  The high-resoln. x-ray structures of three mols. of this series bound to MMP-13 reveal a novel binding mode characterized by the absence of interactions between the inhibitors and the catalytic zinc.  The inhibitors bind in the S1' pocket and extend into an addnl. S1' side pocket, which is unique to MMP-13.  The authors analyze the determinants for selectivity and describe the rational design of improved compds. with low nanomolar affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWxTXaerMLjLVg90H21EOLACvtfcHk0li5V5TfRi4kbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslCmsbY%253D&md5=92bf47d2ceb76db87ecae786fc89fc64</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DC.%2BK.%26atitle%3DStructural%2520basis%2520for%2520the%2520highly%2520selective%2520inhibition%2520of%2520MMP-13%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26issue%3D2%26spage%3D181%26epage%3D9%26doi%3D10.1016%2Fj.chembiol.2004.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Johnson, A. R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x"> (</span><span class="NLM_issue">38</span><span class="NLM_x">) </span> <span class="NLM_fpage">27781</span><span class="NLM_x">â</span> <span class="NLM_lpage">91</span><span class="refDoi">Â DOI: 10.1074/jbc.M703286200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M703286200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=17623656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVeju7nP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=27781-91&issue=38&author=A.+R.+Johnson&title=Discovery+and+characterization+of+a+novel+inhibitor+of+matrix+metalloprotease-13+that+reduces+cartilage+damage+in+vivo+without+joint+fibroplasia+side+effects&doi=10.1074%2Fjbc.M703286200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects</span></div><div class="casAuthors">Johnson, Adam R.; Pavlovsky, Alexander G.; Ortwine, Daniel F.; Prior, Faith; Man, Chiu-Fai; Bornemeier, Dirk A.; Banotai, Craig A.; Mueller, W. Thomas; McConnell, Patrick; Yan, Chunhong; Baragi, Vijay; Lesch, Charles; Roark, W. Howard; Wilson, Michael; Datta, Kaushik; Guzman, Roberto; Han, Hyo-Kyung; Dyer, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">27781-27791</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP13) is a Zn2+-dependent protease that catalyzes the cleavage of type II collagen, the main structural protein in articular cartilage.  Excess MMP13 activity causes cartilage degrdn. in osteoarthritis, making this protease an attractive therapeutic target.  However, clin. tested MMP inhibitors have been assocd. with a painful, joint-stiffening musculoskeletal side effect that may be due to their lack of selectivity.  In our efforts to develop a disease-modifying osteoarthritis drug, we have discovered MMP13 inhibitors that differ greatly from previous MMP inhibitors; they do not bind to the catalytic zinc ion, they are noncompetitive with respect to substrate binding, and they show extreme selectivity for inhibiting MMP13.  By structure-based drug design, we generated an orally active MMP13 inhibitor that effectively reduces cartilage damage in vivo and does not induce joint fibroplasias in a rat model of musculoskeletal syndrome side effects.  Thus, highly selective inhibition of MMP13 in patients may overcome the major safety and efficacy challenges that have limited previously tested non-selective MMP inhibitors.  MMP13 inhibitors such as the ones described here will help further define the role of this protease in arthritis and other diseases and may soon lead to drugs that safely halt cartilage damage in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCiHwTVRtp7bVg90H21EOLACvtfcHk0li5V5TfRi4kbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVeju7nP&md5=9cc5d9b2edff3847141f21c42f86faf8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M703286200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M703286200%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520novel%2520inhibitor%2520of%2520matrix%2520metalloprotease-13%2520that%2520reduces%2520cartilage%2520damage%2520in%2520vivo%2520without%2520joint%2520fibroplasia%2520side%2520effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D38%26spage%3D27781%26epage%3D91%26doi%3D10.1074%2Fjbc.M703286200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Baragi, V. M.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models</i></span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2008</span><span class="NLM_x">â</span> <span class="NLM_lpage">18</span><span class="refDoi">Â DOI: 10.1002/art.24629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1002%2Fart.24629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=19565489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlKku78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=2008-18&issue=7&author=V.+M.+Baragi&title=A+new+class+of+potent+matrix+metalloproteinase+13+inhibitors+for+potential+treatment+of+osteoarthritis%3A+Evidence+of+histologic+and+clinical+efficacy+without+musculoskeletal+toxicity+in+rat+models&doi=10.1002%2Fart.24629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis. Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models</span></div><div class="casAuthors">Baragi, Vijaykumar M.; Becher, Gabriel; Bendele, Alison M.; Biesinger, Ralf; Bluhm, Harald; Boer, Jurgen; Deng, Hongbo; Dodd, Rory; Essers, Michael; Feuerstein, Tim; Gallagher, Brian M., Jr.; Gege, Christian; Hochgurtel, Matthias; Hofmann, Michael; Jaworski, Andreas; Jin, Lixia; Kiely, Andrew; Korniski, Brian; Kroth, Heiko; Nix, Darrell; Nolte, Bert; Piecha, Dorothea; Powers, Timothy S.; Richter, Frank; Schneider, Matthias; Steeneck, Christoph; Sucholeiki, Irving; Taveras, Arthur; Timmermann, Andreas; van Veldhuizen, Joshua; Weik, Juergen; Wu, Xinyuan; Xia, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2008-2018</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: Matrix metalloproteinases (MMPs) have long been considered excellent targets for osteoarthritis (OA) treatment.  However, clin. utility of broad-spectrum MMP inhibitors developed for this purpose has been restricted by dose-limiting musculoskeletal side effects obsd. in humans.  This study was undertaken to identify a new class of potent and selective MMP-13 inhibitors that would provide histol. and clin. efficacy without musculoskeletal toxicity.  Methods. Selectivity assays were developed using catalytic domains of human MMPs.  Freshly isolated bovine articular cartilage or human OA cartilage was used in in vitro cartilage degrdn. assays.  The rat model of monoiodoacetate (MIA)-induced OA was implemented for assessing the effects of MMP-13 inhibitors on cartilage degrdn. and joint pain.  The surgical medial meniscus tear model in rats was used to evaluate the chondroprotective ability of MMP-13 inhibitors in a chronic disease model of OA.  The rat model of musculoskeletal side effects (MSS) was used to assess whether selective MMP-13 inhibitors have the joint toxicity assocd. with broad-spectrum MMP inhibitors.  Results. A no. of non-hydroxamic acid-contg. compds. that showed a high degree of potency for MMP-13 and selectivity against other MMPs were designed and synthesized.  Steady-state kinetics expts. and Lineweaver-Burk plot anal. of rate vs. substrate concn. with one such compd., ALS 1-0635, indicated linear, noncompetitive inhibition, and Dixon plot anal. from competition studies with a zinc chelator (acetoxyhydroxamic acid) and ALS 1-0635 demonstrated nonexclusive binding.  ALS 1-0635 inhibited bovine articular cartilage degrdn. in a dose-dependent manner (48.7% and 87.1% at 500 nM and 5,000 nM, resp.) and was effective in inhibiting interleukin-1Î±- and oncostatin M-induced C1,C2 release in human OA cartilage cultures.  ALS 1-0635 modulated cartilage damage in the rat MIA model (mean Â± SEM damage score 1.3 Â± 0.3, vs. 2.2 Â± 0.4 in vehicle-treated animals).  Most significantly, when treated twice daily with oral ALS 1-0635, rats with surgically induced medial meniscus tear exhibited histol. evidence of chondroprotection and reduced cartilage degeneration, without observable musculoskeletal toxicity.  Conclusion. The compds. investigated in this study represent a novel class of MMP-13 inhibitors.  They are mechanistically distinct from previously reported broad-spectrum MMP inhibitors and do not exhibit the problems previously assocd. with these inhibitors, including selectivity, poor pharmacokinetics, and MSS liability.  MMP-13 inhibitors exert chondro-protective effects and can potentially modulate joint pain, and are, therefore, uniquely suited as potential disease-modifying osteoarthritis drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWH6P91ktaKrVg90H21EOLACvtfcHk0lgfiw3Dz4zIIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlKku78%253D&md5=87a8b16eaf252bf4fd3c28217a78f8d6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fart.24629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24629%26sid%3Dliteratum%253Aachs%26aulast%3DBaragi%26aufirst%3DV.%2BM.%26atitle%3DA%2520new%2520class%2520of%2520potent%2520matrix%2520metalloproteinase%252013%2520inhibitors%2520for%2520potential%2520treatment%2520of%2520osteoarthritis%253A%2520Evidence%2520of%2520histologic%2520and%2520clinical%2520efficacy%2520without%2520musculoskeletal%2520toxicity%2520in%2520rat%2520models%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26issue%3D7%26spage%3D2008%26epage%3D18%26doi%3D10.1002%2Fart.24629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Piecha, D.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants</i></span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">379</span><span class="NLM_x">â</span> <span class="NLM_lpage">89</span><span class="refDoi">Â DOI: 10.1007/s00011-009-0112-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1007%2Fs00011-009-0112-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=19902332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslaktr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&pages=379-89&issue=5&author=D.+Piecha&title=Novel+selective+MMP-13+inhibitors+reduce+collagen+degradation+in+bovine+articular+and+human+osteoarthritis+cartilage+explants&doi=10.1007%2Fs00011-009-0112-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants</span></div><div class="casAuthors">Piecha, Dorothea; Weik, Juergen; Kheil, Heike; Becher, Gabriele; Timmermann, Andreas; Jaworski, Andreas; Burger, Maren; Hofmann, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-389</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Objective: MMP-13 is highly upregulated in arthritis and therefore strongly implicated in the pathogenesis of osteoarthritis (OA).  Selective inhibition of MMP-13 may provide the desired cartilage degrdn. protection, while overcoming the musculoskeletal toxicity seen with nonselective inhibition of MMPs.  Methods: Activity and selectivity of novel MMP-13 inhibitors were detd. in enzymic and collagenase assays.  Inhibition kinetics and competitive binding expts. were performed.  The inhibition of collagen degrdn. was studied in cartilage explants from OA patients and in bovine and human articular cartilage systems.  Results: We have identified a new class of very potent and highly selective non-zinc-binding MMP-13 inhibitors.  Selective MMP-13 inhibitors completely blocked type II collagen degrdn. in bovine explants and showed up to 80% inhibition in human OA cartilage.  Conclusions: These results indicate MMP-13 as the primary collagenase in the human OA cartilage and in the IL-1/OSM-induced cartilage degrdn. process and suggest that selective MMP-13 inhibitors may be a potential treatment of OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyWMZCjknmSLVg90H21EOLACvtfcHk0lgfiw3Dz4zIIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslaktr4%253D&md5=8558dff813c05930e74a6e8658c42645</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00011-009-0112-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-009-0112-9%26sid%3Dliteratum%253Aachs%26aulast%3DPiecha%26aufirst%3DD.%26atitle%3DNovel%2520selective%2520MMP-13%2520inhibitors%2520reduce%2520collagen%2520degradation%2520in%2520bovine%2520articular%2520and%2520human%2520osteoarthritis%2520cartilage%2520explants%26jtitle%3DInflammation%2520Res.%26date%3D2010%26volume%3D59%26issue%3D5%26spage%3D379%26epage%3D89%26doi%3D10.1007%2Fs00011-009-0112-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Li, J. J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">835</span><span class="NLM_x">â</span> <span class="NLM_lpage">41</span><span class="refDoi">Â DOI: 10.1021/jm701274v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701274v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=835-41&issue=4&author=J.+J.+Li&title=Quinazolinones+and+pyrido%5B3%2C4-d%5Dpyrimidin-4-ones+as+orally+active+and+specific+matrix+metalloproteinase-13+inhibitors+for+the+treatment+of+osteoarthritis&doi=10.1021%2Fjm701274v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm701274v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701274v%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26atitle%3DQuinazolinones%2520and%2520pyrido%255B3%252C4-d%255Dpyrimidin-4-ones%2520as%2520orally%2520active%2520and%2520specific%2520matrix%2520metalloproteinase-13%2520inhibitors%2520for%2520the%2520treatment%2520of%2520osteoarthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D835%26epage%3D41%26doi%3D10.1021%2Fjm701274v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Nara, H.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1</i>â³ <i>binding site</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5487</span><span class="NLM_x">â</span> <span class="NLM_lpage">505</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2014.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bmc.2014.07.025" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5487-505&issue=19&author=H.+Nara&title=Thieno%5B2%2C3-d%5Dpyrimidine-2-carboxamides+bearing+a+carboxybenzene+group+at+5-position%3A+Highly+potent%2C+selective%2C+and+orally+available+MMP-13+inhibitors+interacting+with+the+S1%E2%80%B3+binding+site&doi=10.1016%2Fj.bmc.2014.07.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DH.%26atitle%3DThieno%255B2%252C3-d%255Dpyrimidine-2-carboxamides%2520bearing%2520a%2520carboxybenzene%2520group%2520at%25205-position%253A%2520Highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520MMP-13%2520inhibitors%2520interacting%2520with%2520the%2520S1%25E2%2580%25B3%2520binding%2520site%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26issue%3D19%26spage%3D5487%26epage%3D505%26doi%3D10.1016%2Fj.bmc.2014.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Spicer, T. P.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">9598</span><span class="NLM_x">â</span> <span class="NLM_lpage">611</span><span class="refDoi">Â DOI: 10.1021/jm501284e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501284e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOgsrvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9598-611&issue=22&author=T.+P.+Spicer&title=Characterization+of+selective+exosite-binding+inhibitors+of+matrix+metalloproteinase+13+that+prevent+articular+cartilage+degradation+in+vitro&doi=10.1021%2Fjm501284e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro</span></div><div class="casAuthors">Spicer, Timothy P.; Jiang, Jianwen; Taylor, Alexander B.; Choi, Jun Yong; Hart, P. John; Roush, William R.; Fields, Gregg B.; Hodder, Peter S.; Minond, Dmitriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9598-9611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matrix metalloproteinase 13 (MMP-13) has been shown to be the main collagenase responsible for degrdn. of articular cartilage during osteoarthritis and therefore represents a target for drug development.  As a result of high-throughput screening and structure-activity relationship studies, the authors identified a novel, highly selective class of MMP-13 inhibitors.  Mechanistic characterization revealed a noncompetitive nature of these inhibitors with binding consts. in the low micromolar range.  Crystallog. analyses revealed two binding modes for compd. I in the MMP-13 S1' subsite and in an S1/S2* subsite.  Type II collagen- and cartilage-protective effects exhibited by the 3 compds. suggested that these compds. might be efficacious in future in vivo studies.  Finally, these compds. were also highly selective when tested against a panel of 30 proteases, which, in combination with a good CYP inhibition profile, suggested low off-target toxicity and drug-drug interactions in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCW6fx0sdNp7Vg90H21EOLACvtfcHk0lh27KRk3AAShw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOgsrvF&md5=11b482b88311bf59b842995dd23d2b6a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm501284e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501284e%26sid%3Dliteratum%253Aachs%26aulast%3DSpicer%26aufirst%3DT.%2BP.%26atitle%3DCharacterization%2520of%2520selective%2520exosite-binding%2520inhibitors%2520of%2520matrix%2520metalloproteinase%252013%2520that%2520prevent%2520articular%2520cartilage%2520degradation%2520in%2520vitro%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D22%26spage%3D9598%26epage%3D611%26doi%3D10.1021%2Fjm501284e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Roth, J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds</i></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">7180</span><span class="NLM_x">â</span> <span class="NLM_lpage">4</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.09.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bmcl.2011.09.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=22018790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7180-4&issue=23&author=J.+Roth&title=Identification+of+novel%2C+exosite-binding+matrix+metalloproteinase-13+inhibitor+scaffolds&doi=10.1016%2Fj.bmcl.2011.09.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds</span></div><div class="casAuthors">Roth, Joshua; Minond, Dmitriy; Darout, Etzer; Liu, Qin; Lauer, Janelle; Hodder, Peter; Fields, Gregg B.; Roush, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7180-7184</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP-13) has been implicated as the protease responsible for collagen degrdn. in cartilage during osteoarthritis (OA).  Compds. that inhibit the metalloproteinase at the Zn binding site typically lack specificity among MMP family members.  Analogs of the low-micromolar lead MMP-13 inhibitor (I), discovered through high-throughput screening, were synthesized to investigate structure-activity relationships in this inhibitor series.  Systematic modifications of I led to the discovery of MMP-13 inhibitors II and III which are more selective than I against other MMPs.  Compd. II is also approx. fivefold more potent as an MMP-13 inhibitor than the original HTS-derived lead compd. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopP_zkFk8mibVg90H21EOLACvtfcHk0lh27KRk3AAShw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7E&md5=cfde0e006c073edab16683e478bab78a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.077%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520novel%252C%2520exosite-binding%2520matrix%2520metalloproteinase-13%2520inhibitor%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D23%26spage%3D7180%26epage%3D4%26doi%3D10.1016%2Fj.bmcl.2011.09.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lauer-Fields, J. L.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">990</span><span class="NLM_x">â</span> <span class="NLM_lpage">1005</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2008.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bmc.2008.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=18358729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOhur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=990-1005&issue=3&author=J.+L.+Lauer-Fields&title=High+throughput+screening+of+potentially+selective+MMP-13+exosite+inhibitors+utilizing+a+triple-helical+FRET+substrate&doi=10.1016%2Fj.bmc.2008.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate</span></div><div class="casAuthors">Lauer-Fields, Janelle L.; Minond, Dmitriy; Chase, Peter S.; Baillargeon, Pierre E.; Saldanha, S. Adrian; Stawikowska, Roma; Hodder, Peter; Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">990-1005</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The major components of the cartilage extracellular matrix are type II collagen and aggrecan.  Matrix metalloproteinase 13 (MMP-13) has been implicated as the protease responsible for collagen degrdn. in cartilage during osteoarthritis (OA).  In the present study, a triple-helical FRET substrate has been utilized for high throughput screening (HTS) of MMP-13 with the MLSCN compd. library (n â¼ 65,000).  Thirty-four compds. from the HTS produced pharmacol. dose-response curves.  A secondary screen using RP-HPLC validated 25 compds. as MMP-13 inhibitors.  Twelve of these compds. were selected for counter-screening with 6 representative MMP family members.  Five compds. were found to be broad-spectrum MMP inhibitors, 3 inhibited MMP-13 and one other MMP, and 4 were selective for MMP-13.  One of the selective inhibitors was more active against MMP-13 triple-helical peptidase activity compared with single-stranded peptidase activity.  Since the THP FRET substrate has distinct conformational features that may interact with MMP secondary binding sites (exosites), novel non-active site-binding inhibitors may be identified via HTS protocols utilizing such assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc6QPfFleUqrVg90H21EOLACvtfcHk0lh27KRk3AAShw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOhur0%253D&md5=4fb566e532ff6271ba60771cc6453eb3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DLauer-Fields%26aufirst%3DJ.%2BL.%26atitle%3DHigh%2520throughput%2520screening%2520of%2520potentially%2520selective%2520MMP-13%2520exosite%2520inhibitors%2520utilizing%2520a%2520triple-helical%2520FRET%2520substrate%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D3%26spage%3D990%26epage%3D1005%26doi%3D10.1016%2Fj.bmc.2008.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Jungel, A.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis</i></span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">898</span><span class="NLM_x">â</span> <span class="NLM_lpage">902</span><span class="refDoi">Â DOI: 10.1136/ard.2008.106021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1136%2Fard.2008.106021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=19497915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlOks7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2010&pages=898-902&issue=5&author=A.+Jungel&title=Effect+of+the+oral+application+of+a+highly+selective+MMP-13+inhibitor+in+three+different+animal+models+of+rheumatoid+arthritis&doi=10.1136%2Fard.2008.106021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis</span></div><div class="casAuthors">Jungel, Astrid; Ospelt, Caroline; Lesch, Mark; Thiel, Melissa; Sunyer, Teresa; Schorr, Olivier; Michel, Beat A.; Gay, Renate E.; Kolling, Christoph; Flory, Craig; Gay, Steffen; Neidhart, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">898-902</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objective: To evaluate the decrease of cartilage destruction by a novel orally active and specific matrix metalloproteinase 13 (MMP-13) inhibitor in three different animal models of rheumatoid arthritis (RA).  Materials and methods: The SCID mouse co-implantation model of RA, the collagen-induced arthritis (CIA) model in mice and the antigen-induced arthritis model (AIA) in rabbits were used.  Results: In the SCID mouse co-implantation model, the MMP-13 inhibitor reduced cartilage destruction by 75%.  In the CIA model of RA, the MMP-13 inhibitor resulted in a significant and dose-dependent decrease in clin. symptoms as well as of cartilage erosion by 38% (30 mg/kg), 28% (10 mg/kg) and 21% (3 mg/kg).  No significant effects were seen in the AIA model.  No toxic effects were seen in all three animal models.  Conclusion: Although several MMPs in concert with other proteinases have a role in the process of cartilage destruction, there is a need for highly selective MMP inhibitors to reduce severe side effects that occur with non-specific inhibitors.  Significant inhibition of MMP-13 reduced cartilage erosions in two of three tested animal models of RA.  These results strongly support the development of this class of drugs to reduce or halt joint destruction in patients with RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqlsYWFf09frVg90H21EOLACvtfcHk0lh27KRk3AAShw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlOks7c%253D&md5=0cc3a494be3a939b217c19867c12bedd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1136%2Fard.2008.106021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2008.106021%26sid%3Dliteratum%253Aachs%26aulast%3DJungel%26aufirst%3DA.%26atitle%3DEffect%2520of%2520the%2520oral%2520application%2520of%2520a%2520highly%2520selective%2520MMP-13%2520inhibitor%2520in%2520three%2520different%2520animal%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2010%26volume%3D69%26issue%3D5%26spage%3D898%26epage%3D902%26doi%3D10.1136%2Fard.2008.106021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wijdeven, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neefjes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title"><i>How chemistry supports cell biology: the chemical toolbox at your service</i></span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">751</span><span class="NLM_x">â</span> <span class="NLM_lpage">760</span><span class="refDoi">Â DOI: 10.1016/j.tcb.2014.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.tcb.2014.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=25108565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlClurbO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=751-760&issue=12&author=R.+H.+Wijdevenauthor=J.+Neefjesauthor=H.+Ovaa&title=How+chemistry+supports+cell+biology%3A+the+chemical+toolbox+at+your+service&doi=10.1016%2Fj.tcb.2014.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">How chemistry supports cell biology: the chemical toolbox at your service</span></div><div class="casAuthors">Wijdeven, Ruud H.; Neefjes, Jacques; Ovaa, Huib</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">751-760</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Chem. biol. is a young and rapidly developing scientific field.  In this field, chem. is inspired by biol. to create various tools to monitor and modulate biochem. and cell biol. processes.  Chem. contributions such as small-mol. inhibitors and activity-based probes (ABPs) can provide new and unique insights into previously unexplored cellular processes.  This review provides an overview of recent breakthroughs in chem. biol. that are likely to have a significant impact on cell biol.  We also discuss the application of several chem. tools in cell biol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8oGuhRj3PrVg90H21EOLACvtfcHk0lj1vk2XMflOjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlClurbO&md5=df2574ed7d3a5a2f6ca4ddb1443360d7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2014.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2014.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DWijdeven%26aufirst%3DR.%2BH.%26aulast%3DNeefjes%26aufirst%3DJ.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DHow%2520chemistry%2520supports%2520cell%2520biology%253A%2520the%2520chemical%2520toolbox%2520at%2520your%2520service%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2014%26volume%3D24%26issue%3D12%26spage%3D751%26epage%3D760%26doi%3D10.1016%2Fj.tcb.2014.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tape, C. J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Cross-domain inhibition of TACE ectodomain</i></span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">5578</span><span class="NLM_x">â</span> <span class="NLM_lpage">83</span><span class="refDoi">Â DOI: 10.1073/pnas.1017067108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1073%2Fpnas.1017067108" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5578-83&issue=14&author=C.+J.+Tape&title=Cross-domain+inhibition+of+TACE+ectodomain&doi=10.1073%2Fpnas.1017067108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1017067108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1017067108%26sid%3Dliteratum%253Aachs%26aulast%3DTape%26aufirst%3DC.%2BJ.%26atitle%3DCross-domain%2520inhibition%2520of%2520TACE%2520ectodomain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26issue%3D14%26spage%3D5578%26epage%3D83%26doi%3D10.1073%2Fpnas.1017067108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Minond, D.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Discovery of Novel Inhibitors of a Disintegrin and Metalloprotease 17 (ADAM17) Using Glycosylated and Non-glycosylated Substrates</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x"> (</span><span class="NLM_issue">43</span><span class="NLM_x">) </span> <span class="NLM_fpage">36473</span><span class="NLM_x">â</span> <span class="NLM_lpage">87</span><span class="refDoi">Â DOI: 10.1074/jbc.M112.389114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M112.389114" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=36473-87&issue=43&author=D.+Minond&title=Discovery+of+Novel+Inhibitors+of+a+Disintegrin+and+Metalloprotease+17+%28ADAM17%29+Using+Glycosylated+and+Non-glycosylated+Substrates&doi=10.1074%2Fjbc.M112.389114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.389114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.389114%26sid%3Dliteratum%253Aachs%26aulast%3DMinond%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520Novel%2520Inhibitors%2520of%2520a%2520Disintegrin%2520and%2520Metalloprotease%252017%2520%2528ADAM17%2529%2520Using%2520Glycosylated%2520and%2520Non-glycosylated%2520Substrates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D43%26spage%3D36473%26epage%3D87%26doi%3D10.1074%2Fjbc.M112.389114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Rose-John, S.</span><span> </span><span class="NLM_article-title"><i>ADAM17, shedding, TACE as therapeutic targets</i></span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">â</span> <span class="NLM_lpage">22</span><span class="refDoi">Â DOI: 10.1016/j.phrs.2013.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.phrs.2013.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=23415892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1ent7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2013&pages=19-22&author=S.+Rose-John&title=ADAM17%2C+shedding%2C+TACE+as+therapeutic+targets&doi=10.1016%2Fj.phrs.2013.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">ADAM17, shedding, TACE as therapeutic targets</span></div><div class="casAuthors">Rose-John, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-22</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  ADAM17 has been molecularly cloned as the enzyme responsible for cleavage of the transmembrane protein TNFÎ± (TNFÎ± converting enzyme, TACE).  Later it was realized that ADAM17 was also responsible for the processing of cell adhesion proteins, cytokine and growth factor receptors and many ligands of the EGF receptor.  Since TNFÎ± is a target of anti-inflammatory therapies, it was speculated that inhibition of ADAM17 might be a therapeutic strategy in the treatment of inflammation or inflammation assocd. cancer.  Meanwhile it has been recognized that ADAM17 governs many vital functions in the body and loss of ADAM17 leads to severe defects in the skin and to high susceptibility of the intestine to inflammation.  Here I summarize data on the physiol. role of ADAM17 and the feasibility of specific blockade of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5jZzPC8uFnrVg90H21EOLACvtfcHk0lj1vk2XMflOjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1ent7Y%253D&md5=9c8b1157460bc5dd9d1f6135a35598a6</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2013.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2013.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DRose-John%26aufirst%3DS.%26atitle%3DADAM17%252C%2520shedding%252C%2520TACE%2520as%2520therapeutic%2520targets%26jtitle%3DPharmacol.%2520Res.%26date%3D2013%26volume%3D71%26spage%3D19%26epage%3D22%26doi%3D10.1016%2Fj.phrs.2013.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Moss, M. L.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha</i></span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x"> (</span><span class="NLM_issue">6618</span><span class="NLM_x">) </span> <span class="NLM_fpage">733</span><span class="NLM_x">â</span> <span class="NLM_lpage">6</span><span class="refDoi">Â DOI: 10.1038/385733a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2F385733a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=1997&pages=733-6&issue=6618&author=M.+L.+Moss&title=Cloning+of+a+disintegrin+metalloproteinase+that+processes+precursor+tumour-necrosis+factor-alpha&doi=10.1038%2F385733a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F385733a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F385733a0%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DM.%2BL.%26atitle%3DCloning%2520of%2520a%2520disintegrin%2520metalloproteinase%2520that%2520processes%2520precursor%2520tumour-necrosis%2520factor-alpha%26jtitle%3DNature%26date%3D1997%26volume%3D385%26issue%3D6618%26spage%3D733%26epage%3D6%26doi%3D10.1038%2F385733a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Black, R. A.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells</i></span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x"> (</span><span class="NLM_issue">6618</span><span class="NLM_x">) </span> <span class="NLM_fpage">729</span><span class="NLM_x">â</span> <span class="NLM_lpage">33</span><span class="refDoi">Â DOI: 10.1038/385729a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2F385729a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=1997&pages=729-33&issue=6618&author=R.+A.+Black&title=A+metalloproteinase+disintegrin+that+releases+tumour-necrosis+factor-alpha+from+cells&doi=10.1038%2F385729a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2F385729a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F385729a0%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DR.%2BA.%26atitle%3DA%2520metalloproteinase%2520disintegrin%2520that%2520releases%2520tumour-necrosis%2520factor-alpha%2520from%2520cells%26jtitle%3DNature%26date%3D1997%26volume%3D385%26issue%3D6618%26spage%3D729%26epage%3D33%26doi%3D10.1038%2F385729a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Nakanaga, T.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Regulation of interleukin-8 via an airway epithelial signaling cascade</i></span> <span class="citation_source-journal">Am. J. Physiol Lung Cell Mol. Physiol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">L1289</span><span class="NLM_x">â</span> <span class="NLM_lpage">96</span><span class="refDoi">Â DOI: 10.1152/ajplung.00356.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1152%2Fajplung.00356.2006" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=L1289-96&issue=5&author=T.+Nakanaga&title=Regulation+of+interleukin-8+via+an+airway+epithelial+signaling+cascade&doi=10.1152%2Fajplung.00356.2006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00356.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00356.2006%26sid%3Dliteratum%253Aachs%26aulast%3DNakanaga%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520interleukin-8%2520via%2520an%2520airway%2520epithelial%2520signaling%2520cascade%26jtitle%3DAm.%2520J.%2520Physiol%2520Lung%2520Cell%2520Mol.%2520Physiol%26date%3D2007%26volume%3D292%26issue%3D5%26spage%3DL1289%26epage%3D96%26doi%3D10.1152%2Fajplung.00356.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Dreymueller, D.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Smooth muscle cells relay acute pulmonary inflammation via distinct ADAM17/ErbB axes</i></span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">722</span><span class="NLM_x">â</span> <span class="NLM_lpage">31</span><span class="refDoi">Â DOI: 10.4049/jimmunol.1302496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.4049%2Fjimmunol.1302496" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2014&pages=722-31&issue=2&author=D.+Dreymueller&title=Smooth+muscle+cells+relay+acute+pulmonary+inflammation+via+distinct+ADAM17%2FErbB+axes&doi=10.4049%2Fjimmunol.1302496"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1302496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1302496%26sid%3Dliteratum%253Aachs%26aulast%3DDreymueller%26aufirst%3DD.%26atitle%3DSmooth%2520muscle%2520cells%2520relay%2520acute%2520pulmonary%2520inflammation%2520via%2520distinct%2520ADAM17%252FErbB%2520axes%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D192%26issue%3D2%26spage%3D722%26epage%3D31%26doi%3D10.4049%2Fjimmunol.1302496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Garton, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobel, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greaves, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempsey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raines, E. W.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">41</span><span class="NLM_x">) </span> <span class="NLM_fpage">37993</span><span class="NLM_x">â</span> <span class="NLM_lpage">38001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=37993-38001&issue=41&author=K.+J.+Gartonauthor=P.+J.+Goughauthor=C.+P.+Blobelauthor=G.+Murphyauthor=D.+R.+Greavesauthor=P.+J.+Dempseyauthor=E.+W.+Raines&title=Tumor+necrosis+factor-alpha-converting+enzyme+%28ADAM17%29+mediates+the+cleavage+and+shedding+of+fractalkine+%28CX3CL1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarton%26aufirst%3DK.%2BJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBlobel%26aufirst%3DC.%2BP.%26aulast%3DMurphy%26aufirst%3DG.%26aulast%3DGreaves%26aufirst%3DD.%2BR.%26aulast%3DDempsey%26aufirst%3DP.%2BJ.%26aulast%3DRaines%26aufirst%3DE.%2BW.%26atitle%3DTumor%2520necrosis%2520factor-alpha-converting%2520enzyme%2520%2528ADAM17%2529%2520mediates%2520the%2520cleavage%2520and%2520shedding%2520of%2520fractalkine%2520%2528CX3CL1%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D41%26spage%3D37993%26epage%3D38001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hundhausen, C.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion</i></span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1186</span><span class="NLM_x">â</span> <span class="NLM_lpage">95</span><span class="refDoi">Â DOI: 10.1182/blood-2002-12-3775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1182%2Fblood-2002-12-3775" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=1186-95&issue=4&author=C.+Hundhausen&title=The+disintegrin-like+metalloproteinase+ADAM10+is+involved+in+constitutive+cleavage+of+CX3CL1+%28fractalkine%29+and+regulates+CX3CL1-mediated+cell-cell+adhesion&doi=10.1182%2Fblood-2002-12-3775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1182%2Fblood-2002-12-3775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2002-12-3775%26sid%3Dliteratum%253Aachs%26aulast%3DHundhausen%26aufirst%3DC.%26atitle%3DThe%2520disintegrin-like%2520metalloproteinase%2520ADAM10%2520is%2520involved%2520in%2520constitutive%2520cleavage%2520of%2520CX3CL1%2520%2528fractalkine%2529%2520and%2520regulates%2520CX3CL1-mediated%2520cell-cell%2520adhesion%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26issue%3D4%26spage%3D1186%26epage%3D95%26doi%3D10.1182%2Fblood-2002-12-3775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Abel, S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10</i></span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">6362</span><span class="NLM_x">â</span> <span class="NLM_lpage">72</span><span class="refDoi">Â DOI: 10.4049/jimmunol.172.10.6362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.4049%2Fjimmunol.172.10.6362" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2004&pages=6362-72&issue=10&author=S.+Abel&title=The+transmembrane+CXC-chemokine+ligand+16+is+induced+by+IFN-gamma+and+TNF-alpha+and+shed+by+the+activity+of+the+disintegrin-like+metalloproteinase+ADAM10&doi=10.4049%2Fjimmunol.172.10.6362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.172.10.6362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.172.10.6362%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DS.%26atitle%3DThe%2520transmembrane%2520CXC-chemokine%2520ligand%252016%2520is%2520induced%2520by%2520IFN-gamma%2520and%2520TNF-alpha%2520and%2520shed%2520by%2520the%2520activity%2520of%2520the%2520disintegrin-like%2520metalloproteinase%2520ADAM10%26jtitle%3DJ.%2520Immunol.%26date%3D2004%26volume%3D172%26issue%3D10%26spage%3D6362%26epage%3D72%26doi%3D10.4049%2Fjimmunol.172.10.6362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Fu, H. L.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">12114</span><span class="NLM_x">â</span> <span class="NLM_lpage">29</span><span class="refDoi">Â DOI: 10.1074/jbc.M112.409599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M112.409599" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=12114-29&issue=17&author=H.+L.+Fu&title=Shedding+of+discoidin+domain+receptor+1+by+membrane-type+matrix+metalloproteinases&doi=10.1074%2Fjbc.M112.409599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.409599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.409599%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DH.%2BL.%26atitle%3DShedding%2520of%2520discoidin%2520domain%2520receptor%25201%2520by%2520membrane-type%2520matrix%2520metalloproteinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D17%26spage%3D12114%26epage%3D29%26doi%3D10.1074%2Fjbc.M112.409599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleshin, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strongin, A. Y.</span><span> </span><span class="NLM_article-title"><i>Potential relation of aberrant proteolysis of human protein tyrosine kinase 7 (PTK7) chuzhoi by membrane type 1 matrix metalloproteinase (MT1-MMP) to congenital defects</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">20970</span><span class="NLM_x">â</span> <span class="NLM_lpage">6</span><span class="refDoi">Â DOI: 10.1074/jbc.M111.237669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M111.237669" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=20970-6&issue=23&author=V.+S.+Golubkovauthor=A.+E.+Aleshinauthor=A.+Y.+Strongin&title=Potential+relation+of+aberrant+proteolysis+of+human+protein+tyrosine+kinase+7+%28PTK7%29+chuzhoi+by+membrane+type+1+matrix+metalloproteinase+%28MT1-MMP%29+to+congenital+defects&doi=10.1074%2Fjbc.M111.237669"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.237669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.237669%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26aulast%3DAleshin%26aufirst%3DA.%2BE.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26atitle%3DPotential%2520relation%2520of%2520aberrant%2520proteolysis%2520of%2520human%2520protein%2520tyrosine%2520kinase%25207%2520%2528PTK7%2529%2520chuzhoi%2520by%2520membrane%2520type%25201%2520matrix%2520metalloproteinase%2520%2528MT1-MMP%2529%2520to%2520congenital%2520defects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26issue%3D23%26spage%3D20970%26epage%3D6%26doi%3D10.1074%2Fjbc.M111.237669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x"> (</span><span class="NLM_issue">46</span><span class="NLM_x">) </span> <span class="NLM_fpage">35740</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1074/jbc.M110.165159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M110.165159" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=35740-9&issue=46&author=V.+S.+Golubkov&title=The+Wnt%2Fplanar+cell+polarity+protein-tyrosine+kinase-7+%28PTK7%29+is+a+highly+efficient+proteolytic+target+of+membrane+type-1+matrix+metalloproteinase%3A+implications+in+cancer+and+embryogenesis&doi=10.1074%2Fjbc.M110.165159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.165159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.165159%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26atitle%3DThe%2520Wnt%252Fplanar%2520cell%2520polarity%2520protein-tyrosine%2520kinase-7%2520%2528PTK7%2529%2520is%2520a%2520highly%2520efficient%2520proteolytic%2520target%2520of%2520membrane%2520type-1%2520matrix%2520metalloproteinase%253A%2520implications%2520in%2520cancer%2520and%2520embryogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D46%26spage%3D35740%26epage%3D9%26doi%3D10.1074%2Fjbc.M110.165159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strongin, A. Y.</span><span> </span><span class="NLM_article-title"><i>Insights into Ectodomain Shedding and Processing of Protein-tyrosine Pseudokinase 7 (PTK7)</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">42009</span><span class="NLM_x">â</span> <span class="NLM_lpage">18</span><span class="refDoi">Â DOI: 10.1074/jbc.M112.371153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M112.371153" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=42009-18&issue=50&author=V.+S.+Golubkovauthor=A.+Y.+Strongin&title=Insights+into+Ectodomain+Shedding+and+Processing+of+Protein-tyrosine+Pseudokinase+7+%28PTK7%29&doi=10.1074%2Fjbc.M112.371153"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.371153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.371153%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26atitle%3DInsights%2520into%2520Ectodomain%2520Shedding%2520and%2520Processing%2520of%2520Protein-tyrosine%2520Pseudokinase%25207%2520%2528PTK7%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D50%26spage%3D42009%26epage%3D18%26doi%3D10.1074%2Fjbc.M112.371153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Protein-tyrosine pseudokinase 7 (PTK7) directs cancer cell motility and metastasis</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">24238</span><span class="NLM_x">â</span> <span class="NLM_lpage">49</span><span class="refDoi">Â DOI: 10.1074/jbc.M114.574459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M114.574459" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=24238-49&issue=35&author=V.+S.+Golubkov&title=Protein-tyrosine+pseudokinase+7+%28PTK7%29+directs+cancer+cell+motility+and+metastasis&doi=10.1074%2Fjbc.M114.574459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.574459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.574459%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26atitle%3DProtein-tyrosine%2520pseudokinase%25207%2520%2528PTK7%2529%2520directs%2520cancer%2520cell%2520motility%2520and%2520metastasis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26issue%3D35%26spage%3D24238%26epage%3D49%26doi%3D10.1074%2Fjbc.M114.574459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strongin, A. Y.</span><span> </span><span class="NLM_article-title"><i>Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells</i></span> <span class="citation_source-journal">Cell Commun. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="refDoi">Â DOI: 10.1186/1478-811X-12-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1186%2F1478-811X-12-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=24618420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1WrtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=15&author=V.+S.+Golubkovauthor=A.+Y.+Strongin&title=Downstream+signaling+and+genome-wide+regulatory+effects+of+PTK7+pseudokinase+and+its+proteolytic+fragments+in+cancer+cells&doi=10.1186%2F1478-811X-12-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells</span></div><div class="casAuthors">Golubkov, Vladislav S.; Strongin, Alex Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Communication and Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15/1-15/12, 12</span>CODEN:
                <span class="NLM_cas:coden">CCSEC6</span>;
        ISSN:<span class="NLM_cas:issn">1478-811X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The full-length membrane protein tyrosine kinase 7 (PTK7) pseudokinase, an important component of the planar cell polarity and the Wnt canonical and non-canonical pathways, is a subject of step-wise proteolysis in cells and tissues.  The proteolysis of PTK7 involves membrane type-matrix metalloproteinase (MT1-MMP), members of the Disintegrin Domain and Metalloproteinase (ADAM) family, and Î³-secretase.  This multi-step proteolysis results in the generation of the digest fragments of PTK7.  These fragments may be either liberated into the extracellular milieu or retained on the plasma membrane or released into the cytoplasm and then transported into the nucleus.  Results: We employed the genome-wide transcriptional and kinome array analyses to det. the role of the full-length membrane PTK7 and its proteolytic fragments in the downstream regulatory mechanisms, with an emphasis on the cell migration-related genes and proteins.  Using fibrosarcoma HT1080 cells stably expressing PTK7 and its mutant and truncated species, the structure of which corresponded to the major PTK7 digest fragments, we demonstrated that the full-length membrane 1-1070 PTK7, the N-terminal 1-694 sol. ectodomain fragment, and the C-terminal 622-1070 and 726-1070 fragments differentially regulate multiple genes and signaling pathways in our highly invasive cancer cell model.  Immunoblotting of the selected proteins were used to validate the results of our high throughput assays.  Conclusions: Our results suggest that PTK7 levels need to be tightly controlled to enable migration and that the anti-migratory effect of the full-length membrane PTK7 is linked to the down-regulation of multiple migration-related genes and to the activation of the Akt and c-Jun pathway.  In turn, the C-terminal fragments of PTK7 act predominantly via the RAS-ERK and CREB/ATF1 pathway and through the up-regulation of cadherin-11.  In general, our data correlate well with the distinct functionality of the full-length receptor tyrosine kinases and their resp. intracellular domain (ICD) proteolytic fragments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZmNUp3suDi7Vg90H21EOLACvtfcHk0lgNtFEWwRHtdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1WrtrY%253D&md5=1d464e8ae948a02479ddeec4b6c46d95</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-12-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-12-15%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26atitle%3DDownstream%2520signaling%2520and%2520genome-wide%2520regulatory%2520effects%2520of%2520PTK7%2520pseudokinase%2520and%2520its%2520proteolytic%2520fragments%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2014%26volume%3D12%26spage%3D15%26doi%3D10.1186%2F1478-811X-12-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Zhou, B. B.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer</i></span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">39</span><span class="NLM_x">â</span> <span class="NLM_lpage">50</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2006.05.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.ccr.2006.05.024" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=39-50&issue=1&author=B.+B.+Zhou&title=Targeting+ADAM-mediated+ligand+cleavage+to+inhibit+HER3+and+EGFR+pathways+in+non-small+cell+lung+cancer&doi=10.1016%2Fj.ccr.2006.05.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DB.%2BB.%26atitle%3DTargeting%2520ADAM-mediated%2520ligand%2520cleavage%2520to%2520inhibit%2520HER3%2520and%2520EGFR%2520pathways%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26issue%3D1%26spage%3D39%26epage%3D50%26doi%3D10.1016%2Fj.ccr.2006.05.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Horiuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobel, C. P.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx</i></span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">176</span><span class="NLM_x">â</span> <span class="NLM_lpage">88</span><span class="refDoi">Â DOI: 10.1091/mbc.E06-01-0014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1091%2Fmbc.E06-01-0014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=17079736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFynuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=176-88&issue=1&author=K.+Horiuchiauthor=M.+Schulteauthor=S.+Le+Gallauthor=T.+Yamaguchiauthor=K.+Reissauthor=G.+Murphyauthor=Y.+Toyamaauthor=D.+Hartmannauthor=P.+Saftigauthor=C.+P.+Blobel&title=Substrate+selectivity+of+epidermal+growth+factor-receptor+ligand+sheddases+and+their+regulation+by+phorbol+esters+and+calcium+influx&doi=10.1091%2Fmbc.E06-01-0014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx</span></div><div class="casAuthors">Horiuchi, Keisuke; Le Gall, Sylvain; Schulte, Marc; Yamaguchi, Takafumi; Reiss, Karina; Murphy, Gillian; Toyama, Yoshiaki; Hartmann, Dieter; Saftig, Paul; Blobel, Carl P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-188</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Signaling via the epidermal growth factor receptor (EGFR), which has crit. roles in development and diseases such as cancer, is regulated by proteolytic shedding of its membrane-tethered ligands.  Sheddases for EGFR-ligands are therefore key signaling switches in the EGFR pathway.  Here, we detd. which ADAMs (a disintegrin and metalloprotease) can shed various EGFR-ligands, and we analyzed the regulation of EGFR-ligand shedding by 2 commonly used stimuli, phorbol esters and calcium influx.  Phorbol esters predominantly activate ADAM17, thereby triggering a burst of shedding of EGFR-ligands from a late secretory pathway compartment.  Calcium influx stimulates ADAM10, requiring its cytoplasmic domain.  However, calcium influx-stimulated shedding of transforming growth factor Î± and amphiregulin does not require ADAM17, even though ADAM17 is essential for phorbol ester-stimulated shedding of these EGFR-ligands.  This study provides new insight into the machinery responsible for EGFR-ligand release and thus EGFR signaling and demonstrates that dysregulated EGFR-ligand shedding may be caused by increased expression of constitutively active sheddases or activation of different sheddases by distinct stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeWjP3a2hMqrVg90H21EOLACvtfcHk0lin-5UQdK831w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFynuw%253D%253D&md5=3e768fc9f6b378ba4fe0b252696f8be6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E06-01-0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E06-01-0014%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DK.%26aulast%3DSchulte%26aufirst%3DM.%26aulast%3DLe%2BGall%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DReiss%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DG.%26aulast%3DToyama%26aufirst%3DY.%26aulast%3DHartmann%26aufirst%3DD.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBlobel%26aufirst%3DC.%2BP.%26atitle%3DSubstrate%2520selectivity%2520of%2520epidermal%2520growth%2520factor-receptor%2520ligand%2520sheddases%2520and%2520their%2520regulation%2520by%2520phorbol%2520esters%2520and%2520calcium%2520influx%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2007%26volume%3D18%26issue%3D1%26spage%3D176%26epage%3D88%26doi%3D10.1091%2Fmbc.E06-01-0014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Ni, S. S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival</i></span> <span class="citation_source-journal">Tumor Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1813</span><span class="NLM_x">â</span> <span class="NLM_lpage">8</span><span class="refDoi">Â DOI: 10.1007/s13277-013-0721-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1007%2Fs13277-013-0721-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=23475633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3sXos1yls7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1813-8&issue=3&author=S.+S.+Ni&title=ADAM17+is+overexpressed+in+non-small+cell+lung+cancer+and+its+expression+correlates+with+poor+patient+survival&doi=10.1007%2Fs13277-013-0721-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival</span></div><div class="casAuthors">Ni, Shuang-Shuang; Zhang, Ji; Zhao, Wei-Li; Dong, Xiao-Chun; Wang, Jin-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1813-1818</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The purpose of this study was to assess ADAM17 expression and to explore its contribution to the non-small cell lung cancer (NSCLC).  Real-time quant. reverse transcriptase-polymerase chain reaction was conducted to detect ADAM17 mRNA expression.  In addn., ADAM17 expression was analyzed by immunohistochem. in 124 clinicopathol. characterized NSCLC cases.  The correlation of ADAM17 expression with patients' survival rate was assessed by Kaplan-Meier and Cox regression.  The expression levels of ADAM17 mRNA and protein in NSCLC tissues were both significantly higher than those in non-cancerous tissues.  In addn., high expression of ADAM17 was significantly correlated with tumor grade (P = 0.026), tumor size (P = 0.001), clin. stage (P = 0.016), and lymph node metastases (P < 0.001).  Furthermore, multivariate anal. suggested that tumor grade, tumor size, clin. stage, lymph node metastases, and ADAM17 expression were independent prognostic indicators for NSCLC.  Our data suggest for the first time that the increased expression of ADAM17 in NSCLC is assocd. significantly with aggressive progression and poor prognosis.  ADAM17 may be an important mol. marker for predicting the carcinogenesis, progression, and prognosis of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv0LP0Dg2tuLVg90H21EOLACvtfcHk0lin-5UQdK831w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXos1yls7c%253D&md5=7e6b503aa72e2036b9658f3975328d73</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs13277-013-0721-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-013-0721-3%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%2BS.%26atitle%3DADAM17%2520is%2520overexpressed%2520in%2520non-small%2520cell%2520lung%2520cancer%2520and%2520its%2520expression%2520correlates%2520with%2520poor%2520patient%2520survival%26jtitle%3DTumor%2520Biol.%26date%3D2013%26volume%3D34%26issue%3D3%26spage%3D1813%26epage%3D8%26doi%3D10.1007%2Fs13277-013-0721-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Hynes, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlange, T.</span><span> </span><span class="NLM_article-title"><i>Targeting ADAMS and ERBBs in lung cancer</i></span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">7</span><span class="NLM_x">â</span> <span class="NLM_lpage">11</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2006.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.ccr.2006.06.012" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=7-11&issue=1&author=N.+E.+Hynesauthor=T.+Schlange&title=Targeting+ADAMS+and+ERBBs+in+lung+cancer&doi=10.1016%2Fj.ccr.2006.06.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DN.%2BE.%26aulast%3DSchlange%26aufirst%3DT.%26atitle%3DTargeting%2520ADAMS%2520and%2520ERBBs%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26issue%3D1%26spage%3D7%26epage%3D11%26doi%3D10.1016%2Fj.ccr.2006.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Rocks, N.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Emerging roles of ADAM and ADAMTS metalloproteinases in cancer</i></span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">369</span><span class="NLM_x">â</span> <span class="NLM_lpage">79</span><span class="refDoi">Â DOI: 10.1016/j.biochi.2007.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.biochi.2007.08.008" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2008&pages=369-79&issue=2&author=N.+Rocks&title=Emerging+roles+of+ADAM+and+ADAMTS+metalloproteinases+in+cancer&doi=10.1016%2Fj.biochi.2007.08.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2007.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2007.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DRocks%26aufirst%3DN.%26atitle%3DEmerging%2520roles%2520of%2520ADAM%2520and%2520ADAMTS%2520metalloproteinases%2520in%2520cancer%26jtitle%3DBiochimie%26date%3D2008%26volume%3D90%26issue%3D2%26spage%3D369%26epage%3D79%26doi%3D10.1016%2Fj.biochi.2007.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Horiuchi, K.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2</i></span> <span class="citation_source-journal">Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">459</span><span class="NLM_x">â</span> <span class="NLM_lpage">71</span><span class="refDoi">Â DOI: 10.1016/j.ydbio.2005.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.ydbio.2005.05.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2005&pages=459-71&issue=2&author=K.+Horiuchi&title=Evaluation+of+the+contributions+of+ADAMs+9%2C+12%2C+15%2C+17%2C+and+19+to+heart+development+and+ectodomain+shedding+of+neuregulins+beta1+and+beta2&doi=10.1016%2Fj.ydbio.2005.05.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ydbio.2005.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ydbio.2005.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DK.%26atitle%3DEvaluation%2520of%2520the%2520contributions%2520of%2520ADAMs%25209%252C%252012%252C%252015%252C%252017%252C%2520and%252019%2520to%2520heart%2520development%2520and%2520ectodomain%2520shedding%2520of%2520neuregulins%2520beta1%2520and%2520beta2%26jtitle%3DDev.%2520Biol.%26date%3D2005%26volume%3D283%26issue%3D2%26spage%3D459%26epage%3D71%26doi%3D10.1016%2Fj.ydbio.2005.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Stawikowska, R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">22871</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1074/jbc.M113.462267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M113.462267" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=22871-9&issue=31&author=R.+Stawikowska&title=Activity+of+ADAM17+%28a+disintegrin+and+metalloprotease+17%29+is+regulated+by+its+noncatalytic+domains+and+secondary+structure+of+its+substrates&doi=10.1074%2Fjbc.M113.462267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.462267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.462267%26sid%3Dliteratum%253Aachs%26aulast%3DStawikowska%26aufirst%3DR.%26atitle%3DActivity%2520of%2520ADAM17%2520%2528a%2520disintegrin%2520and%2520metalloprotease%252017%2529%2520is%2520regulated%2520by%2520its%2520noncatalytic%2520domains%2520and%2520secondary%2520structure%2520of%2520its%2520substrates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D31%26spage%3D22871%26epage%3D9%26doi%3D10.1074%2Fjbc.M113.462267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Scheller, J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>ADAM17: a molecular switch to control inflammation and tissue regeneration</i></span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">380</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span><span class="refDoi">Â DOI: 10.1016/j.it.2011.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.it.2011.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=21752713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFGgs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=380-7&issue=8&author=J.+Scheller&title=ADAM17%3A+a+molecular+switch+to+control+inflammation+and+tissue+regeneration&doi=10.1016%2Fj.it.2011.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">ADAM17: a molecular switch to control inflammation and tissue regeneration</span></div><div class="casAuthors">Scheller, Juergen; Chalaris, Athena; Garbers, Christoph; Rose-John, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">380-387</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A disintegrin and metalloproteinase 17 (ADAM17), also known as tumor necrosis factor-Î± converting enzyme (TACE), is a membrane-bound enzyme that cleaves cell surface proteins, such as cytokines (e.g. TNFÎ±), cytokine receptors (e.g. IL-6R and TNF-R), ligands of ErbB (e.g. TGFÎ± and amphiregulin) and adhesion proteins (e.g. L-selectin and ICAM-1).  Here we examine how ectodomain shedding of these mols. can alter their biol. and impact on immune and inflammatory responses and cancer development.  Gene targeting of Adam17 is embryonic lethal, highlighting the importance of ectodomain shedding during development.  Tissue-specific deletion, or hypomorphic knock-in, of Adam17 demonstrates an in vivo role for ADAM17 in controlling inflammation and tissue regeneration.  The potential of ADAM17 as therapeutic target is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0fckd1XTx7LVg90H21EOLACvtfcHk0lip7AQy_NWg9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFGgs74%253D&md5=1a09afb1495753956134f90e7a43d415</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2011.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2011.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DScheller%26aufirst%3DJ.%26atitle%3DADAM17%253A%2520a%2520molecular%2520switch%2520to%2520control%2520inflammation%2520and%2520tissue%2520regeneration%26jtitle%3DTrends%2520Immunol.%26date%3D2011%26volume%3D32%26issue%3D8%26spage%3D380%26epage%3D7%26doi%3D10.1016%2Fj.it.2011.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, R. A.</span><span> </span><span class="NLM_article-title"><i>Allosteric inhibition of BACE1 by an exosite-binding antibody</i></span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">797</span><span class="NLM_x">â</span> <span class="NLM_lpage">805</span><span class="refDoi">Â DOI: 10.1016/j.sbi.2013.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.sbi.2013.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=23998983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKrur%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=797-805&issue=6&author=W.+Wangauthor=Y.+Liuauthor=R.+A.+Lazarus&title=Allosteric+inhibition+of+BACE1+by+an+exosite-binding+antibody&doi=10.1016%2Fj.sbi.2013.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of BACE1 by an exosite-binding antibody</span></div><div class="casAuthors">Wang, Weiru; Liu, Yichin; Lazarus, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">797-805</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Î²-Secretase (BACE1) is a membrane-anchored pepsin-like aspartic protease and is the rate-limiting enzyme in the Î²-amyloidogenic pathway.  Thus, inhibitors of BACE1 activity have therapeutic potential for Alzheimer's disease.  While much effort has focused on small mol. active site inhibitors, recent exploration of BACE1 inhibition by peptides and antibodies has revealed exosites that can regulate enzymic activity.  This type of allosteric regulation by proteinaceous factors, while frequently found in serine and cysteine proteases, is rarely seen in aspartic proteases.  A crystal structure of the anti-BACE1/enzyme complex shows altered structural features and dynamic characteristics near the substrate-binding cleft.  This binding mode, along with the enzymic inhibition pattern, suggests that anti-BACE1 functions through an allosteric inhibition mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7NPCYEibKVLVg90H21EOLACvtfcHk0lip7AQy_NWg9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrur%252FI&md5=0ed0c714b3d00d40c0d6ad67e841cbd3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2013.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2013.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLazarus%26aufirst%3DR.%2BA.%26atitle%3DAllosteric%2520inhibition%2520of%2520BACE1%2520by%2520an%2520exosite-binding%2520antibody%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2013%26volume%3D23%26issue%3D6%26spage%3D797%26epage%3D805%26doi%3D10.1016%2Fj.sbi.2013.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Hermanson, D. J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation</i></span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">358</span><span class="NLM_x">â</span> <span class="NLM_lpage">67</span><span class="refDoi">Â DOI: 10.1016/j.tips.2014.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.tips.2014.04.006" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=358-67&issue=7&author=D.+J.+Hermanson&title=Substrate-selective+COX-2+inhibition+as+a+novel+strategy+for+therapeutic+endocannabinoid+augmentation&doi=10.1016%2Fj.tips.2014.04.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DHermanson%26aufirst%3DD.%2BJ.%26atitle%3DSubstrate-selective%2520COX-2%2520inhibition%2520as%2520a%2520novel%2520strategy%2520for%2520therapeutic%2520endocannabinoid%2520augmentation%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26issue%3D7%26spage%3D358%26epage%3D67%26doi%3D10.1016%2Fj.tips.2014.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Busschots, K.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site</i></span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1152</span><span class="NLM_x">â</span> <span class="NLM_lpage">63</span><span class="refDoi">Â DOI: 10.1016/j.chembiol.2012.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.chembiol.2012.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=22999883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2ksbvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1152-63&issue=9&author=K.+Busschots&title=Substrate-selective+inhibition+of+protein+kinase+PDK1+by+small+compounds+that+bind+to+the+PIF-pocket+allosteric+docking+site&doi=10.1016%2Fj.chembiol.2012.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site</span></div><div class="casAuthors">Busschots, Katrien; Lopez-Garcia, Laura A.; Lammi, Carmen; Stroba, Adriana; Zeuzem, Stefan; Piiper, Albrecht; Alzari, Pedro M.; Neimanis, Sonja; Arencibia, Jose M.; Engel, Matthias; Schulze, Joerg O.; Biondi, Ricardo M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1152-1163</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The PIF-pocket of AGC protein kinases participates in the physiol. mechanism of regulation by acting as a docking site for substrates and as a switch for the transduction of the conformational changes needed for activation or inhibition.  We describe the effects of compds. that bind to the PIF-pocket of PDK1.  In vitro, PS210 is a potent activator of PDK1, and the crystal structure of the PDK1-ATP-PS210 complex shows that PS210 stimulates the closure of the kinase domain.  However, in cells, the prodrug of PS210 (PS423) acts as a substrate-selective inhibitor of PDK1, inhibiting the phosphorylation and activation of S6K, which requires docking to the PIF-pocket, but not affecting PKB/Akt.  This work describes a tool to study the dynamics of PDK1 activity and a potential approach for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCik10255dpLVg90H21EOLACvtfcHk0lip7AQy_NWg9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2ksbvO&md5=8efdcf836d5d910e979a2640709c1d4e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DBusschots%26aufirst%3DK.%26atitle%3DSubstrate-selective%2520inhibition%2520of%2520protein%2520kinase%2520PDK1%2520by%2520small%2520compounds%2520that%2520bind%2520to%2520the%2520PIF-pocket%2520allosteric%2520docking%2520site%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26issue%3D9%26spage%3D1152%26epage%3D63%26doi%3D10.1016%2Fj.chembiol.2012.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Balbin, M.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Loss of collagenase-2 confers increased skin tumor susceptibility to male mice</i></span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">252</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span><span class="refDoi">Â DOI: 10.1038/ng1249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2Fng1249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=14517555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosFWrtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=252-7&issue=3&author=M.+Balbin&title=Loss+of+collagenase-2+confers+increased+skin+tumor+susceptibility+to+male+mice&doi=10.1038%2Fng1249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of collagenase-2 confers increased skin tumor susceptibility to male mice</span></div><div class="casAuthors">Balbin, Milagros; Fueyo, Antonio; Tester, Angus M.; Pendas, Alberto M.; Pitiot, Ana S.; Astudillo, Aurora; Overall, Christopher M.; Shapiro, Steven D.; Lopez-Otin, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-257</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) have fundamental roles in tumor progression, but most clin. trials with MMP inhibitors have not shown improvements in individuals with cancer.  This may be partly because broad-range inhibitors also reduce host-protective antitumor properties of individual MMPs.  We generated mice deficient in collagenase-2 (Mmp8), an MMP mainly produced by neutrophils in inflammatory reactions and detected in some malignant tumors.  Loss of Mmp8 did not cause abnormalities during embryonic development or in adult mice.  Contrary to previous studies with MMP-deficient mice, however, the absence of Mmp8 strongly increased the incidence of skin tumors in male Mmp8-/-mice.  Female Mmp8-/-mice whose ovaries were removed or were treated with tamoxifen were also more susceptible to tumors compared with wild-type mice.  Bone marrow transplantation expts. confirmed that Mmp8 supplied by neutrophils was sufficient to restore the natural protection against tumor development mediated by this protease in male mice.  Histopathol. anal. showed that mutant mice had abnormalities in the inflammatory response induced by carcinogens.  Our study identifies a paradoxical protective role for Mmp8 in cancer and provides a genetic model to evaluate the mol. basis of gender differences in cancer susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrkAXGJEpZ-LVg90H21EOLACvtfcHk0lip7AQy_NWg9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosFWrtr8%253D&md5=868e8c71adecec4fa823297a56859294</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fng1249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1249%26sid%3Dliteratum%253Aachs%26aulast%3DBalbin%26aufirst%3DM.%26atitle%3DLoss%2520of%2520collagenase-2%2520confers%2520increased%2520skin%2520tumor%2520susceptibility%2520to%2520male%2520mice%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D35%26issue%3D3%26spage%3D252%26epage%3D7%26doi%3D10.1038%2Fng1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Palavalli, L. H.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma</i></span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">518</span><span class="NLM_x">â</span> <span class="NLM_lpage">20</span><span class="refDoi">Â DOI: 10.1038/ng.340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2Fng.340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=19330028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsl2ns7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=518-20&issue=5&author=L.+H.+Palavalli&title=Analysis+of+the+matrix+metalloproteinase+family+reveals+that+MMP8+is+often+mutated+in+melanoma&doi=10.1038%2Fng.340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma</span></div><div class="casAuthors">Palavalli, Lavanya H.; Prickett, Todd D.; Wunderlich, John R.; Wei, Xiaomu; Burrell, Allison S.; Porter-Gill, Patricia; Davis, Sean; Wang, Chenwei; Cronin, Julia C.; Agrawal, Neena S.; Lin, Jimmy C.; Westbroek, Wendy; Hoogstraten-Miller, Shelley; Molinolo, Alfredo A.; Fetsch, Patricia; Filie, Armando C.; O'Connell, Michael P.; Banister, Carolyn E.; Howard, Jason D.; Buckhaults, Phillip; Weeraratna, Ashani T.; Brody, Lawrence C.; Rosenberg, Steven A.; Samuels, Yardena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">518-520</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A mutational anal. of the matrix metalloproteinase (MMP) gene family in human melanoma identified somatic mutations in 23% of melanomas.  Five mutations in one of the most commonly mutated genes, MMP8, reduced MMP enzyme activity.  Expression of wild-type but not mutant MMP8 in human melanoma cells inhibited growth on soft agar in vitro and tumor formation in vivo, suggesting that wild-type MMP-8 has the ability to inhibit melanoma progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmD7XN4TsMaLVg90H21EOLACvtfcHk0lg4RP7iZGonIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsl2ns7w%253D&md5=73ee57103454bd38a2798570af1a516d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fng.340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.340%26sid%3Dliteratum%253Aachs%26aulast%3DPalavalli%26aufirst%3DL.%2BH.%26atitle%3DAnalysis%2520of%2520the%2520matrix%2520metalloproteinase%2520family%2520reveals%2520that%2520MMP8%2520is%2520often%2520mutated%2520in%2520melanoma%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26issue%3D5%26spage%3D518%26epage%3D20%26doi%3D10.1038%2Fng.340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Szabova, L.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease</i></span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">3274</span><span class="NLM_x">â</span> <span class="NLM_lpage">81</span><span class="refDoi">Â DOI: 10.1038/sj.onc.1210982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2Fsj.onc.1210982" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3274-81&issue=23&author=L.+Szabova&title=MT1-MMP+is+required+for+efficient+tumor+dissemination+in+experimental+metastatic+disease&doi=10.1038%2Fsj.onc.1210982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210982%26sid%3Dliteratum%253Aachs%26aulast%3DSzabova%26aufirst%3DL.%26atitle%3DMT1-MMP%2520is%2520required%2520for%2520efficient%2520tumor%2520dissemination%2520in%2520experimental%2520metastatic%2520disease%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26issue%3D23%26spage%3D3274%26epage%3D81%26doi%3D10.1038%2Fsj.onc.1210982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title"><i>gamma-Secretase inhibitors and modulators for Alzheimerâs disease</i></span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl S1</span><span class="NLM_x">) </span> <span class="NLM_fpage">89</span><span class="NLM_x">â</span> <span class="NLM_lpage">98</span><span class="refDoi">Â DOI: 10.1111/j.1471-4159.2011.07501.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1111%2Fj.1471-4159.2011.07501.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=22122056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyns70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=89-98&issue=Suppl+S1&author=M.+S.+Wolfe&title=gamma-Secretase+inhibitors+and+modulators+for+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2011.07501.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Î³-secretase inhibitors and modulators for Alzheimer's disease</span></div><div class="casAuthors">Wolfe, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">89-98</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Î³-Secretase is a membrane embedded aspartyl protease complex with presenilin as the catalytic component.  Along with Î²-secretase, this enzyme produces the amyloid Î²-protein of Alzheimer's disease (AD) from the amyloid Î²-protein precursor.  Because of its key role in the pathogenesis of AD, Î³-secretase has been a prime target for drug discovery, and many inhibitors of this protease have been developed.  The therapeutic potential of these inhibitors is virtually negated by the fact that Î³-secretase is an essential part of the Notch signaling pathway, rendering the compds. unacceptably toxic upon chronic exposure.  However, these compds. have served as useful chem. tools for biol. investigations.  In contrast, Î³-secretase modulators continue to be of keen interest as possible AD therapeutics.  These modulators either shift amyloid Î²-protein prodn. to shorter, less pathogenic peptides or inhibit the proteolysis of amyloid Î²-protein precursor selectively compared to that of Notch.  The various chem. types of inhibitors and modulators will be discussed, along with their use as probes for basic biol. and their potential as AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_F2j1GafgnLVg90H21EOLACvtfcHk0lg4RP7iZGonIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyns70%253D&md5=f495ec06da422076c7110ea4d0d37bbb</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07501.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07501.x%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3Dgamma-Secretase%2520inhibitors%2520and%2520modulators%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26issue%3DSuppl%2520S1%26spage%3D89%26epage%3D98%26doi%3D10.1111%2Fj.1471-4159.2011.07501.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Houghten, R. A.</span><span> </span><span class="NLM_article-title"><i>General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids</i></span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5131</span><span class="NLM_x">â</span> <span class="NLM_lpage">5</span><span class="refDoi">Â DOI: 10.1073/pnas.82.15.5131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1073%2Fpnas.82.15.5131" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=5131-5&issue=15&author=R.+A.+Houghten&title=General+method+for+the+rapid+solid-phase+synthesis+of+large+numbers+of+peptides%3A+specificity+of+antigen-antibody+interaction+at+the+level+of+individual+amino+acids&doi=10.1073%2Fpnas.82.15.5131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.15.5131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.15.5131%26sid%3Dliteratum%253Aachs%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26atitle%3DGeneral%2520method%2520for%2520the%2520rapid%2520solid-phase%2520synthesis%2520of%2520large%2520numbers%2520of%2520peptides%253A%2520specificity%2520of%2520antigen-antibody%2520interaction%2520at%2520the%2520level%2520of%2520individual%2520amino%2520acids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1985%26volume%3D82%26issue%3D15%26spage%3D5131%26epage%3D5%26doi%3D10.1073%2Fpnas.82.15.5131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Pinilla, C.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries</i></span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">314</span><span class="NLM_x">â</span> <span class="NLM_lpage">24</span><span class="refDoi">Â DOI: 10.1124/mol.113.086595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1124%2Fmol.113.086595" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=314-24&issue=3&author=C.+Pinilla&title=Selective+agonists+and+antagonists+of+formylpeptide+receptors%3A+duplex+flow+cytometry+and+mixture-based+positional+scanning+libraries&doi=10.1124%2Fmol.113.086595"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.086595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.086595%26sid%3Dliteratum%253Aachs%26aulast%3DPinilla%26aufirst%3DC.%26atitle%3DSelective%2520agonists%2520and%2520antagonists%2520of%2520formylpeptide%2520receptors%253A%2520duplex%2520flow%2520cytometry%2520and%2520mixture-based%2520positional%2520scanning%2520libraries%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26issue%3D3%26spage%3D314%26epage%3D24%26doi%3D10.1124%2Fmol.113.086595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Pinilla, C.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Advances in the use of synthetic combinatorial chemistry: mixture-based libraries</i></span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">118</span><span class="NLM_x">â</span> <span class="NLM_lpage">22</span><span class="refDoi">Â DOI: 10.1038/nm0103-118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2Fnm0103-118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=12514724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFKk" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=118-22&issue=1&author=C.+Pinilla&title=Advances+in+the+use+of+synthetic+combinatorial+chemistry%3A+mixture-based+libraries&doi=10.1038%2Fnm0103-118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the use of synthetic combinatorial chemistry: Mixture-based libraries</span></div><div class="casAuthors">Pinilla, Clemencia; Appel, Jon R.; Borras, Eva; Houghten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-122</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mixt.-based combinatorial libraries, large collections of thousands to millions of compds. in systematically arranged mixts., were reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobTCpBOIQ7-rVg90H21EOLACvtfcHk0ljuLvmHHCfvUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFKk&md5=007987b5a17da538f60a4358f9ee834e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnm0103-118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0103-118%26sid%3Dliteratum%253Aachs%26aulast%3DPinilla%26aufirst%3DC.%26atitle%3DAdvances%2520in%2520the%2520use%2520of%2520synthetic%2520combinatorial%2520chemistry%253A%2520mixture-based%2520libraries%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26issue%3D1%26spage%3D118%26epage%3D22%26doi%3D10.1038%2Fnm0103-118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Houghten, R. A.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods</i></span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">19</span><span class="refDoi">Â DOI: 10.1021/cc7001205</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc7001205" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWgurfK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=3-19&issue=1&author=R.+A.+Houghten&title=Strategies+for+the+use+of+mixture-based+synthetic+combinatorial+libraries%3A+scaffold+ranking%2C+direct+testing+in+vivo%2C+and+enhanced+deconvolution+by+computational+methods&doi=10.1021%2Fcc7001205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Use of Mixture-Based Synthetic Combinatorial Libraries: Scaffold Ranking, Direct Testing In Vivo, and Enhanced Deconvolution by Computational Methods</span></div><div class="casAuthors">Houghten, Richard A.; Pinilla, Clemencia; Giulianotti, Marc A.; Appel, Jon R.; Dooley, Colette T.; Nefzi, Adel; Ostresh, John M.; Yu, Yongping; Maggiora, Gerald M.; Medina-Franco, Jose L.; Brunner, Daniela; Schneider, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-19</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHw0Bw1Gl2KLVg90H21EOLACvtfcHk0ljuLvmHHCfvUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWgurfK&md5=9693c04842ee3232043fd2d8a5dabd44</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fcc7001205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc7001205%26sid%3Dliteratum%253Aachs%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26atitle%3DStrategies%2520for%2520the%2520use%2520of%2520mixture-based%2520synthetic%2520combinatorial%2520libraries%253A%2520scaffold%2520ranking%252C%2520direct%2520testing%2520in%2520vivo%252C%2520and%2520enhanced%2520deconvolution%2520by%2520computational%2520methods%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2008%26volume%3D10%26issue%3D1%26spage%3D3%26epage%3D19%26doi%3D10.1021%2Fcc7001205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Zhang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title"><i>A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</i></span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">67</span><span class="NLM_x">â</span> <span class="NLM_lpage">73</span><span class="refDoi">Â DOI: 10.1177/108705719900400206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&issue=2&author=J.+H.+Zhangauthor=T.+D.+Chungauthor=K.+R.+Oldenburg&title=A+Simple+Statistical+Parameter+for+Use+in+Evaluation+and+Validation+of+High+Throughput+Screening+Assays&doi=10.1177%2F108705719900400206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2eZQ0qE357kaKbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520Simple%2520Statistical%2520Parameter%2520for%2520Use%2520in%2520Evaluation%2520and%2520Validation%2520of%2520High%2520Throughput%2520Screening%2520Assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26issue%3D2%26spage%3D67%26epage%3D73%26doi%3D10.1177%2F108705719900400206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Leister, K. P.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Two High Throughput Screen Assays for Measurement of TNF-alpha in THP-1 Cells</i></span> <span class="citation_source-journal">Curr. Chem. Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.2174/1875397301105010021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.2174%2F1875397301105010021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=21643507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3MXms1KgtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=21-9&author=K.+P.+Leister&title=Two+High+Throughput+Screen+Assays+for+Measurement+of+TNF-alpha+in+THP-1+Cells&doi=10.2174%2F1875397301105010021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Two high throughput screen assays for measurement of TNF-Î± in THP-1 cells</span></div><div class="casAuthors">Leister, Kristin P.; Huang, Ruili; Goodwin, Bonnie L.; Chen, Andrew; Austin, Christopher P.; Xia, Menghang</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Genomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">CCGUAQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-3973</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Tumor Necrosis Factor-Î± (TNF-Î±), a secreted cytokine, plays an important role in inflammatory diseases and immune disorders, and is a potential target for drug development.  The traditional assays for detecting TNF-Î±, enzyme linked immunosorbent assay (ELISA) and RIA, are not suitable for the large size compd. screens.  Both assays suffer from a complicated protocol, multiple plate wash steps and/or excessive radioactive waste.  A simple and quick measurement of TNF-Î± prodn. in a cell based assay is needed for high throughput screening to identify the lead compds. from the compd. library.  We have developed and optimized two homogeneous TNF-Î± assays using the HTRF (homogeneous time resolved fluorescence) and AlphaLISA assay formats.  We have validated the HTRF based TNF-Î± assay in a 1536-well plate format by screening a library of 1280 pharmacol. active compds.  The active compds. identified from the screen were confirmed in the AlphaLISA TNF-Î± assay using a bead-based technol.  These compds. were also confirmed in a traditional ELISA assay.  From this study, several beta adrenergic agonists have been identified as TNF-Î± inhibitors.  We also identified several novel inhibitors of TNF-Î±, such as BTO-1, CCG-2046, ellipticine, and PD 169316.  The results demonstrated that both homogeneous TNF-Î± assays are robust and suitable for high throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQz3I9GaaciLVg90H21EOLACvtfcHk0ljuLvmHHCfvUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXms1KgtLs%253D&md5=5b132f9fbbe2577774018f0e750df4d7</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F1875397301105010021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1875397301105010021%26sid%3Dliteratum%253Aachs%26aulast%3DLeister%26aufirst%3DK.%2BP.%26atitle%3DTwo%2520High%2520Throughput%2520Screen%2520Assays%2520for%2520Measurement%2520of%2520TNF-alpha%2520in%2520THP-1%2520Cells%26jtitle%3DCurr.%2520Chem.%2520Genomics%26date%3D2011%26volume%3D5%26spage%3D21%26epage%3D9%26doi%3D10.2174%2F1875397301105010021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Ludwig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hundhausen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadway, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leesnitzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becherer, J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules</i></span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">161</span><span class="NLM_x">â</span> <span class="NLM_lpage">171</span><span class="refDoi">Â DOI: 10.2174/1386207053258488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.2174%2F1386207053258488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=15777180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVGgurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=161-171&issue=2&author=A.+Ludwigauthor=C.+Hundhausenauthor=M.+Lambertauthor=N.+Broadwayauthor=R.+Andrewsauthor=D.+Bickettauthor=M.+Leesnitzerauthor=J.+Becherer&title=Metalloproteinase+inhibitors+for+the+disintegrin-like+metalloproteinases+ADAM10+and+ADAM17+that+differentially+block+constitutive+and+phorbol+ester-inducible+shedding+of+cell+surface+molecules&doi=10.2174%2F1386207053258488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules</span></div><div class="casAuthors">Ludwig, Andreas; Hundhausen, Christian; Lambert, Millard H.; Broadway, Neil; Andrews, Robert C.; Bickett, D. Mark; Leesnitzer, M. Anthony; Becherer, J. David</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-171</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The transmembrane metzinkin-proteases of the ADAM (a disintegrin and a metalloproteinase)-family ADAM10 and ADAM 17 are both implicated in the ectodomain shedding of various cell surface mols. including the IL6-receptor and the transmembrane chemokines CX3CL1 and CXCL16.  These mols. are constitutively released from cultured cells, a process that can be rapidly enhanced by cell stimulation with phorbol esters such as PMA.  Recent research supports the view that the constitutive cleavage predominantly involves ADAM10 while the inducible one is mediated to a large extent by ADAM17.  We here describe the discovery of hydroxamate compds. with different potency against ADAM10 and ADAM17 and different ability to block constitutive and inducible cleavage of IL6R, CX3CL1 and CXCL16 by the two proteases.  By screening a no. of hydroxamate inhibitors for the inhibition of recombinant metalloproteinases, a compd. was found inhibiting ADAM10 with more than 100-fold higher potency than ADAM17, which may be explained by an improved fit of the compd. to the S1' specificity pocket of ADAM10 as compared to that of ADAM17.  In cell-based cleavage expts. this compd. (GI254023X) potently blocked the constitutive release of IL6R, CX3CL1 and CXCL16, which was in line with the reported involvement of ADAM10 but not ADAM17 in this process.  By contrast, the compd. did not affect the PMA-induced shedding, which was only blocked by GW280264X, a potent inhibitor of ADAM17.  As expected, GI254023X did not further decrease the residual release of CX3CL1 and CXCL16 in ADAM10-deficient cells verifying that the compd.'s effect on the constitutive shedding of these mols. was exclusively due to the inhibition of ADAM10.  Thus, GI254023X may by of use as a preferential inhibitor of constitutive shedding events without effecting the inducible shedding in response to agonists acting similar to PMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyuZAUznlqdbVg90H21EOLACvtfcHk0lhxLfHGVAyAsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVGgurk%253D&md5=8c474e5cc77e96573d90a18ab9768d7b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.2174%2F1386207053258488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207053258488%26sid%3Dliteratum%253Aachs%26aulast%3DLudwig%26aufirst%3DA.%26aulast%3DHundhausen%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DM.%26aulast%3DBroadway%26aufirst%3DN.%26aulast%3DAndrews%26aufirst%3DR.%26aulast%3DBickett%26aufirst%3DD.%26aulast%3DLeesnitzer%26aufirst%3DM.%26aulast%3DBecherer%26aufirst%3DJ.%26atitle%3DMetalloproteinase%2520inhibitors%2520for%2520the%2520disintegrin-like%2520metalloproteinases%2520ADAM10%2520and%2520ADAM17%2520that%2520differentially%2520block%2520constitutive%2520and%2520phorbol%2520ester-inducible%2520shedding%2520of%2520cell%2520surface%2520molecules%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2005%26volume%3D8%26issue%3D2%26spage%3D161%26epage%3D171%26doi%3D10.2174%2F1386207053258488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells</i></span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">10460</span><span class="NLM_x">â</span> <span class="NLM_lpage">5</span><span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-06-2997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1158%2F0008-5472.CAN-06-2997" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=10460-5&issue=21&author=V.+S.+Golubkov&title=Membrane+type-1+matrix+metalloproteinase+confers+aneuploidy+and+tumorigenicity+on+mammary+epithelial+cells&doi=10.1158%2F0008-5472.CAN-06-2997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-2997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-2997%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26atitle%3DMembrane%2520type-1%2520matrix%2520metalloproteinase%2520confers%2520aneuploidy%2520and%2520tumorigenicity%2520on%2520mammary%2520epithelial%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D21%26spage%3D10460%26epage%3D5%26doi%3D10.1158%2F0008-5472.CAN-06-2997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Kuruppu, S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Production of soluble Neprilysin by endothelial cells</i></span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">423</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span><span class="refDoi">Â DOI: 10.1016/j.bbrc.2014.01.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bbrc.2014.01.158" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2014&pages=423-7&issue=2&author=S.+Kuruppu&title=Production+of+soluble+Neprilysin+by+endothelial+cells&doi=10.1016%2Fj.bbrc.2014.01.158"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.01.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.01.158%26sid%3Dliteratum%253Aachs%26aulast%3DKuruppu%26aufirst%3DS.%26atitle%3DProduction%2520of%2520soluble%2520Neprilysin%2520by%2520endothelial%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D446%26issue%3D2%26spage%3D423%26epage%3D7%26doi%3D10.1016%2Fj.bbrc.2014.01.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matteo  Calligaris</span>, <span class="hlFld-ContribAuthor ">Doretta  Cuffaro</span>, <span class="hlFld-ContribAuthor ">Simone  Bonelli</span>, <span class="hlFld-ContribAuthor ">Donatella Pia  SpanÃ²</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Simone Dario  Scilabra</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 944. <a href="https://doi.org/10.3390/molecules26040944" title="DOI URL">https://doi.org/10.3390/molecules26040944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26040944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26040944%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStrategies%252Bto%252BTarget%252BADAM17%252Bin%252BDisease%25253A%252BFrom%252BIts%252BDiscovery%252Bto%252Bthe%252BiRhom%252BRevolution%26aulast%3DCalligaris%26aufirst%3DMatteo%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Doretta  Cuffaro</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Felicia  DâAndrea</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>. </span><span class="cited-content_cbyCitation_article-title">Developments in Carbohydrate-Based Metzincin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (11)
                                     , 376. <a href="https://doi.org/10.3390/ph13110376" title="DOI URL">https://doi.org/10.3390/ph13110376</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13110376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13110376%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DDevelopments%252Bin%252BCarbohydrate-Based%252BMetzincin%252BInhibitors%26aulast%3DCuffaro%26aufirst%3DDoretta%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D11%26spage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Camodeca</span>, <span class="hlFld-ContribAuthor ">Doretta  Cuffaro</span>, <span class="hlFld-ContribAuthor ">Elisa  Nuti</span>, <span class="hlFld-ContribAuthor ">Armando  Rossello</span>. </span><span class="cited-content_cbyCitation_article-title">ADAM Metalloproteinases as Potential Drug Targets. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (15)
                                     , 2661-2689. <a href="https://doi.org/10.2174/0929867325666180326164104" title="DOI URL">https://doi.org/10.2174/0929867325666180326164104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180326164104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180326164104%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DADAM%252BMetalloproteinases%252Bas%252BPotential%252BDrug%252BTargets%26aulast%3DCamodeca%26aufirst%3DCaterina%26date%3D2019%26volume%3D26%26issue%3D15%26spage%3D2661%26epage%3D2689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip Kumar  Baidya</span>, <span class="hlFld-ContribAuthor ">Sk. Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Suvankar  Banerjee</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">Structural exploration of arylsulfonamide-based ADAM17 inhibitors through validated comparative multi-QSAR modelling studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1185 </em>, 128-142. <a href="https://doi.org/10.1016/j.molstruc.2019.02.081" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.02.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.02.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.02.081%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DStructural%252Bexploration%252Bof%252Barylsulfonamide-based%252BADAM17%252Binhibitors%252Bthrough%252Bvalidated%252Bcomparative%252Bmulti-QSAR%252Bmodelling%252Bstudies%26aulast%3DBaidya%26aufirst%3DSandip%2BKumar%26date%3D2019%26volume%3D1185%26spage%3D128%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan Pablo  Maianti</span>, <span class="hlFld-ContribAuthor ">Grace A.  Tan</span>, <span class="hlFld-ContribAuthor ">Amedeo  Vetere</span>, <span class="hlFld-ContribAuthor ">Amie J.  Welsh</span>, <span class="hlFld-ContribAuthor ">Bridget K.  Wagner</span>, <span class="hlFld-ContribAuthor ">Markus A.  Seeliger</span>, <span class="hlFld-ContribAuthor ">David R.  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2019,</strong> <em>15 </em>
                                    (6)
                                     , 565-574. <a href="https://doi.org/10.1038/s41589-019-0271-0" title="DOI URL">https://doi.org/10.1038/s41589-019-0271-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-019-0271-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-019-0271-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DSubstrate-selective%252Binhibitors%252Bthat%252Breprogram%252Bthe%252Bactivity%252Bof%252Binsulin-degrading%252Benzyme%26aulast%3DMaianti%26aufirst%3DJuan%2BPablo%26date%3D2019%26date%3D2019%26volume%3D15%26issue%3D6%26spage%3D565%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Arai</span>, <span class="hlFld-ContribAuthor ">Kaku  Goto</span>, <span class="hlFld-ContribAuthor ">Yasushi  Tanoue</span>, <span class="hlFld-ContribAuthor ">Sayaka  Ito</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Muroyama</span>, <span class="hlFld-ContribAuthor ">Yasuo  Matsubara</span>, <span class="hlFld-ContribAuthor ">Ryo  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Yoshimi  Kaise</span>, <span class="hlFld-ContribAuthor ">Lay Ahyoung  Lim</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Yoshida</span>, <span class="hlFld-ContribAuthor ">Naoya  Kato</span>. </span><span class="cited-content_cbyCitation_article-title">Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2018,</strong> <em>143 </em>
                                    (10)
                                     , 2575-2583. <a href="https://doi.org/10.1002/ijc.31615" title="DOI URL">https://doi.org/10.1002/ijc.31615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.31615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.31615%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DEnzymatic%252Binhibition%252Bof%252BMICA%252Bsheddase%252BADAM17%252Bby%252Blomofungin%252Bin%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DArai%26aufirst%3DJun%26date%3D2018%26date%3D2018%26volume%3D143%26issue%3D10%26spage%3D2575%26epage%3D2583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Amar</span>, <span class="hlFld-ContribAuthor ">Dmitriy  Minond</span>, <span class="hlFld-ContribAuthor ">Gregg B.  Fields</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Implications of Compounds Designed to Inhibit ECM-Modifying Metalloproteinases. </span><span class="cited-content_cbyCitation_journal-name">PROTEOMICS</span><span> <strong>2017,</strong> <em>17 </em>
                                    (23-24)
                                     , 1600389. <a href="https://doi.org/10.1002/pmic.201600389" title="DOI URL">https://doi.org/10.1002/pmic.201600389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pmic.201600389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpmic.201600389%26sid%3Dliteratum%253Aachs%26jtitle%3DPROTEOMICS%26atitle%3DClinical%252BImplications%252Bof%252BCompounds%252BDesigned%252Bto%252BInhibit%252BECM-Modifying%252BMetalloproteinases%26aulast%3DAmar%26aufirst%3DSabrina%26date%3D2017%26date%3D2017%26volume%3D17%26issue%3D23-24%26spage%3D1600389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Dreymueller</span>, <span class="hlFld-ContribAuthor ">Andreas  Ludwig</span>. </span><span class="cited-content_cbyCitation_article-title">Considerations on inhibition approaches for proinflammatory functions of ADAM proteases. </span><span class="cited-content_cbyCitation_journal-name">Platelets</span><span> <strong>2017,</strong> <em>28 </em>
                                    (4)
                                     , 354-361. <a href="https://doi.org/10.1080/09537104.2016.1203396" title="DOI URL">https://doi.org/10.1080/09537104.2016.1203396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/09537104.2016.1203396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F09537104.2016.1203396%26sid%3Dliteratum%253Aachs%26jtitle%3DPlatelets%26atitle%3DConsiderations%252Bon%252Binhibition%252Bapproaches%252Bfor%252Bproinflammatory%252Bfunctions%252Bof%252BADAM%252Bproteases%26aulast%3DDreymueller%26aufirst%3DDaniela%26date%3D2017%26date%3D2016%26volume%3D28%26issue%3D4%26spage%3D354%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcia L.  Moss</span>, <span class="hlFld-ContribAuthor ">Dmitry  Minond</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Mediators of Inflammation</span><span> <strong>2017,</strong> <em>2017 </em>, 1-21. <a href="https://doi.org/10.1155/2017/9673537" title="DOI URL">https://doi.org/10.1155/2017/9673537</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2017/9673537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2017%2F9673537%26sid%3Dliteratum%253Aachs%26jtitle%3DMediators%2520of%2520Inflammation%26atitle%3DRecent%252BAdvances%252Bin%252BADAM17%252BResearch%25253A%252BA%252BPromising%252BTarget%252Bfor%252BCancer%252Band%252BInflammation%26aulast%3DMoss%26aufirst%3DMarcia%2BL.%26date%3D2017%26volume%3D2017%26spage%3D1%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franck  Madoux</span>, <span class="hlFld-ContribAuthor ">Daniela  Dreymuller</span>, <span class="hlFld-ContribAuthor ">Jean-Phillipe  Pettiloud</span>, <span class="hlFld-ContribAuthor ">Radleigh  Santos</span>, <span class="hlFld-ContribAuthor ">Christoph  Becker-Pauly</span>, <span class="hlFld-ContribAuthor ">Andreas  Ludwig</span>, <span class="hlFld-ContribAuthor ">Gregg B.  Fields</span>, <span class="hlFld-ContribAuthor ">Thomas  Bannister</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Spicer</span>, <span class="hlFld-ContribAuthor ">Mare  Cudic</span>, <span class="hlFld-ContribAuthor ">Louis D.  Scampavia</span>, <span class="hlFld-ContribAuthor ">Dmitriy  Minond</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-016-0013-4" title="DOI URL">https://doi.org/10.1038/s41598-016-0013-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-016-0013-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-016-0013-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252Ban%252Benzyme%252Band%252Bsubstrate%252Bselective%252Binhibitor%252Bof%252BADAM10%252Busing%252Ban%252Bexosite-binding%252Bglycosylated%252Bsubstrate%26aulast%3DMadoux%26aufirst%3DFranck%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Results of cell viability assay with ADAM17 inhibitors. (A) Viability assay with CHO-K1 cells. (B) Viability assay with A549 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Results of TNFÎ± shedding assay in THP-1 cells with ADAM17 inhibitors. (A) Single point assay. One-way analysis of variance (ANOVA) was used followed by Dunnett posthoc test. The data shown are the mean Â± SEM, <i>n</i> = 5. *****<i>p</i> < 0.0001; ***<i>p</i> < 0.001, **<i>p</i> < 0.01, *<i>p</i> < 0.05. (B) Doseâresponse assay with compounds <b>17</b> and <b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of ADAM17 inhibitors on cytokine shedding in HTMS cells. (A) LPS-stimulated IL-8 shedding inhibition assay. (B) IL-1-stimulated IL-8 shedding inhibition assay. (C) Fractalkine constitutive shedding inhibition assay. One-way analysis of variance (ANOVA) was used followed by Dunnett posthoc test. The data shown are the mean Â± SEM, <i>n</i> = 3 from three independent experiments. *****<i>p</i> value <0.0001, ***<i>p</i> value <0.001, **<i>p</i> value <0.01, *<i>p</i> value <0.05. GI: control ADAM10 selective inhibitor GI254023X.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Results of DDR1 release assay in HCC1806 breast cancer cells with compound <b>17</b>. One, untreated control; <b>2</b>, 10 Î¼M compound <b>17</b>; 3, 20 Î¼M compound <b>17</b>, 4â40 Î¼M compound <b>17</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound <b>17</b> on PTK7 shedding and invasion. (A) PTK7 shedding assay in HT1080 (fibrosarcoma) and SW480 (colorectal cancer) cells. (B) Invasion assay in HT1080 cells. sPTK7: soluble PTK7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of ADAM17 inhibitors on growth factors shedding in A549 cells. (A) Effect on shedding of heregulin. M-stat: marimastat. (B) Effect on shedding of betacellulin. One-way analysis of variance (ANOVA) was used followed by Dunnett posthoc test. The data shown are the mean Â± SEM, <i>n</i> = 3. ***<i>p</i> <0.001. (C) Effect on shedding of TGFÎ±. One-way analysis of variance (ANOVA) was used followed by Dunnett posthoc test. The data shown are the mean Â± SEM, <i>n</i> = 3. ***<i>p</i> <0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0014.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Results of synergy studies of compound <b>17</b> with FDA-approved lung cancer drugs. (A) Synergy study with gefitinib. (B) Synergy study with etoposide. (C) Synergy study with doxorubicin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/medium/jm-2015-00354a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis Procedure for Leads of Pyrrollidine-bis-diketopiperazine Series Used in Present Studies</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00354/20150807/images/large/jm-2015-00354a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00354&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33705" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33705" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 63 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Edwards, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handsley, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, C. J.</span><span> </span><span class="NLM_article-title"><i>The ADAM metalloproteinases</i></span> <span class="citation_source-journal">Mol. Aspects Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">258</span><span class="NLM_x">â</span> <span class="NLM_lpage">89</span><span class="refDoi">Â DOI: 10.1016/j.mam.2008.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.mam.2008.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=18762209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ShsLnM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=258-89&issue=5&author=D.+R.+Edwardsauthor=M.+M.+Handsleyauthor=C.+J.+Pennington&title=The+ADAM+metalloproteinases&doi=10.1016%2Fj.mam.2008.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The ADAM metalloproteinases</span></div><div class="casAuthors">Edwards, Dylan R.; Handsley, Madeleine M.; Pennington, Caroline J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">258-289</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ADAMs (a disintegrin and metalloproteinase) are a fascinating family of transmembrane and secreted proteins with important roles in regulating cell phenotype via their effects on cell adhesion, migration, proteolysis and signalling.  Though all ADAMs contain metalloproteinase domains, in humans only 13 of the 21 genes in the family encode functional proteases, indicating that at least for the other eight members, protein-protein interactions are crit. aspects of their biol. functions.  The functional ADAM metalloproteinases are involved in "ectodomain shedding" of diverse growth factors, cytokines, receptors and adhesion mols.  The archetypal activity is shown by ADAM-17 (tumor necrosis factor-Î± convertase, TACE), which is the principal protease involved in the activation of pro-TNF-Î±, but whose sheddase functions cover a broad range of cell surface mols.  In particular, ADAM-17 is required for generation of the active forms of Epidermal Growth Factor Receptor (EGFR) ligands, and its function is essential for the development of epithelial tissues.  Several other ADAMs have important sheddase functions in particular tissue contexts.  Another major family member, ADAM-10, is a principal player in signalling via the Notch and Eph/ephrin pathways.  For a growing no. of substrates, foremost among them being Notch, cleavage by ADAM sheddases is essential for their subsequent "regulated intramembrane proteolysis" (RIP), which generates cleaved intracellular domains that translocate to the nucleus and regulate gene transcription.  Several ADAMs play roles in spermatogenesis and sperm function, potentially by effecting maturation of sperm and their adhesion and migration in the uterus.  Other non-catalytic ADAMs function in the CNS via effects on guidance mechanisms.  The ADAM family are thus fundamental to many control processes in development and homeostasis, and unsurprisingly they are also linked to pathol. states when their functions are dysregulated, including cancer, cardiovascular disease, asthma, Alzheimer's disease.  This review will provide an overview of current knowledge of the human ADAMs, discussing their structure, function, regulation and disease involvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5y6VHfdnkV7Vg90H21EOLACvtfcHk0ljdYgR1GyD6Tw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ShsLnM&md5=f2a2ba7a28bfeedd908526c5e0fb20ac</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2008.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2008.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DD.%2BR.%26aulast%3DHandsley%26aufirst%3DM.%2BM.%26aulast%3DPennington%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520ADAM%2520metalloproteinases%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2008%26volume%3D29%26issue%3D5%26spage%3D258%26epage%3D89%26doi%3D10.1016%2Fj.mam.2008.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Moss, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sklair-Tavron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, R.</span><span> </span><span class="NLM_article-title"><i>Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis</i></span> <span class="citation_source-journal">Nat. Clin. Pract. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">300</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1038/ncprheum0797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2Fncprheum0797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=18414459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFyktrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=300-9&issue=6&author=M.+L.+Mossauthor=L.+Sklair-Tavronauthor=R.+Nudelman&title=Drug+insight%3A+tumor+necrosis+factor-converting+enzyme+as+a+pharmaceutical+target+for+rheumatoid+arthritis&doi=10.1038%2Fncprheum0797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis</span></div><div class="casAuthors">Moss, Marcia L.; Sklair-Tavron, Liora; Nudelman, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Rheumatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">300-309</span>CODEN:
                <span class="NLM_cas:coden">NCPRCF</span>;
        ISSN:<span class="NLM_cas:issn">1745-8382</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Drugs that inhibit tumor necrosis factor (TNF) provide considerable benefit in treatment of rheumatoid arthritis (RA); however, there is an unmet medical need for alternative therapies with higher clin. benefit and lower safety risk and cost.  The potential to treat RA by targeting TNF-converting enzyme, which promotes the release of sol. TNF from its membrane-bound precursor, is outlined in this Review.  The success of agents that inhibit tumor necrosis factor (TNF), such as infliximab, adalimumab and etanercept, has led to a desire for orally available small mols. that have a better safety profile and are less costly to produce than current agents.  One target for anti-TNF therapy that is currently under investigation is TNF-converting enzyme, which promotes the release of sol. TNF from its membrane-bound precursor.  Inhibitors of this enzyme with drug-like properties have been made and tested in the clinic.  These inhibitors include TMI-005 and BMS-561392, both of which have entered into phase II clin. trials.  This article summarizes preclin. and clin. findings regarding the use of inhibitors of TNF-converting enzyme for the treatment of rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSuKdTCwfevLVg90H21EOLACvtfcHk0lhJC0-jPSrNrA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFyktrg%253D&md5=010f075b0cfb6379a47a5aabbcc2ac0b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fncprheum0797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncprheum0797%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DM.%2BL.%26aulast%3DSklair-Tavron%26aufirst%3DL.%26aulast%3DNudelman%26aufirst%3DR.%26atitle%3DDrug%2520insight%253A%2520tumor%2520necrosis%2520factor-converting%2520enzyme%2520as%2520a%2520pharmaceutical%2520target%2520for%2520rheumatoid%2520arthritis%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Rheumatol.%26date%3D2008%26volume%3D4%26issue%3D6%26spage%3D300%26epage%3D9%26doi%3D10.1038%2Fncprheum0797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kataoka, H.</span><span> </span><span class="NLM_article-title"><i>EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments</i></span> <span class="citation_source-journal">J. Dermatol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">148</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span><span class="refDoi">Â DOI: 10.1016/j.jdermsci.2009.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.jdermsci.2009.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=19896805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlt77L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2009&pages=148-53&issue=3&author=H.+Kataoka&title=EGFR+ligands+and+their+signaling+scissors%2C+ADAMs%2C+as+new+molecular+targets+for+anticancer+treatments&doi=10.1016%2Fj.jdermsci.2009.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments</span></div><div class="casAuthors">Kataoka, Hiromi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-153</span>CODEN:
                <span class="NLM_cas:coden">JDSCEI</span>;
        ISSN:<span class="NLM_cas:issn">0923-1811</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Members of the human epidermal growth factor receptor (HER) family of receptor tyrosine kinases and their ligands (EGFR ligands) are known to play crucial roles in the regulation of cell proliferation and differentiation, and in the survival of many types of cancer.  HER family members are activated in cancer cells and are now considered to be useful mol. targets for cancer therapy.  Recently, several new drugs, including monoclonal antibodies and small-mol. inhibitors that target HER members, have been developed and clin. used to treat solid tumors.  Members of a disintegrin and metalloproteinase (ADAM) family are thought to mediate the shedding of EGFR ligands and this event is crit. for the prodn. of sol. functional EGFR ligands.  In melanoma cells, UV irradn. activates some ADAM members and induces melanoma cell growth through EGFR ligand shedding by activated ADAMs.  These findings suggest that ADAM inhibitors are also candidate anticancer drugs acting via the blockade of HER family signaling pathways.  After shedding of EGFR ligands by ADAMs, the carboxy-terminal fragments (CTFs) of EGFR ligands in the cytoplasm are translocated to the nucleus and induce cell proliferation by binding and exporting repressors and activating cyclin A and c-Myc.  Based on these findings, the present mol. targeting therapy against HER members, EGFR and HER2, may not be sufficient, while ADAMs and nuclear translocation of the CTF of EGFR ligands are potential targets for the treatment of cancer, particularly malignancies that are dependent on the EGF family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7c8NW9kenQLVg90H21EOLACvtfcHk0lhJC0-jPSrNrA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlt77L&md5=7a2fc57ff061bac8416e7c1087817d01</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jdermsci.2009.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdermsci.2009.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DKataoka%26aufirst%3DH.%26atitle%3DEGFR%2520ligands%2520and%2520their%2520signaling%2520scissors%252C%2520ADAMs%252C%2520as%2520new%2520molecular%2520targets%2520for%2520anticancer%2520treatments%26jtitle%3DJ.%2520Dermatol.%2520Sci.%26date%3D2009%26volume%3D56%26issue%3D3%26spage%3D148%26epage%3D53%26doi%3D10.1016%2Fj.jdermsci.2009.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Asai, M.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase</i></span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">231</span><span class="NLM_x">â</span> <span class="NLM_lpage">5</span><span class="refDoi">Â DOI: 10.1016/S0006-291X(02)02999-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2FS0006-291X%2802%2902999-6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2003&pages=231-5&issue=1&author=M.+Asai&title=Putative+function+of+ADAM9%2C+ADAM10%2C+and+ADAM17+as+APP+alpha-secretase&doi=10.1016%2FS0006-291X%2802%2902999-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2802%2902999-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252802%252902999-6%26sid%3Dliteratum%253Aachs%26aulast%3DAsai%26aufirst%3DM.%26atitle%3DPutative%2520function%2520of%2520ADAM9%252C%2520ADAM10%252C%2520and%2520ADAM17%2520as%2520APP%2520alpha-secretase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D301%26issue%3D1%26spage%3D231%26epage%3D5%26doi%3D10.1016%2FS0006-291X%2802%2902999-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Murumkar, P. R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Novel TACE inhibitors in drug discovery: a review of patented compounds</i></span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">31</span><span class="NLM_x">â</span> <span class="NLM_lpage">57</span><span class="refDoi">Â DOI: 10.1517/13543770903465157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1517%2F13543770903465157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=20021284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SmsbvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=31-57&issue=1&author=P.+R.+Murumkar&title=Novel+TACE+inhibitors+in+drug+discovery%3A+a+review+of+patented+compounds&doi=10.1517%2F13543770903465157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Novel TACE inhibitors in drug discovery: a review of patented compounds</span></div><div class="casAuthors">Murumkar, Prashant R.; Das Gupta, Shirshendu; Chandani, Sneha R.; Giridhar, Rajani; Yadav, Mange Ram</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-57</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  TNF-Î± converting enzyme (TACE), a pro-inflammatory cytokine, catalyzes the formation of TNF-Î± from membrane bound TNF-Î± precursor protein.  TNF-Î± is believed to play pathophysiol. roles in inflammation, anorexia, cachexia, septic shock, viral replication and so on.  TNF-Î± is a key player in inflammation and joint damage in rheumatoid arthritis.  While a variety of TACE inhibitors have been reported in the literature, a vast majority of these compds. are peptidic and peptide-like compds. that are expected to have bioavailability and pharmacokinetic problems, common to such compds., limiting their clin. effectiveness.  Low mol. mass, long acting, orally bioavailable inhibitors of TACE are, therefore, highly desirable for the treatment of potential chronic diseases mentioned above.  A review of patented compds. as TACE inhibitors in drug discovery is given.  A selection of interesting patents recorded from 2001 to 2009 is presented.  Various novel TACE inhibitors developed by different companies have been discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGron3ywSCYrb7Vg90H21EOLACvtfcHk0lhJC0-jPSrNrA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SmsbvO&md5=2bb922b5dad96f3f721e861d6f2c7bf4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543770903465157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903465157%26sid%3Dliteratum%253Aachs%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26atitle%3DNovel%2520TACE%2520inhibitors%2520in%2520drug%2520discovery%253A%2520a%2520review%2520of%2520patented%2520compounds%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D31%26epage%3D57%26doi%3D10.1517%2F13543770903465157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Renkiewicz, R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats</i></span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1742</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1002/art.11030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1002%2Fart.11030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=12794843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlSgu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=1742-9&issue=6&author=R.+Renkiewicz&title=Broad-spectrum+matrix+metalloproteinase+inhibitor+marimastat-induced+musculoskeletal+side+effects+in+rats&doi=10.1002%2Fart.11030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats</span></div><div class="casAuthors">Renkiewicz, Richard; Qiu, Luping; Lesch, Charles; Sun, Xin; Devalaraja, Radhika; Cody, Theresa; Kaldjian, Eric; Welgus, Howard; Baragi, Vijaykumar</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1742-1749</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The aim was to characterize the clin. and histopathol. changes in a rat model of broad-spectrum matrix metalloproteinase (MMP)-induced musculoskeletal syndrome (MSS), and to facilitate research into the causes and treatments of MSS in humans.  Male Lewis rats weighing 150-180 gm were administered 10-30 mg of the broad-spectrum MMP inhibitor marimastat over a 2-wk period via surgically implanted s.c. osmotic pumps.  The animals were monitored and scored for the onset and severity of MSS, using clin. and histol. parameters.  Marimastat-treated rats exhibited various clin. signs, including compromised ability to rest on their hind feet, high-stepping gait, reluctance or inability to move, and hind paw swelling.  Histol., marimastat-treated rat joints were characterized by soft tissue and bone changes, such as increased epiphyseal growth plate, synovial hyperplasia, and increased cellularity in the joint capsule and extracapsular ligaments.  The severity of MSS, as judged by clin. criteria (2 blinded observers using 3 clin. parameters), paw vol., and histol. score, was nearly identical.  The obsd. changes were indistinguishable from those reported for primate models and mimic MSS in humans.  This simple and sensitive model of MSS is an attractive alternative for studying the pathol. of MSS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp15ajNWrmIbLVg90H21EOLACvtfcHk0lg0QGefadH3ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlSgu7c%253D&md5=83cf556e52d5873e969cf526347bfe92</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fart.11030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.11030%26sid%3Dliteratum%253Aachs%26aulast%3DRenkiewicz%26aufirst%3DR.%26atitle%3DBroad-spectrum%2520matrix%2520metalloproteinase%2520inhibitor%2520marimastat-induced%2520musculoskeletal%2520side%2520effects%2520in%2520rats%26jtitle%3DArthritis%2520Rheum.%26date%3D2003%26volume%3D48%26issue%3D6%26spage%3D1742%26epage%3D9%26doi%3D10.1002%2Fart.11030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Murumkar, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giridhar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, M. R.</span><span> </span><span class="NLM_article-title"><i>Novel methods and strategies in the discovery of TACE inhibitors</i></span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">157</span><span class="NLM_x">â</span> <span class="NLM_lpage">81</span><span class="refDoi">Â DOI: 10.1517/17460441.2013.744745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1517%2F17460441.2013.744745" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=157-81&issue=2&author=P.+R.+Murumkarauthor=R.+Giridharauthor=M.+R.+Yadav&title=Novel+methods+and+strategies+in+the+discovery+of+TACE+inhibitors&doi=10.1517%2F17460441.2013.744745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.744745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.744745%26sid%3Dliteratum%253Aachs%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DGiridhar%26aufirst%3DR.%26aulast%3DYadav%26aufirst%3DM.%2BR.%26atitle%3DNovel%2520methods%2520and%2520strategies%2520in%2520the%2520discovery%2520of%2520TACE%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26issue%3D2%26spage%3D157%26epage%3D81%26doi%3D10.1517%2F17460441.2013.744745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Yadav, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murumkar, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zambre, V. P.</span><span> </span><span class="NLM_article-title"><i>Advances in studies on collagenase inhibitors</i></span> <span class="citation_source-journal">EXS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">â</span> <span class="NLM_lpage">135</span><span class="refDoi">Â DOI: 10.1007/978-3-0348-0364-9_4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1007%2F978-3-0348-0364-9_4" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2012&pages=83-135&author=M.+R.+Yadavauthor=P.+R.+Murumkarauthor=V.+P.+Zambre&title=Advances+in+studies+on+collagenase+inhibitors&doi=10.1007%2F978-3-0348-0364-9_4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2F978-3-0348-0364-9_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-0348-0364-9_4%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DM.%2BR.%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DZambre%26aufirst%3DV.%2BP.%26atitle%3DAdvances%2520in%2520studies%2520on%2520collagenase%2520inhibitors%26jtitle%3DEXS%26date%3D2012%26volume%3D103%26spage%3D83%26epage%3D135%26doi%3D10.1007%2F978-3-0348-0364-9_4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">DasGupta, S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Current perspective of TACE inhibitors: a review</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">444</span><span class="NLM_x">â</span> <span class="NLM_lpage">59</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2008.11.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bmc.2008.11.067" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=444-59&issue=2&author=S.+DasGupta&title=Current+perspective+of+TACE+inhibitors%3A+a+review&doi=10.1016%2Fj.bmc.2008.11.067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.11.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.11.067%26sid%3Dliteratum%253Aachs%26aulast%3DDasGupta%26aufirst%3DS.%26atitle%3DCurrent%2520perspective%2520of%2520TACE%2520inhibitors%253A%2520a%2520review%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D2%26spage%3D444%26epage%3D59%26doi%3D10.1016%2Fj.bmc.2008.11.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Georgiadis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiotakis, A.</span><span> </span><span class="NLM_article-title"><i>Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">8781</span><span class="NLM_x">â</span> <span class="NLM_lpage">94</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2008.08.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bmc.2008.08.058" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8781-94&issue=19&author=D.+Georgiadisauthor=A.+Yiotakis&title=Specific+targeting+of+metzincin+family+members+with+small-molecule+inhibitors%3A+progress+toward+a+multifarious+challenge&doi=10.1016%2Fj.bmc.2008.08.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.08.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.08.058%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DYiotakis%26aufirst%3DA.%26atitle%3DSpecific%2520targeting%2520of%2520metzincin%2520family%2520members%2520with%2520small-molecule%2520inhibitors%253A%2520progress%2520toward%2520a%2520multifarious%2520challenge%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26issue%3D19%26spage%3D8781%26epage%3D94%26doi%3D10.1016%2Fj.bmc.2008.08.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Fisher, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashery, S.</span><span> </span><span class="NLM_article-title"><i>Recent advances in MMP inhibitor design</i></span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">115</span><span class="NLM_x">â</span> <span class="NLM_lpage">36</span><span class="refDoi">Â DOI: 10.1007/s10555-006-7894-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1007%2Fs10555-006-7894-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=16680577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=115-36&issue=1&author=J.+F.+Fisherauthor=S.+Mobashery&title=Recent+advances+in+MMP+inhibitor+design&doi=10.1007%2Fs10555-006-7894-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in MMP inhibitor design</span></div><div class="casAuthors">Fisher, Jed F.; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-136</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The search for an MMP inhibitor with anticancer efficacy is a nearly three-decade endeavor.  This inhibitor is yet to be found.  The reasons for this failure include shortcomings in the chem. of these compds. (including broad MMP sub-type selectivity, metabolic lability, and toxicity) as well as the emerging, and arguably extraordinary, complexity of MMP cell (and cancer) biol.  Together these suggest that the successful anticancer inhibitor must possess MMP selectivity against the MMP subtype whose involvement is crit., yet highly temporally (with respect to metastatic progression) and mechanistically (with respect to matrix degrdn.) regulated.  This review summarizes the progression of chem. structure and mechanistic thinking toward these objectives, with emphasis on the disappointment, the perseverance, and the resilient optimism that such an inhibitor is there to be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgy2dldRRXLVg90H21EOLACvtfcHk0lg0QGefadH3ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D&md5=ceed8438ad533dac294e22102e5ba8bf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10555-006-7894-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-006-7894-9%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520MMP%2520inhibitor%2520design%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2006%26volume%3D25%26issue%3D1%26spage%3D115%26epage%3D36%26doi%3D10.1007%2Fs10555-006-7894-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Yiotakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dive, V.</span><span> </span><span class="NLM_article-title"><i>Synthetic active site-directed inhibitors of metzincins: achievement and perspectives</i></span> <span class="citation_source-journal">Mol. Aspects Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span><span class="NLM_x">â</span> <span class="NLM_lpage">38</span><span class="refDoi">Â DOI: 10.1016/j.mam.2008.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.mam.2008.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=18657570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ShsLnP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=329-38&issue=5&author=A.+Yiotakisauthor=V.+Dive&title=Synthetic+active+site-directed+inhibitors+of+metzincins%3A+achievement+and+perspectives&doi=10.1016%2Fj.mam.2008.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic active site-directed inhibitors of metzincins: Achievement and perspectives</span></div><div class="casAuthors">Yiotakis, Athanasios; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">329-338</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The involvement of many zinc metalloproteinases belonging to the metzincin family with a variety of pathol. states raises the possibility of therapeutic intervention using synthetic inhibitors with appropriate selectivity.  Knowledge of the catalytic domain 3D-structures for various members of the metzincin family has been successfully exploited by chemists to develop potent synthetic inhibitors.  However, despite intense efforts, very few highly selective inhibitors of metzincins have been discovered up to now.  A survey of the literature suggests that the over-exploitation of the hydroxamate function as a zinc-binding group to develop inhibitors might be responsible for this situation.  The use of alternative zinc-binding groups has led to more selective inhibitors, but the most encouraging results have been obtained for MMP-13 with compds. that do not incorporate zinc-binding groups in their structure.  This new family of inhibitors exploits the presence of a deep S 1 ' cavity in the protease active site, a specific trait shared by many members of the metzincin family.  However, to be successfully transposed to the metzincin members, this strategy will not only be able to exploit the structural detail of these S 1 ' cavities, but probably also subtle difference in their dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGory6HknHN-obVg90H21EOLACvtfcHk0lgc_Dm4KP9iSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ShsLnP&md5=44bb1c612fad4769f3bdea1de9ba4792</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2008.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2008.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYiotakis%26aufirst%3DA.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DSynthetic%2520active%2520site-directed%2520inhibitors%2520of%2520metzincins%253A%2520achievement%2520and%2520perspectives%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2008%26volume%3D29%26issue%3D5%26spage%3D329%26epage%3D38%26doi%3D10.1016%2Fj.mam.2008.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Engel, C. K.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Structural basis for the highly selective inhibition of MMP-13</i></span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">181</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1016/j.chembiol.2004.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.chembiol.2004.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=15734645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslCmsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=181-9&issue=2&author=C.+K.+Engel&title=Structural+basis+for+the+highly+selective+inhibition+of+MMP-13&doi=10.1016%2Fj.chembiol.2004.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Highly Selective Inhibition of MMP-13</span></div><div class="casAuthors">Engel, Christian K.; Pirard, Bernard; Schimanski, Sandra; Kirsch, Reinhard; Habermann, Joerg; Klingler, Otmar; Schlotte, Volkhard; Weithmann, Klaus Ulrich; Wendt, K. Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-189</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Inhibitors for matrix metalloproteinases (MMPs) are under investigation for the treatment of cancer, arthritis, and cardiovascular disease.  Here, the authors report a class of highly selective MMP-13 inhibitors (pyrimidine dicarboxamides) that exhibit no detectable activity against other MMPs.  The high-resoln. x-ray structures of three mols. of this series bound to MMP-13 reveal a novel binding mode characterized by the absence of interactions between the inhibitors and the catalytic zinc.  The inhibitors bind in the S1' pocket and extend into an addnl. S1' side pocket, which is unique to MMP-13.  The authors analyze the determinants for selectivity and describe the rational design of improved compds. with low nanomolar affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWxTXaerMLjLVg90H21EOLACvtfcHk0lgc_Dm4KP9iSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslCmsbY%253D&md5=92bf47d2ceb76db87ecae786fc89fc64</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DC.%2BK.%26atitle%3DStructural%2520basis%2520for%2520the%2520highly%2520selective%2520inhibition%2520of%2520MMP-13%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26issue%3D2%26spage%3D181%26epage%3D9%26doi%3D10.1016%2Fj.chembiol.2004.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Johnson, A. R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x"> (</span><span class="NLM_issue">38</span><span class="NLM_x">) </span> <span class="NLM_fpage">27781</span><span class="NLM_x">â</span> <span class="NLM_lpage">91</span><span class="refDoi">Â DOI: 10.1074/jbc.M703286200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M703286200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=17623656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVeju7nP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=27781-91&issue=38&author=A.+R.+Johnson&title=Discovery+and+characterization+of+a+novel+inhibitor+of+matrix+metalloprotease-13+that+reduces+cartilage+damage+in+vivo+without+joint+fibroplasia+side+effects&doi=10.1074%2Fjbc.M703286200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects</span></div><div class="casAuthors">Johnson, Adam R.; Pavlovsky, Alexander G.; Ortwine, Daniel F.; Prior, Faith; Man, Chiu-Fai; Bornemeier, Dirk A.; Banotai, Craig A.; Mueller, W. Thomas; McConnell, Patrick; Yan, Chunhong; Baragi, Vijay; Lesch, Charles; Roark, W. Howard; Wilson, Michael; Datta, Kaushik; Guzman, Roberto; Han, Hyo-Kyung; Dyer, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">27781-27791</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP13) is a Zn2+-dependent protease that catalyzes the cleavage of type II collagen, the main structural protein in articular cartilage.  Excess MMP13 activity causes cartilage degrdn. in osteoarthritis, making this protease an attractive therapeutic target.  However, clin. tested MMP inhibitors have been assocd. with a painful, joint-stiffening musculoskeletal side effect that may be due to their lack of selectivity.  In our efforts to develop a disease-modifying osteoarthritis drug, we have discovered MMP13 inhibitors that differ greatly from previous MMP inhibitors; they do not bind to the catalytic zinc ion, they are noncompetitive with respect to substrate binding, and they show extreme selectivity for inhibiting MMP13.  By structure-based drug design, we generated an orally active MMP13 inhibitor that effectively reduces cartilage damage in vivo and does not induce joint fibroplasias in a rat model of musculoskeletal syndrome side effects.  Thus, highly selective inhibition of MMP13 in patients may overcome the major safety and efficacy challenges that have limited previously tested non-selective MMP inhibitors.  MMP13 inhibitors such as the ones described here will help further define the role of this protease in arthritis and other diseases and may soon lead to drugs that safely halt cartilage damage in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCiHwTVRtp7bVg90H21EOLACvtfcHk0lgc_Dm4KP9iSQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVeju7nP&md5=9cc5d9b2edff3847141f21c42f86faf8</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M703286200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M703286200%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520novel%2520inhibitor%2520of%2520matrix%2520metalloprotease-13%2520that%2520reduces%2520cartilage%2520damage%2520in%2520vivo%2520without%2520joint%2520fibroplasia%2520side%2520effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D38%26spage%3D27781%26epage%3D91%26doi%3D10.1074%2Fjbc.M703286200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Baragi, V. M.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models</i></span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2008</span><span class="NLM_x">â</span> <span class="NLM_lpage">18</span><span class="refDoi">Â DOI: 10.1002/art.24629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1002%2Fart.24629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=19565489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlKku78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=2008-18&issue=7&author=V.+M.+Baragi&title=A+new+class+of+potent+matrix+metalloproteinase+13+inhibitors+for+potential+treatment+of+osteoarthritis%3A+Evidence+of+histologic+and+clinical+efficacy+without+musculoskeletal+toxicity+in+rat+models&doi=10.1002%2Fart.24629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis. Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models</span></div><div class="casAuthors">Baragi, Vijaykumar M.; Becher, Gabriel; Bendele, Alison M.; Biesinger, Ralf; Bluhm, Harald; Boer, Jurgen; Deng, Hongbo; Dodd, Rory; Essers, Michael; Feuerstein, Tim; Gallagher, Brian M., Jr.; Gege, Christian; Hochgurtel, Matthias; Hofmann, Michael; Jaworski, Andreas; Jin, Lixia; Kiely, Andrew; Korniski, Brian; Kroth, Heiko; Nix, Darrell; Nolte, Bert; Piecha, Dorothea; Powers, Timothy S.; Richter, Frank; Schneider, Matthias; Steeneck, Christoph; Sucholeiki, Irving; Taveras, Arthur; Timmermann, Andreas; van Veldhuizen, Joshua; Weik, Juergen; Wu, Xinyuan; Xia, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2008-2018</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: Matrix metalloproteinases (MMPs) have long been considered excellent targets for osteoarthritis (OA) treatment.  However, clin. utility of broad-spectrum MMP inhibitors developed for this purpose has been restricted by dose-limiting musculoskeletal side effects obsd. in humans.  This study was undertaken to identify a new class of potent and selective MMP-13 inhibitors that would provide histol. and clin. efficacy without musculoskeletal toxicity.  Methods. Selectivity assays were developed using catalytic domains of human MMPs.  Freshly isolated bovine articular cartilage or human OA cartilage was used in in vitro cartilage degrdn. assays.  The rat model of monoiodoacetate (MIA)-induced OA was implemented for assessing the effects of MMP-13 inhibitors on cartilage degrdn. and joint pain.  The surgical medial meniscus tear model in rats was used to evaluate the chondroprotective ability of MMP-13 inhibitors in a chronic disease model of OA.  The rat model of musculoskeletal side effects (MSS) was used to assess whether selective MMP-13 inhibitors have the joint toxicity assocd. with broad-spectrum MMP inhibitors.  Results. A no. of non-hydroxamic acid-contg. compds. that showed a high degree of potency for MMP-13 and selectivity against other MMPs were designed and synthesized.  Steady-state kinetics expts. and Lineweaver-Burk plot anal. of rate vs. substrate concn. with one such compd., ALS 1-0635, indicated linear, noncompetitive inhibition, and Dixon plot anal. from competition studies with a zinc chelator (acetoxyhydroxamic acid) and ALS 1-0635 demonstrated nonexclusive binding.  ALS 1-0635 inhibited bovine articular cartilage degrdn. in a dose-dependent manner (48.7% and 87.1% at 500 nM and 5,000 nM, resp.) and was effective in inhibiting interleukin-1Î±- and oncostatin M-induced C1,C2 release in human OA cartilage cultures.  ALS 1-0635 modulated cartilage damage in the rat MIA model (mean Â± SEM damage score 1.3 Â± 0.3, vs. 2.2 Â± 0.4 in vehicle-treated animals).  Most significantly, when treated twice daily with oral ALS 1-0635, rats with surgically induced medial meniscus tear exhibited histol. evidence of chondroprotection and reduced cartilage degeneration, without observable musculoskeletal toxicity.  Conclusion. The compds. investigated in this study represent a novel class of MMP-13 inhibitors.  They are mechanistically distinct from previously reported broad-spectrum MMP inhibitors and do not exhibit the problems previously assocd. with these inhibitors, including selectivity, poor pharmacokinetics, and MSS liability.  MMP-13 inhibitors exert chondro-protective effects and can potentially modulate joint pain, and are, therefore, uniquely suited as potential disease-modifying osteoarthritis drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWH6P91ktaKrVg90H21EOLACvtfcHk0liu8Ftu0488YA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlKku78%253D&md5=87a8b16eaf252bf4fd3c28217a78f8d6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fart.24629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24629%26sid%3Dliteratum%253Aachs%26aulast%3DBaragi%26aufirst%3DV.%2BM.%26atitle%3DA%2520new%2520class%2520of%2520potent%2520matrix%2520metalloproteinase%252013%2520inhibitors%2520for%2520potential%2520treatment%2520of%2520osteoarthritis%253A%2520Evidence%2520of%2520histologic%2520and%2520clinical%2520efficacy%2520without%2520musculoskeletal%2520toxicity%2520in%2520rat%2520models%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26issue%3D7%26spage%3D2008%26epage%3D18%26doi%3D10.1002%2Fart.24629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Piecha, D.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants</i></span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">379</span><span class="NLM_x">â</span> <span class="NLM_lpage">89</span><span class="refDoi">Â DOI: 10.1007/s00011-009-0112-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1007%2Fs00011-009-0112-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=19902332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslaktr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&pages=379-89&issue=5&author=D.+Piecha&title=Novel+selective+MMP-13+inhibitors+reduce+collagen+degradation+in+bovine+articular+and+human+osteoarthritis+cartilage+explants&doi=10.1007%2Fs00011-009-0112-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants</span></div><div class="casAuthors">Piecha, Dorothea; Weik, Juergen; Kheil, Heike; Becher, Gabriele; Timmermann, Andreas; Jaworski, Andreas; Burger, Maren; Hofmann, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">379-389</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Objective: MMP-13 is highly upregulated in arthritis and therefore strongly implicated in the pathogenesis of osteoarthritis (OA).  Selective inhibition of MMP-13 may provide the desired cartilage degrdn. protection, while overcoming the musculoskeletal toxicity seen with nonselective inhibition of MMPs.  Methods: Activity and selectivity of novel MMP-13 inhibitors were detd. in enzymic and collagenase assays.  Inhibition kinetics and competitive binding expts. were performed.  The inhibition of collagen degrdn. was studied in cartilage explants from OA patients and in bovine and human articular cartilage systems.  Results: We have identified a new class of very potent and highly selective non-zinc-binding MMP-13 inhibitors.  Selective MMP-13 inhibitors completely blocked type II collagen degrdn. in bovine explants and showed up to 80% inhibition in human OA cartilage.  Conclusions: These results indicate MMP-13 as the primary collagenase in the human OA cartilage and in the IL-1/OSM-induced cartilage degrdn. process and suggest that selective MMP-13 inhibitors may be a potential treatment of OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyWMZCjknmSLVg90H21EOLACvtfcHk0liu8Ftu0488YA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslaktr4%253D&md5=8558dff813c05930e74a6e8658c42645</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00011-009-0112-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00011-009-0112-9%26sid%3Dliteratum%253Aachs%26aulast%3DPiecha%26aufirst%3DD.%26atitle%3DNovel%2520selective%2520MMP-13%2520inhibitors%2520reduce%2520collagen%2520degradation%2520in%2520bovine%2520articular%2520and%2520human%2520osteoarthritis%2520cartilage%2520explants%26jtitle%3DInflammation%2520Res.%26date%3D2010%26volume%3D59%26issue%3D5%26spage%3D379%26epage%3D89%26doi%3D10.1007%2Fs00011-009-0112-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Li, J. J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">835</span><span class="NLM_x">â</span> <span class="NLM_lpage">41</span><span class="refDoi">Â DOI: 10.1021/jm701274v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701274v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=835-41&issue=4&author=J.+J.+Li&title=Quinazolinones+and+pyrido%5B3%2C4-d%5Dpyrimidin-4-ones+as+orally+active+and+specific+matrix+metalloproteinase-13+inhibitors+for+the+treatment+of+osteoarthritis&doi=10.1021%2Fjm701274v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm701274v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701274v%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26atitle%3DQuinazolinones%2520and%2520pyrido%255B3%252C4-d%255Dpyrimidin-4-ones%2520as%2520orally%2520active%2520and%2520specific%2520matrix%2520metalloproteinase-13%2520inhibitors%2520for%2520the%2520treatment%2520of%2520osteoarthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D835%26epage%3D41%26doi%3D10.1021%2Fjm701274v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Nara, H.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1</i>â³ <i>binding site</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5487</span><span class="NLM_x">â</span> <span class="NLM_lpage">505</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2014.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bmc.2014.07.025" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5487-505&issue=19&author=H.+Nara&title=Thieno%5B2%2C3-d%5Dpyrimidine-2-carboxamides+bearing+a+carboxybenzene+group+at+5-position%3A+Highly+potent%2C+selective%2C+and+orally+available+MMP-13+inhibitors+interacting+with+the+S1%E2%80%B3+binding+site&doi=10.1016%2Fj.bmc.2014.07.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DH.%26atitle%3DThieno%255B2%252C3-d%255Dpyrimidine-2-carboxamides%2520bearing%2520a%2520carboxybenzene%2520group%2520at%25205-position%253A%2520Highly%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520MMP-13%2520inhibitors%2520interacting%2520with%2520the%2520S1%25E2%2580%25B3%2520binding%2520site%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26issue%3D19%26spage%3D5487%26epage%3D505%26doi%3D10.1016%2Fj.bmc.2014.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Spicer, T. P.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">9598</span><span class="NLM_x">â</span> <span class="NLM_lpage">611</span><span class="refDoi">Â DOI: 10.1021/jm501284e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501284e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOgsrvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9598-611&issue=22&author=T.+P.+Spicer&title=Characterization+of+selective+exosite-binding+inhibitors+of+matrix+metalloproteinase+13+that+prevent+articular+cartilage+degradation+in+vitro&doi=10.1021%2Fjm501284e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro</span></div><div class="casAuthors">Spicer, Timothy P.; Jiang, Jianwen; Taylor, Alexander B.; Choi, Jun Yong; Hart, P. John; Roush, William R.; Fields, Gregg B.; Hodder, Peter S.; Minond, Dmitriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9598-9611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matrix metalloproteinase 13 (MMP-13) has been shown to be the main collagenase responsible for degrdn. of articular cartilage during osteoarthritis and therefore represents a target for drug development.  As a result of high-throughput screening and structure-activity relationship studies, the authors identified a novel, highly selective class of MMP-13 inhibitors.  Mechanistic characterization revealed a noncompetitive nature of these inhibitors with binding consts. in the low micromolar range.  Crystallog. analyses revealed two binding modes for compd. I in the MMP-13 S1' subsite and in an S1/S2* subsite.  Type II collagen- and cartilage-protective effects exhibited by the 3 compds. suggested that these compds. might be efficacious in future in vivo studies.  Finally, these compds. were also highly selective when tested against a panel of 30 proteases, which, in combination with a good CYP inhibition profile, suggested low off-target toxicity and drug-drug interactions in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCW6fx0sdNp7Vg90H21EOLACvtfcHk0lilw-4slgnCAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOgsrvF&md5=11b482b88311bf59b842995dd23d2b6a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm501284e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501284e%26sid%3Dliteratum%253Aachs%26aulast%3DSpicer%26aufirst%3DT.%2BP.%26atitle%3DCharacterization%2520of%2520selective%2520exosite-binding%2520inhibitors%2520of%2520matrix%2520metalloproteinase%252013%2520that%2520prevent%2520articular%2520cartilage%2520degradation%2520in%2520vitro%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D22%26spage%3D9598%26epage%3D611%26doi%3D10.1021%2Fjm501284e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Roth, J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds</i></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">7180</span><span class="NLM_x">â</span> <span class="NLM_lpage">4</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.09.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bmcl.2011.09.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=22018790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7180-4&issue=23&author=J.+Roth&title=Identification+of+novel%2C+exosite-binding+matrix+metalloproteinase-13+inhibitor+scaffolds&doi=10.1016%2Fj.bmcl.2011.09.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds</span></div><div class="casAuthors">Roth, Joshua; Minond, Dmitriy; Darout, Etzer; Liu, Qin; Lauer, Janelle; Hodder, Peter; Fields, Gregg B.; Roush, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7180-7184</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP-13) has been implicated as the protease responsible for collagen degrdn. in cartilage during osteoarthritis (OA).  Compds. that inhibit the metalloproteinase at the Zn binding site typically lack specificity among MMP family members.  Analogs of the low-micromolar lead MMP-13 inhibitor (I), discovered through high-throughput screening, were synthesized to investigate structure-activity relationships in this inhibitor series.  Systematic modifications of I led to the discovery of MMP-13 inhibitors II and III which are more selective than I against other MMPs.  Compd. II is also approx. fivefold more potent as an MMP-13 inhibitor than the original HTS-derived lead compd. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopP_zkFk8mibVg90H21EOLACvtfcHk0lilw-4slgnCAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7E&md5=cfde0e006c073edab16683e478bab78a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.077%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520novel%252C%2520exosite-binding%2520matrix%2520metalloproteinase-13%2520inhibitor%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D23%26spage%3D7180%26epage%3D4%26doi%3D10.1016%2Fj.bmcl.2011.09.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lauer-Fields, J. L.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">990</span><span class="NLM_x">â</span> <span class="NLM_lpage">1005</span><span class="refDoi">Â DOI: 10.1016/j.bmc.2008.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bmc.2008.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=18358729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOhur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=990-1005&issue=3&author=J.+L.+Lauer-Fields&title=High+throughput+screening+of+potentially+selective+MMP-13+exosite+inhibitors+utilizing+a+triple-helical+FRET+substrate&doi=10.1016%2Fj.bmc.2008.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate</span></div><div class="casAuthors">Lauer-Fields, Janelle L.; Minond, Dmitriy; Chase, Peter S.; Baillargeon, Pierre E.; Saldanha, S. Adrian; Stawikowska, Roma; Hodder, Peter; Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">990-1005</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The major components of the cartilage extracellular matrix are type II collagen and aggrecan.  Matrix metalloproteinase 13 (MMP-13) has been implicated as the protease responsible for collagen degrdn. in cartilage during osteoarthritis (OA).  In the present study, a triple-helical FRET substrate has been utilized for high throughput screening (HTS) of MMP-13 with the MLSCN compd. library (n â¼ 65,000).  Thirty-four compds. from the HTS produced pharmacol. dose-response curves.  A secondary screen using RP-HPLC validated 25 compds. as MMP-13 inhibitors.  Twelve of these compds. were selected for counter-screening with 6 representative MMP family members.  Five compds. were found to be broad-spectrum MMP inhibitors, 3 inhibited MMP-13 and one other MMP, and 4 were selective for MMP-13.  One of the selective inhibitors was more active against MMP-13 triple-helical peptidase activity compared with single-stranded peptidase activity.  Since the THP FRET substrate has distinct conformational features that may interact with MMP secondary binding sites (exosites), novel non-active site-binding inhibitors may be identified via HTS protocols utilizing such assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc6QPfFleUqrVg90H21EOLACvtfcHk0lilw-4slgnCAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOhur0%253D&md5=4fb566e532ff6271ba60771cc6453eb3</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DLauer-Fields%26aufirst%3DJ.%2BL.%26atitle%3DHigh%2520throughput%2520screening%2520of%2520potentially%2520selective%2520MMP-13%2520exosite%2520inhibitors%2520utilizing%2520a%2520triple-helical%2520FRET%2520substrate%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D3%26spage%3D990%26epage%3D1005%26doi%3D10.1016%2Fj.bmc.2008.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Jungel, A.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis</i></span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">898</span><span class="NLM_x">â</span> <span class="NLM_lpage">902</span><span class="refDoi">Â DOI: 10.1136/ard.2008.106021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1136%2Fard.2008.106021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=19497915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlOks7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2010&pages=898-902&issue=5&author=A.+Jungel&title=Effect+of+the+oral+application+of+a+highly+selective+MMP-13+inhibitor+in+three+different+animal+models+of+rheumatoid+arthritis&doi=10.1136%2Fard.2008.106021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis</span></div><div class="casAuthors">Jungel, Astrid; Ospelt, Caroline; Lesch, Mark; Thiel, Melissa; Sunyer, Teresa; Schorr, Olivier; Michel, Beat A.; Gay, Renate E.; Kolling, Christoph; Flory, Craig; Gay, Steffen; Neidhart, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">898-902</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objective: To evaluate the decrease of cartilage destruction by a novel orally active and specific matrix metalloproteinase 13 (MMP-13) inhibitor in three different animal models of rheumatoid arthritis (RA).  Materials and methods: The SCID mouse co-implantation model of RA, the collagen-induced arthritis (CIA) model in mice and the antigen-induced arthritis model (AIA) in rabbits were used.  Results: In the SCID mouse co-implantation model, the MMP-13 inhibitor reduced cartilage destruction by 75%.  In the CIA model of RA, the MMP-13 inhibitor resulted in a significant and dose-dependent decrease in clin. symptoms as well as of cartilage erosion by 38% (30 mg/kg), 28% (10 mg/kg) and 21% (3 mg/kg).  No significant effects were seen in the AIA model.  No toxic effects were seen in all three animal models.  Conclusion: Although several MMPs in concert with other proteinases have a role in the process of cartilage destruction, there is a need for highly selective MMP inhibitors to reduce severe side effects that occur with non-specific inhibitors.  Significant inhibition of MMP-13 reduced cartilage erosions in two of three tested animal models of RA.  These results strongly support the development of this class of drugs to reduce or halt joint destruction in patients with RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqlsYWFf09frVg90H21EOLACvtfcHk0lilw-4slgnCAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlOks7c%253D&md5=0cc3a494be3a939b217c19867c12bedd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1136%2Fard.2008.106021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2008.106021%26sid%3Dliteratum%253Aachs%26aulast%3DJungel%26aufirst%3DA.%26atitle%3DEffect%2520of%2520the%2520oral%2520application%2520of%2520a%2520highly%2520selective%2520MMP-13%2520inhibitor%2520in%2520three%2520different%2520animal%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2010%26volume%3D69%26issue%3D5%26spage%3D898%26epage%3D902%26doi%3D10.1136%2Fard.2008.106021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wijdeven, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neefjes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ovaa, H.</span><span> </span><span class="NLM_article-title"><i>How chemistry supports cell biology: the chemical toolbox at your service</i></span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">751</span><span class="NLM_x">â</span> <span class="NLM_lpage">760</span><span class="refDoi">Â DOI: 10.1016/j.tcb.2014.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.tcb.2014.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=25108565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlClurbO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=751-760&issue=12&author=R.+H.+Wijdevenauthor=J.+Neefjesauthor=H.+Ovaa&title=How+chemistry+supports+cell+biology%3A+the+chemical+toolbox+at+your+service&doi=10.1016%2Fj.tcb.2014.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">How chemistry supports cell biology: the chemical toolbox at your service</span></div><div class="casAuthors">Wijdeven, Ruud H.; Neefjes, Jacques; Ovaa, Huib</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">751-760</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Chem. biol. is a young and rapidly developing scientific field.  In this field, chem. is inspired by biol. to create various tools to monitor and modulate biochem. and cell biol. processes.  Chem. contributions such as small-mol. inhibitors and activity-based probes (ABPs) can provide new and unique insights into previously unexplored cellular processes.  This review provides an overview of recent breakthroughs in chem. biol. that are likely to have a significant impact on cell biol.  We also discuss the application of several chem. tools in cell biol. research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8oGuhRj3PrVg90H21EOLACvtfcHk0liZcz6mfGrzCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlClurbO&md5=df2574ed7d3a5a2f6ca4ddb1443360d7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2014.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2014.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DWijdeven%26aufirst%3DR.%2BH.%26aulast%3DNeefjes%26aufirst%3DJ.%26aulast%3DOvaa%26aufirst%3DH.%26atitle%3DHow%2520chemistry%2520supports%2520cell%2520biology%253A%2520the%2520chemical%2520toolbox%2520at%2520your%2520service%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2014%26volume%3D24%26issue%3D12%26spage%3D751%26epage%3D760%26doi%3D10.1016%2Fj.tcb.2014.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tape, C. J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Cross-domain inhibition of TACE ectodomain</i></span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">5578</span><span class="NLM_x">â</span> <span class="NLM_lpage">83</span><span class="refDoi">Â DOI: 10.1073/pnas.1017067108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1073%2Fpnas.1017067108" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5578-83&issue=14&author=C.+J.+Tape&title=Cross-domain+inhibition+of+TACE+ectodomain&doi=10.1073%2Fpnas.1017067108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1017067108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1017067108%26sid%3Dliteratum%253Aachs%26aulast%3DTape%26aufirst%3DC.%2BJ.%26atitle%3DCross-domain%2520inhibition%2520of%2520TACE%2520ectodomain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26issue%3D14%26spage%3D5578%26epage%3D83%26doi%3D10.1073%2Fpnas.1017067108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Minond, D.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Discovery of Novel Inhibitors of a Disintegrin and Metalloprotease 17 (ADAM17) Using Glycosylated and Non-glycosylated Substrates</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x"> (</span><span class="NLM_issue">43</span><span class="NLM_x">) </span> <span class="NLM_fpage">36473</span><span class="NLM_x">â</span> <span class="NLM_lpage">87</span><span class="refDoi">Â DOI: 10.1074/jbc.M112.389114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M112.389114" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=36473-87&issue=43&author=D.+Minond&title=Discovery+of+Novel+Inhibitors+of+a+Disintegrin+and+Metalloprotease+17+%28ADAM17%29+Using+Glycosylated+and+Non-glycosylated+Substrates&doi=10.1074%2Fjbc.M112.389114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.389114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.389114%26sid%3Dliteratum%253Aachs%26aulast%3DMinond%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520Novel%2520Inhibitors%2520of%2520a%2520Disintegrin%2520and%2520Metalloprotease%252017%2520%2528ADAM17%2529%2520Using%2520Glycosylated%2520and%2520Non-glycosylated%2520Substrates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D43%26spage%3D36473%26epage%3D87%26doi%3D10.1074%2Fjbc.M112.389114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Rose-John, S.</span><span> </span><span class="NLM_article-title"><i>ADAM17, shedding, TACE as therapeutic targets</i></span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">â</span> <span class="NLM_lpage">22</span><span class="refDoi">Â DOI: 10.1016/j.phrs.2013.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.phrs.2013.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=23415892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1ent7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2013&pages=19-22&author=S.+Rose-John&title=ADAM17%2C+shedding%2C+TACE+as+therapeutic+targets&doi=10.1016%2Fj.phrs.2013.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">ADAM17, shedding, TACE as therapeutic targets</span></div><div class="casAuthors">Rose-John, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-22</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  ADAM17 has been molecularly cloned as the enzyme responsible for cleavage of the transmembrane protein TNFÎ± (TNFÎ± converting enzyme, TACE).  Later it was realized that ADAM17 was also responsible for the processing of cell adhesion proteins, cytokine and growth factor receptors and many ligands of the EGF receptor.  Since TNFÎ± is a target of anti-inflammatory therapies, it was speculated that inhibition of ADAM17 might be a therapeutic strategy in the treatment of inflammation or inflammation assocd. cancer.  Meanwhile it has been recognized that ADAM17 governs many vital functions in the body and loss of ADAM17 leads to severe defects in the skin and to high susceptibility of the intestine to inflammation.  Here I summarize data on the physiol. role of ADAM17 and the feasibility of specific blockade of this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5jZzPC8uFnrVg90H21EOLACvtfcHk0liZcz6mfGrzCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1ent7Y%253D&md5=9c8b1157460bc5dd9d1f6135a35598a6</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2013.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2013.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DRose-John%26aufirst%3DS.%26atitle%3DADAM17%252C%2520shedding%252C%2520TACE%2520as%2520therapeutic%2520targets%26jtitle%3DPharmacol.%2520Res.%26date%3D2013%26volume%3D71%26spage%3D19%26epage%3D22%26doi%3D10.1016%2Fj.phrs.2013.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Moss, M. L.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha</i></span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x"> (</span><span class="NLM_issue">6618</span><span class="NLM_x">) </span> <span class="NLM_fpage">733</span><span class="NLM_x">â</span> <span class="NLM_lpage">6</span><span class="refDoi">Â DOI: 10.1038/385733a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2F385733a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=1997&pages=733-6&issue=6618&author=M.+L.+Moss&title=Cloning+of+a+disintegrin+metalloproteinase+that+processes+precursor+tumour-necrosis+factor-alpha&doi=10.1038%2F385733a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F385733a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F385733a0%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%26aufirst%3DM.%2BL.%26atitle%3DCloning%2520of%2520a%2520disintegrin%2520metalloproteinase%2520that%2520processes%2520precursor%2520tumour-necrosis%2520factor-alpha%26jtitle%3DNature%26date%3D1997%26volume%3D385%26issue%3D6618%26spage%3D733%26epage%3D6%26doi%3D10.1038%2F385733a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Black, R. A.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells</i></span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x"> (</span><span class="NLM_issue">6618</span><span class="NLM_x">) </span> <span class="NLM_fpage">729</span><span class="NLM_x">â</span> <span class="NLM_lpage">33</span><span class="refDoi">Â DOI: 10.1038/385729a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2F385729a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=1997&pages=729-33&issue=6618&author=R.+A.+Black&title=A+metalloproteinase+disintegrin+that+releases+tumour-necrosis+factor-alpha+from+cells&doi=10.1038%2F385729a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2F385729a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F385729a0%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DR.%2BA.%26atitle%3DA%2520metalloproteinase%2520disintegrin%2520that%2520releases%2520tumour-necrosis%2520factor-alpha%2520from%2520cells%26jtitle%3DNature%26date%3D1997%26volume%3D385%26issue%3D6618%26spage%3D729%26epage%3D33%26doi%3D10.1038%2F385729a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Nakanaga, T.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Regulation of interleukin-8 via an airway epithelial signaling cascade</i></span> <span class="citation_source-journal">Am. J. Physiol Lung Cell Mol. Physiol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">L1289</span><span class="NLM_x">â</span> <span class="NLM_lpage">96</span><span class="refDoi">Â DOI: 10.1152/ajplung.00356.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1152%2Fajplung.00356.2006" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=L1289-96&issue=5&author=T.+Nakanaga&title=Regulation+of+interleukin-8+via+an+airway+epithelial+signaling+cascade&doi=10.1152%2Fajplung.00356.2006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00356.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00356.2006%26sid%3Dliteratum%253Aachs%26aulast%3DNakanaga%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520interleukin-8%2520via%2520an%2520airway%2520epithelial%2520signaling%2520cascade%26jtitle%3DAm.%2520J.%2520Physiol%2520Lung%2520Cell%2520Mol.%2520Physiol%26date%3D2007%26volume%3D292%26issue%3D5%26spage%3DL1289%26epage%3D96%26doi%3D10.1152%2Fajplung.00356.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Dreymueller, D.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Smooth muscle cells relay acute pulmonary inflammation via distinct ADAM17/ErbB axes</i></span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">722</span><span class="NLM_x">â</span> <span class="NLM_lpage">31</span><span class="refDoi">Â DOI: 10.4049/jimmunol.1302496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.4049%2Fjimmunol.1302496" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2014&pages=722-31&issue=2&author=D.+Dreymueller&title=Smooth+muscle+cells+relay+acute+pulmonary+inflammation+via+distinct+ADAM17%2FErbB+axes&doi=10.4049%2Fjimmunol.1302496"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1302496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1302496%26sid%3Dliteratum%253Aachs%26aulast%3DDreymueller%26aufirst%3DD.%26atitle%3DSmooth%2520muscle%2520cells%2520relay%2520acute%2520pulmonary%2520inflammation%2520via%2520distinct%2520ADAM17%252FErbB%2520axes%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D192%26issue%3D2%26spage%3D722%26epage%3D31%26doi%3D10.4049%2Fjimmunol.1302496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Garton, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobel, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greaves, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempsey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raines, E. W.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">41</span><span class="NLM_x">) </span> <span class="NLM_fpage">37993</span><span class="NLM_x">â</span> <span class="NLM_lpage">38001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=37993-38001&issue=41&author=K.+J.+Gartonauthor=P.+J.+Goughauthor=C.+P.+Blobelauthor=G.+Murphyauthor=D.+R.+Greavesauthor=P.+J.+Dempseyauthor=E.+W.+Raines&title=Tumor+necrosis+factor-alpha-converting+enzyme+%28ADAM17%29+mediates+the+cleavage+and+shedding+of+fractalkine+%28CX3CL1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarton%26aufirst%3DK.%2BJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBlobel%26aufirst%3DC.%2BP.%26aulast%3DMurphy%26aufirst%3DG.%26aulast%3DGreaves%26aufirst%3DD.%2BR.%26aulast%3DDempsey%26aufirst%3DP.%2BJ.%26aulast%3DRaines%26aufirst%3DE.%2BW.%26atitle%3DTumor%2520necrosis%2520factor-alpha-converting%2520enzyme%2520%2528ADAM17%2529%2520mediates%2520the%2520cleavage%2520and%2520shedding%2520of%2520fractalkine%2520%2528CX3CL1%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D41%26spage%3D37993%26epage%3D38001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hundhausen, C.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion</i></span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1186</span><span class="NLM_x">â</span> <span class="NLM_lpage">95</span><span class="refDoi">Â DOI: 10.1182/blood-2002-12-3775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1182%2Fblood-2002-12-3775" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=1186-95&issue=4&author=C.+Hundhausen&title=The+disintegrin-like+metalloproteinase+ADAM10+is+involved+in+constitutive+cleavage+of+CX3CL1+%28fractalkine%29+and+regulates+CX3CL1-mediated+cell-cell+adhesion&doi=10.1182%2Fblood-2002-12-3775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1182%2Fblood-2002-12-3775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2002-12-3775%26sid%3Dliteratum%253Aachs%26aulast%3DHundhausen%26aufirst%3DC.%26atitle%3DThe%2520disintegrin-like%2520metalloproteinase%2520ADAM10%2520is%2520involved%2520in%2520constitutive%2520cleavage%2520of%2520CX3CL1%2520%2528fractalkine%2529%2520and%2520regulates%2520CX3CL1-mediated%2520cell-cell%2520adhesion%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26issue%3D4%26spage%3D1186%26epage%3D95%26doi%3D10.1182%2Fblood-2002-12-3775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Abel, S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10</i></span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">6362</span><span class="NLM_x">â</span> <span class="NLM_lpage">72</span><span class="refDoi">Â DOI: 10.4049/jimmunol.172.10.6362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.4049%2Fjimmunol.172.10.6362" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2004&pages=6362-72&issue=10&author=S.+Abel&title=The+transmembrane+CXC-chemokine+ligand+16+is+induced+by+IFN-gamma+and+TNF-alpha+and+shed+by+the+activity+of+the+disintegrin-like+metalloproteinase+ADAM10&doi=10.4049%2Fjimmunol.172.10.6362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.172.10.6362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.172.10.6362%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DS.%26atitle%3DThe%2520transmembrane%2520CXC-chemokine%2520ligand%252016%2520is%2520induced%2520by%2520IFN-gamma%2520and%2520TNF-alpha%2520and%2520shed%2520by%2520the%2520activity%2520of%2520the%2520disintegrin-like%2520metalloproteinase%2520ADAM10%26jtitle%3DJ.%2520Immunol.%26date%3D2004%26volume%3D172%26issue%3D10%26spage%3D6362%26epage%3D72%26doi%3D10.4049%2Fjimmunol.172.10.6362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Fu, H. L.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">12114</span><span class="NLM_x">â</span> <span class="NLM_lpage">29</span><span class="refDoi">Â DOI: 10.1074/jbc.M112.409599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M112.409599" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=12114-29&issue=17&author=H.+L.+Fu&title=Shedding+of+discoidin+domain+receptor+1+by+membrane-type+matrix+metalloproteinases&doi=10.1074%2Fjbc.M112.409599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.409599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.409599%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DH.%2BL.%26atitle%3DShedding%2520of%2520discoidin%2520domain%2520receptor%25201%2520by%2520membrane-type%2520matrix%2520metalloproteinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D17%26spage%3D12114%26epage%3D29%26doi%3D10.1074%2Fjbc.M112.409599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleshin, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strongin, A. Y.</span><span> </span><span class="NLM_article-title"><i>Potential relation of aberrant proteolysis of human protein tyrosine kinase 7 (PTK7) chuzhoi by membrane type 1 matrix metalloproteinase (MT1-MMP) to congenital defects</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">20970</span><span class="NLM_x">â</span> <span class="NLM_lpage">6</span><span class="refDoi">Â DOI: 10.1074/jbc.M111.237669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M111.237669" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=20970-6&issue=23&author=V.+S.+Golubkovauthor=A.+E.+Aleshinauthor=A.+Y.+Strongin&title=Potential+relation+of+aberrant+proteolysis+of+human+protein+tyrosine+kinase+7+%28PTK7%29+chuzhoi+by+membrane+type+1+matrix+metalloproteinase+%28MT1-MMP%29+to+congenital+defects&doi=10.1074%2Fjbc.M111.237669"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.237669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.237669%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26aulast%3DAleshin%26aufirst%3DA.%2BE.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26atitle%3DPotential%2520relation%2520of%2520aberrant%2520proteolysis%2520of%2520human%2520protein%2520tyrosine%2520kinase%25207%2520%2528PTK7%2529%2520chuzhoi%2520by%2520membrane%2520type%25201%2520matrix%2520metalloproteinase%2520%2528MT1-MMP%2529%2520to%2520congenital%2520defects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26issue%3D23%26spage%3D20970%26epage%3D6%26doi%3D10.1074%2Fjbc.M111.237669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x"> (</span><span class="NLM_issue">46</span><span class="NLM_x">) </span> <span class="NLM_fpage">35740</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1074/jbc.M110.165159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M110.165159" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=35740-9&issue=46&author=V.+S.+Golubkov&title=The+Wnt%2Fplanar+cell+polarity+protein-tyrosine+kinase-7+%28PTK7%29+is+a+highly+efficient+proteolytic+target+of+membrane+type-1+matrix+metalloproteinase%3A+implications+in+cancer+and+embryogenesis&doi=10.1074%2Fjbc.M110.165159"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.165159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.165159%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26atitle%3DThe%2520Wnt%252Fplanar%2520cell%2520polarity%2520protein-tyrosine%2520kinase-7%2520%2528PTK7%2529%2520is%2520a%2520highly%2520efficient%2520proteolytic%2520target%2520of%2520membrane%2520type-1%2520matrix%2520metalloproteinase%253A%2520implications%2520in%2520cancer%2520and%2520embryogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D46%26spage%3D35740%26epage%3D9%26doi%3D10.1074%2Fjbc.M110.165159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strongin, A. Y.</span><span> </span><span class="NLM_article-title"><i>Insights into Ectodomain Shedding and Processing of Protein-tyrosine Pseudokinase 7 (PTK7)</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x"> (</span><span class="NLM_issue">50</span><span class="NLM_x">) </span> <span class="NLM_fpage">42009</span><span class="NLM_x">â</span> <span class="NLM_lpage">18</span><span class="refDoi">Â DOI: 10.1074/jbc.M112.371153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M112.371153" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=42009-18&issue=50&author=V.+S.+Golubkovauthor=A.+Y.+Strongin&title=Insights+into+Ectodomain+Shedding+and+Processing+of+Protein-tyrosine+Pseudokinase+7+%28PTK7%29&doi=10.1074%2Fjbc.M112.371153"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.371153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.371153%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26atitle%3DInsights%2520into%2520Ectodomain%2520Shedding%2520and%2520Processing%2520of%2520Protein-tyrosine%2520Pseudokinase%25207%2520%2528PTK7%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D50%26spage%3D42009%26epage%3D18%26doi%3D10.1074%2Fjbc.M112.371153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Protein-tyrosine pseudokinase 7 (PTK7) directs cancer cell motility and metastasis</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x"> (</span><span class="NLM_issue">35</span><span class="NLM_x">) </span> <span class="NLM_fpage">24238</span><span class="NLM_x">â</span> <span class="NLM_lpage">49</span><span class="refDoi">Â DOI: 10.1074/jbc.M114.574459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M114.574459" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=24238-49&issue=35&author=V.+S.+Golubkov&title=Protein-tyrosine+pseudokinase+7+%28PTK7%29+directs+cancer+cell+motility+and+metastasis&doi=10.1074%2Fjbc.M114.574459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.574459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.574459%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26atitle%3DProtein-tyrosine%2520pseudokinase%25207%2520%2528PTK7%2529%2520directs%2520cancer%2520cell%2520motility%2520and%2520metastasis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26issue%3D35%26spage%3D24238%26epage%3D49%26doi%3D10.1074%2Fjbc.M114.574459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strongin, A. Y.</span><span> </span><span class="NLM_article-title"><i>Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells</i></span> <span class="citation_source-journal">Cell Commun. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="refDoi">Â DOI: 10.1186/1478-811X-12-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1186%2F1478-811X-12-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=24618420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1WrtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=15&author=V.+S.+Golubkovauthor=A.+Y.+Strongin&title=Downstream+signaling+and+genome-wide+regulatory+effects+of+PTK7+pseudokinase+and+its+proteolytic+fragments+in+cancer+cells&doi=10.1186%2F1478-811X-12-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells</span></div><div class="casAuthors">Golubkov, Vladislav S.; Strongin, Alex Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Communication and Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15/1-15/12, 12</span>CODEN:
                <span class="NLM_cas:coden">CCSEC6</span>;
        ISSN:<span class="NLM_cas:issn">1478-811X</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The full-length membrane protein tyrosine kinase 7 (PTK7) pseudokinase, an important component of the planar cell polarity and the Wnt canonical and non-canonical pathways, is a subject of step-wise proteolysis in cells and tissues.  The proteolysis of PTK7 involves membrane type-matrix metalloproteinase (MT1-MMP), members of the Disintegrin Domain and Metalloproteinase (ADAM) family, and Î³-secretase.  This multi-step proteolysis results in the generation of the digest fragments of PTK7.  These fragments may be either liberated into the extracellular milieu or retained on the plasma membrane or released into the cytoplasm and then transported into the nucleus.  Results: We employed the genome-wide transcriptional and kinome array analyses to det. the role of the full-length membrane PTK7 and its proteolytic fragments in the downstream regulatory mechanisms, with an emphasis on the cell migration-related genes and proteins.  Using fibrosarcoma HT1080 cells stably expressing PTK7 and its mutant and truncated species, the structure of which corresponded to the major PTK7 digest fragments, we demonstrated that the full-length membrane 1-1070 PTK7, the N-terminal 1-694 sol. ectodomain fragment, and the C-terminal 622-1070 and 726-1070 fragments differentially regulate multiple genes and signaling pathways in our highly invasive cancer cell model.  Immunoblotting of the selected proteins were used to validate the results of our high throughput assays.  Conclusions: Our results suggest that PTK7 levels need to be tightly controlled to enable migration and that the anti-migratory effect of the full-length membrane PTK7 is linked to the down-regulation of multiple migration-related genes and to the activation of the Akt and c-Jun pathway.  In turn, the C-terminal fragments of PTK7 act predominantly via the RAS-ERK and CREB/ATF1 pathway and through the up-regulation of cadherin-11.  In general, our data correlate well with the distinct functionality of the full-length receptor tyrosine kinases and their resp. intracellular domain (ICD) proteolytic fragments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZmNUp3suDi7Vg90H21EOLACvtfcHk0li0ZZBlUtnnuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1WrtrY%253D&md5=1d464e8ae948a02479ddeec4b6c46d95</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1186%2F1478-811X-12-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1478-811X-12-15%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26atitle%3DDownstream%2520signaling%2520and%2520genome-wide%2520regulatory%2520effects%2520of%2520PTK7%2520pseudokinase%2520and%2520its%2520proteolytic%2520fragments%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Commun.%2520Signaling%26date%3D2014%26volume%3D12%26spage%3D15%26doi%3D10.1186%2F1478-811X-12-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Zhou, B. B.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer</i></span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">39</span><span class="NLM_x">â</span> <span class="NLM_lpage">50</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2006.05.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.ccr.2006.05.024" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=39-50&issue=1&author=B.+B.+Zhou&title=Targeting+ADAM-mediated+ligand+cleavage+to+inhibit+HER3+and+EGFR+pathways+in+non-small+cell+lung+cancer&doi=10.1016%2Fj.ccr.2006.05.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DB.%2BB.%26atitle%3DTargeting%2520ADAM-mediated%2520ligand%2520cleavage%2520to%2520inhibit%2520HER3%2520and%2520EGFR%2520pathways%2520in%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26issue%3D1%26spage%3D39%26epage%3D50%26doi%3D10.1016%2Fj.ccr.2006.05.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Horiuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobel, C. P.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx</i></span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">176</span><span class="NLM_x">â</span> <span class="NLM_lpage">88</span><span class="refDoi">Â DOI: 10.1091/mbc.E06-01-0014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1091%2Fmbc.E06-01-0014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=17079736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFynuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=176-88&issue=1&author=K.+Horiuchiauthor=M.+Schulteauthor=S.+Le+Gallauthor=T.+Yamaguchiauthor=K.+Reissauthor=G.+Murphyauthor=Y.+Toyamaauthor=D.+Hartmannauthor=P.+Saftigauthor=C.+P.+Blobel&title=Substrate+selectivity+of+epidermal+growth+factor-receptor+ligand+sheddases+and+their+regulation+by+phorbol+esters+and+calcium+influx&doi=10.1091%2Fmbc.E06-01-0014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx</span></div><div class="casAuthors">Horiuchi, Keisuke; Le Gall, Sylvain; Schulte, Marc; Yamaguchi, Takafumi; Reiss, Karina; Murphy, Gillian; Toyama, Yoshiaki; Hartmann, Dieter; Saftig, Paul; Blobel, Carl P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-188</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Signaling via the epidermal growth factor receptor (EGFR), which has crit. roles in development and diseases such as cancer, is regulated by proteolytic shedding of its membrane-tethered ligands.  Sheddases for EGFR-ligands are therefore key signaling switches in the EGFR pathway.  Here, we detd. which ADAMs (a disintegrin and metalloprotease) can shed various EGFR-ligands, and we analyzed the regulation of EGFR-ligand shedding by 2 commonly used stimuli, phorbol esters and calcium influx.  Phorbol esters predominantly activate ADAM17, thereby triggering a burst of shedding of EGFR-ligands from a late secretory pathway compartment.  Calcium influx stimulates ADAM10, requiring its cytoplasmic domain.  However, calcium influx-stimulated shedding of transforming growth factor Î± and amphiregulin does not require ADAM17, even though ADAM17 is essential for phorbol ester-stimulated shedding of these EGFR-ligands.  This study provides new insight into the machinery responsible for EGFR-ligand release and thus EGFR signaling and demonstrates that dysregulated EGFR-ligand shedding may be caused by increased expression of constitutively active sheddases or activation of different sheddases by distinct stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeWjP3a2hMqrVg90H21EOLACvtfcHk0li0ZZBlUtnnuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFynuw%253D%253D&md5=3e768fc9f6b378ba4fe0b252696f8be6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E06-01-0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E06-01-0014%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DK.%26aulast%3DSchulte%26aufirst%3DM.%26aulast%3DLe%2BGall%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DReiss%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DG.%26aulast%3DToyama%26aufirst%3DY.%26aulast%3DHartmann%26aufirst%3DD.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBlobel%26aufirst%3DC.%2BP.%26atitle%3DSubstrate%2520selectivity%2520of%2520epidermal%2520growth%2520factor-receptor%2520ligand%2520sheddases%2520and%2520their%2520regulation%2520by%2520phorbol%2520esters%2520and%2520calcium%2520influx%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2007%26volume%3D18%26issue%3D1%26spage%3D176%26epage%3D88%26doi%3D10.1091%2Fmbc.E06-01-0014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Ni, S. S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival</i></span> <span class="citation_source-journal">Tumor Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1813</span><span class="NLM_x">â</span> <span class="NLM_lpage">8</span><span class="refDoi">Â DOI: 10.1007/s13277-013-0721-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1007%2Fs13277-013-0721-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=23475633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3sXos1yls7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1813-8&issue=3&author=S.+S.+Ni&title=ADAM17+is+overexpressed+in+non-small+cell+lung+cancer+and+its+expression+correlates+with+poor+patient+survival&doi=10.1007%2Fs13277-013-0721-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival</span></div><div class="casAuthors">Ni, Shuang-Shuang; Zhang, Ji; Zhao, Wei-Li; Dong, Xiao-Chun; Wang, Jin-Lin</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1813-1818</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The purpose of this study was to assess ADAM17 expression and to explore its contribution to the non-small cell lung cancer (NSCLC).  Real-time quant. reverse transcriptase-polymerase chain reaction was conducted to detect ADAM17 mRNA expression.  In addn., ADAM17 expression was analyzed by immunohistochem. in 124 clinicopathol. characterized NSCLC cases.  The correlation of ADAM17 expression with patients' survival rate was assessed by Kaplan-Meier and Cox regression.  The expression levels of ADAM17 mRNA and protein in NSCLC tissues were both significantly higher than those in non-cancerous tissues.  In addn., high expression of ADAM17 was significantly correlated with tumor grade (P = 0.026), tumor size (P = 0.001), clin. stage (P = 0.016), and lymph node metastases (P < 0.001).  Furthermore, multivariate anal. suggested that tumor grade, tumor size, clin. stage, lymph node metastases, and ADAM17 expression were independent prognostic indicators for NSCLC.  Our data suggest for the first time that the increased expression of ADAM17 in NSCLC is assocd. significantly with aggressive progression and poor prognosis.  ADAM17 may be an important mol. marker for predicting the carcinogenesis, progression, and prognosis of NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv0LP0Dg2tuLVg90H21EOLACvtfcHk0li0ZZBlUtnnuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXos1yls7c%253D&md5=7e6b503aa72e2036b9658f3975328d73</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1007%2Fs13277-013-0721-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-013-0721-3%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DS.%2BS.%26atitle%3DADAM17%2520is%2520overexpressed%2520in%2520non-small%2520cell%2520lung%2520cancer%2520and%2520its%2520expression%2520correlates%2520with%2520poor%2520patient%2520survival%26jtitle%3DTumor%2520Biol.%26date%3D2013%26volume%3D34%26issue%3D3%26spage%3D1813%26epage%3D8%26doi%3D10.1007%2Fs13277-013-0721-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Hynes, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlange, T.</span><span> </span><span class="NLM_article-title"><i>Targeting ADAMS and ERBBs in lung cancer</i></span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">7</span><span class="NLM_x">â</span> <span class="NLM_lpage">11</span><span class="refDoi">Â DOI: 10.1016/j.ccr.2006.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.ccr.2006.06.012" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=7-11&issue=1&author=N.+E.+Hynesauthor=T.+Schlange&title=Targeting+ADAMS+and+ERBBs+in+lung+cancer&doi=10.1016%2Fj.ccr.2006.06.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DN.%2BE.%26aulast%3DSchlange%26aufirst%3DT.%26atitle%3DTargeting%2520ADAMS%2520and%2520ERBBs%2520in%2520lung%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26issue%3D1%26spage%3D7%26epage%3D11%26doi%3D10.1016%2Fj.ccr.2006.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Rocks, N.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Emerging roles of ADAM and ADAMTS metalloproteinases in cancer</i></span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">369</span><span class="NLM_x">â</span> <span class="NLM_lpage">79</span><span class="refDoi">Â DOI: 10.1016/j.biochi.2007.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.biochi.2007.08.008" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2008&pages=369-79&issue=2&author=N.+Rocks&title=Emerging+roles+of+ADAM+and+ADAMTS+metalloproteinases+in+cancer&doi=10.1016%2Fj.biochi.2007.08.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2007.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2007.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DRocks%26aufirst%3DN.%26atitle%3DEmerging%2520roles%2520of%2520ADAM%2520and%2520ADAMTS%2520metalloproteinases%2520in%2520cancer%26jtitle%3DBiochimie%26date%3D2008%26volume%3D90%26issue%3D2%26spage%3D369%26epage%3D79%26doi%3D10.1016%2Fj.biochi.2007.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Horiuchi, K.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2</i></span> <span class="citation_source-journal">Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">459</span><span class="NLM_x">â</span> <span class="NLM_lpage">71</span><span class="refDoi">Â DOI: 10.1016/j.ydbio.2005.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.ydbio.2005.05.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2005&pages=459-71&issue=2&author=K.+Horiuchi&title=Evaluation+of+the+contributions+of+ADAMs+9%2C+12%2C+15%2C+17%2C+and+19+to+heart+development+and+ectodomain+shedding+of+neuregulins+beta1+and+beta2&doi=10.1016%2Fj.ydbio.2005.05.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ydbio.2005.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ydbio.2005.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DK.%26atitle%3DEvaluation%2520of%2520the%2520contributions%2520of%2520ADAMs%25209%252C%252012%252C%252015%252C%252017%252C%2520and%252019%2520to%2520heart%2520development%2520and%2520ectodomain%2520shedding%2520of%2520neuregulins%2520beta1%2520and%2520beta2%26jtitle%3DDev.%2520Biol.%26date%3D2005%26volume%3D283%26issue%3D2%26spage%3D459%26epage%3D71%26doi%3D10.1016%2Fj.ydbio.2005.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Stawikowska, R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates</i></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">22871</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.1074/jbc.M113.462267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1074%2Fjbc.M113.462267" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=22871-9&issue=31&author=R.+Stawikowska&title=Activity+of+ADAM17+%28a+disintegrin+and+metalloprotease+17%29+is+regulated+by+its+noncatalytic+domains+and+secondary+structure+of+its+substrates&doi=10.1074%2Fjbc.M113.462267"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.462267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.462267%26sid%3Dliteratum%253Aachs%26aulast%3DStawikowska%26aufirst%3DR.%26atitle%3DActivity%2520of%2520ADAM17%2520%2528a%2520disintegrin%2520and%2520metalloprotease%252017%2529%2520is%2520regulated%2520by%2520its%2520noncatalytic%2520domains%2520and%2520secondary%2520structure%2520of%2520its%2520substrates%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D31%26spage%3D22871%26epage%3D9%26doi%3D10.1074%2Fjbc.M113.462267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Scheller, J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>ADAM17: a molecular switch to control inflammation and tissue regeneration</i></span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">380</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span><span class="refDoi">Â DOI: 10.1016/j.it.2011.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.it.2011.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=21752713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFGgs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=380-7&issue=8&author=J.+Scheller&title=ADAM17%3A+a+molecular+switch+to+control+inflammation+and+tissue+regeneration&doi=10.1016%2Fj.it.2011.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">ADAM17: a molecular switch to control inflammation and tissue regeneration</span></div><div class="casAuthors">Scheller, Juergen; Chalaris, Athena; Garbers, Christoph; Rose-John, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">380-387</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A disintegrin and metalloproteinase 17 (ADAM17), also known as tumor necrosis factor-Î± converting enzyme (TACE), is a membrane-bound enzyme that cleaves cell surface proteins, such as cytokines (e.g. TNFÎ±), cytokine receptors (e.g. IL-6R and TNF-R), ligands of ErbB (e.g. TGFÎ± and amphiregulin) and adhesion proteins (e.g. L-selectin and ICAM-1).  Here we examine how ectodomain shedding of these mols. can alter their biol. and impact on immune and inflammatory responses and cancer development.  Gene targeting of Adam17 is embryonic lethal, highlighting the importance of ectodomain shedding during development.  Tissue-specific deletion, or hypomorphic knock-in, of Adam17 demonstrates an in vivo role for ADAM17 in controlling inflammation and tissue regeneration.  The potential of ADAM17 as therapeutic target is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0fckd1XTx7LVg90H21EOLACvtfcHk0ljBlP_WxcjJ9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFGgs74%253D&md5=1a09afb1495753956134f90e7a43d415</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2011.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2011.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DScheller%26aufirst%3DJ.%26atitle%3DADAM17%253A%2520a%2520molecular%2520switch%2520to%2520control%2520inflammation%2520and%2520tissue%2520regeneration%26jtitle%3DTrends%2520Immunol.%26date%3D2011%26volume%3D32%26issue%3D8%26spage%3D380%26epage%3D7%26doi%3D10.1016%2Fj.it.2011.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, R. A.</span><span> </span><span class="NLM_article-title"><i>Allosteric inhibition of BACE1 by an exosite-binding antibody</i></span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">797</span><span class="NLM_x">â</span> <span class="NLM_lpage">805</span><span class="refDoi">Â DOI: 10.1016/j.sbi.2013.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.sbi.2013.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=23998983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKrur%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=797-805&issue=6&author=W.+Wangauthor=Y.+Liuauthor=R.+A.+Lazarus&title=Allosteric+inhibition+of+BACE1+by+an+exosite-binding+antibody&doi=10.1016%2Fj.sbi.2013.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of BACE1 by an exosite-binding antibody</span></div><div class="casAuthors">Wang, Weiru; Liu, Yichin; Lazarus, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">797-805</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Î²-Secretase (BACE1) is a membrane-anchored pepsin-like aspartic protease and is the rate-limiting enzyme in the Î²-amyloidogenic pathway.  Thus, inhibitors of BACE1 activity have therapeutic potential for Alzheimer's disease.  While much effort has focused on small mol. active site inhibitors, recent exploration of BACE1 inhibition by peptides and antibodies has revealed exosites that can regulate enzymic activity.  This type of allosteric regulation by proteinaceous factors, while frequently found in serine and cysteine proteases, is rarely seen in aspartic proteases.  A crystal structure of the anti-BACE1/enzyme complex shows altered structural features and dynamic characteristics near the substrate-binding cleft.  This binding mode, along with the enzymic inhibition pattern, suggests that anti-BACE1 functions through an allosteric inhibition mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7NPCYEibKVLVg90H21EOLACvtfcHk0ljBlP_WxcjJ9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKrur%252FI&md5=0ed0c714b3d00d40c0d6ad67e841cbd3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2013.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2013.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLazarus%26aufirst%3DR.%2BA.%26atitle%3DAllosteric%2520inhibition%2520of%2520BACE1%2520by%2520an%2520exosite-binding%2520antibody%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2013%26volume%3D23%26issue%3D6%26spage%3D797%26epage%3D805%26doi%3D10.1016%2Fj.sbi.2013.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Hermanson, D. J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation</i></span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">358</span><span class="NLM_x">â</span> <span class="NLM_lpage">67</span><span class="refDoi">Â DOI: 10.1016/j.tips.2014.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.tips.2014.04.006" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=358-67&issue=7&author=D.+J.+Hermanson&title=Substrate-selective+COX-2+inhibition+as+a+novel+strategy+for+therapeutic+endocannabinoid+augmentation&doi=10.1016%2Fj.tips.2014.04.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DHermanson%26aufirst%3DD.%2BJ.%26atitle%3DSubstrate-selective%2520COX-2%2520inhibition%2520as%2520a%2520novel%2520strategy%2520for%2520therapeutic%2520endocannabinoid%2520augmentation%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26issue%3D7%26spage%3D358%26epage%3D67%26doi%3D10.1016%2Fj.tips.2014.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Busschots, K.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site</i></span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1152</span><span class="NLM_x">â</span> <span class="NLM_lpage">63</span><span class="refDoi">Â DOI: 10.1016/j.chembiol.2012.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.chembiol.2012.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=22999883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2ksbvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1152-63&issue=9&author=K.+Busschots&title=Substrate-selective+inhibition+of+protein+kinase+PDK1+by+small+compounds+that+bind+to+the+PIF-pocket+allosteric+docking+site&doi=10.1016%2Fj.chembiol.2012.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site</span></div><div class="casAuthors">Busschots, Katrien; Lopez-Garcia, Laura A.; Lammi, Carmen; Stroba, Adriana; Zeuzem, Stefan; Piiper, Albrecht; Alzari, Pedro M.; Neimanis, Sonja; Arencibia, Jose M.; Engel, Matthias; Schulze, Joerg O.; Biondi, Ricardo M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1152-1163</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The PIF-pocket of AGC protein kinases participates in the physiol. mechanism of regulation by acting as a docking site for substrates and as a switch for the transduction of the conformational changes needed for activation or inhibition.  We describe the effects of compds. that bind to the PIF-pocket of PDK1.  In vitro, PS210 is a potent activator of PDK1, and the crystal structure of the PDK1-ATP-PS210 complex shows that PS210 stimulates the closure of the kinase domain.  However, in cells, the prodrug of PS210 (PS423) acts as a substrate-selective inhibitor of PDK1, inhibiting the phosphorylation and activation of S6K, which requires docking to the PIF-pocket, but not affecting PKB/Akt.  This work describes a tool to study the dynamics of PDK1 activity and a potential approach for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCik10255dpLVg90H21EOLACvtfcHk0liUvfDZn5CXFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2ksbvO&md5=8efdcf836d5d910e979a2640709c1d4e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DBusschots%26aufirst%3DK.%26atitle%3DSubstrate-selective%2520inhibition%2520of%2520protein%2520kinase%2520PDK1%2520by%2520small%2520compounds%2520that%2520bind%2520to%2520the%2520PIF-pocket%2520allosteric%2520docking%2520site%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26issue%3D9%26spage%3D1152%26epage%3D63%26doi%3D10.1016%2Fj.chembiol.2012.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Balbin, M.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Loss of collagenase-2 confers increased skin tumor susceptibility to male mice</i></span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">252</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span><span class="refDoi">Â DOI: 10.1038/ng1249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2Fng1249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=14517555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosFWrtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=252-7&issue=3&author=M.+Balbin&title=Loss+of+collagenase-2+confers+increased+skin+tumor+susceptibility+to+male+mice&doi=10.1038%2Fng1249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of collagenase-2 confers increased skin tumor susceptibility to male mice</span></div><div class="casAuthors">Balbin, Milagros; Fueyo, Antonio; Tester, Angus M.; Pendas, Alberto M.; Pitiot, Ana S.; Astudillo, Aurora; Overall, Christopher M.; Shapiro, Steven D.; Lopez-Otin, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">252-257</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) have fundamental roles in tumor progression, but most clin. trials with MMP inhibitors have not shown improvements in individuals with cancer.  This may be partly because broad-range inhibitors also reduce host-protective antitumor properties of individual MMPs.  We generated mice deficient in collagenase-2 (Mmp8), an MMP mainly produced by neutrophils in inflammatory reactions and detected in some malignant tumors.  Loss of Mmp8 did not cause abnormalities during embryonic development or in adult mice.  Contrary to previous studies with MMP-deficient mice, however, the absence of Mmp8 strongly increased the incidence of skin tumors in male Mmp8-/-mice.  Female Mmp8-/-mice whose ovaries were removed or were treated with tamoxifen were also more susceptible to tumors compared with wild-type mice.  Bone marrow transplantation expts. confirmed that Mmp8 supplied by neutrophils was sufficient to restore the natural protection against tumor development mediated by this protease in male mice.  Histopathol. anal. showed that mutant mice had abnormalities in the inflammatory response induced by carcinogens.  Our study identifies a paradoxical protective role for Mmp8 in cancer and provides a genetic model to evaluate the mol. basis of gender differences in cancer susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrkAXGJEpZ-LVg90H21EOLACvtfcHk0liUvfDZn5CXFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosFWrtr8%253D&md5=868e8c71adecec4fa823297a56859294</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fng1249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1249%26sid%3Dliteratum%253Aachs%26aulast%3DBalbin%26aufirst%3DM.%26atitle%3DLoss%2520of%2520collagenase-2%2520confers%2520increased%2520skin%2520tumor%2520susceptibility%2520to%2520male%2520mice%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D35%26issue%3D3%26spage%3D252%26epage%3D7%26doi%3D10.1038%2Fng1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Palavalli, L. H.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma</i></span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">518</span><span class="NLM_x">â</span> <span class="NLM_lpage">20</span><span class="refDoi">Â DOI: 10.1038/ng.340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2Fng.340" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=19330028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsl2ns7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=518-20&issue=5&author=L.+H.+Palavalli&title=Analysis+of+the+matrix+metalloproteinase+family+reveals+that+MMP8+is+often+mutated+in+melanoma&doi=10.1038%2Fng.340"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma</span></div><div class="casAuthors">Palavalli, Lavanya H.; Prickett, Todd D.; Wunderlich, John R.; Wei, Xiaomu; Burrell, Allison S.; Porter-Gill, Patricia; Davis, Sean; Wang, Chenwei; Cronin, Julia C.; Agrawal, Neena S.; Lin, Jimmy C.; Westbroek, Wendy; Hoogstraten-Miller, Shelley; Molinolo, Alfredo A.; Fetsch, Patricia; Filie, Armando C.; O'Connell, Michael P.; Banister, Carolyn E.; Howard, Jason D.; Buckhaults, Phillip; Weeraratna, Ashani T.; Brody, Lawrence C.; Rosenberg, Steven A.; Samuels, Yardena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">518-520</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A mutational anal. of the matrix metalloproteinase (MMP) gene family in human melanoma identified somatic mutations in 23% of melanomas.  Five mutations in one of the most commonly mutated genes, MMP8, reduced MMP enzyme activity.  Expression of wild-type but not mutant MMP8 in human melanoma cells inhibited growth on soft agar in vitro and tumor formation in vivo, suggesting that wild-type MMP-8 has the ability to inhibit melanoma progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmD7XN4TsMaLVg90H21EOLACvtfcHk0liUvfDZn5CXFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsl2ns7w%253D&md5=73ee57103454bd38a2798570af1a516d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fng.340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.340%26sid%3Dliteratum%253Aachs%26aulast%3DPalavalli%26aufirst%3DL.%2BH.%26atitle%3DAnalysis%2520of%2520the%2520matrix%2520metalloproteinase%2520family%2520reveals%2520that%2520MMP8%2520is%2520often%2520mutated%2520in%2520melanoma%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26issue%3D5%26spage%3D518%26epage%3D20%26doi%3D10.1038%2Fng.340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Szabova, L.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease</i></span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">3274</span><span class="NLM_x">â</span> <span class="NLM_lpage">81</span><span class="refDoi">Â DOI: 10.1038/sj.onc.1210982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2Fsj.onc.1210982" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3274-81&issue=23&author=L.+Szabova&title=MT1-MMP+is+required+for+efficient+tumor+dissemination+in+experimental+metastatic+disease&doi=10.1038%2Fsj.onc.1210982"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210982%26sid%3Dliteratum%253Aachs%26aulast%3DSzabova%26aufirst%3DL.%26atitle%3DMT1-MMP%2520is%2520required%2520for%2520efficient%2520tumor%2520dissemination%2520in%2520experimental%2520metastatic%2520disease%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26issue%3D23%26spage%3D3274%26epage%3D81%26doi%3D10.1038%2Fsj.onc.1210982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title"><i>gamma-Secretase inhibitors and modulators for Alzheimerâs disease</i></span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl S1</span><span class="NLM_x">) </span> <span class="NLM_fpage">89</span><span class="NLM_x">â</span> <span class="NLM_lpage">98</span><span class="refDoi">Â DOI: 10.1111/j.1471-4159.2011.07501.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1111%2Fj.1471-4159.2011.07501.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=22122056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFyns70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=89-98&issue=Suppl+S1&author=M.+S.+Wolfe&title=gamma-Secretase+inhibitors+and+modulators+for+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1471-4159.2011.07501.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Î³-secretase inhibitors and modulators for Alzheimer's disease</span></div><div class="casAuthors">Wolfe, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">89-98</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Î³-Secretase is a membrane embedded aspartyl protease complex with presenilin as the catalytic component.  Along with Î²-secretase, this enzyme produces the amyloid Î²-protein of Alzheimer's disease (AD) from the amyloid Î²-protein precursor.  Because of its key role in the pathogenesis of AD, Î³-secretase has been a prime target for drug discovery, and many inhibitors of this protease have been developed.  The therapeutic potential of these inhibitors is virtually negated by the fact that Î³-secretase is an essential part of the Notch signaling pathway, rendering the compds. unacceptably toxic upon chronic exposure.  However, these compds. have served as useful chem. tools for biol. investigations.  In contrast, Î³-secretase modulators continue to be of keen interest as possible AD therapeutics.  These modulators either shift amyloid Î²-protein prodn. to shorter, less pathogenic peptides or inhibit the proteolysis of amyloid Î²-protein precursor selectively compared to that of Notch.  The various chem. types of inhibitors and modulators will be discussed, along with their use as probes for basic biol. and their potential as AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_F2j1GafgnLVg90H21EOLACvtfcHk0lh5AUj5qLUz8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFyns70%253D&md5=f495ec06da422076c7110ea4d0d37bbb</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2011.07501.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2011.07501.x%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3Dgamma-Secretase%2520inhibitors%2520and%2520modulators%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2012%26volume%3D120%26issue%3DSuppl%2520S1%26spage%3D89%26epage%3D98%26doi%3D10.1111%2Fj.1471-4159.2011.07501.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Houghten, R. A.</span><span> </span><span class="NLM_article-title"><i>General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids</i></span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5131</span><span class="NLM_x">â</span> <span class="NLM_lpage">5</span><span class="refDoi">Â DOI: 10.1073/pnas.82.15.5131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1073%2Fpnas.82.15.5131" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=5131-5&issue=15&author=R.+A.+Houghten&title=General+method+for+the+rapid+solid-phase+synthesis+of+large+numbers+of+peptides%3A+specificity+of+antigen-antibody+interaction+at+the+level+of+individual+amino+acids&doi=10.1073%2Fpnas.82.15.5131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.15.5131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.15.5131%26sid%3Dliteratum%253Aachs%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26atitle%3DGeneral%2520method%2520for%2520the%2520rapid%2520solid-phase%2520synthesis%2520of%2520large%2520numbers%2520of%2520peptides%253A%2520specificity%2520of%2520antigen-antibody%2520interaction%2520at%2520the%2520level%2520of%2520individual%2520amino%2520acids%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1985%26volume%3D82%26issue%3D15%26spage%3D5131%26epage%3D5%26doi%3D10.1073%2Fpnas.82.15.5131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Pinilla, C.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries</i></span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">314</span><span class="NLM_x">â</span> <span class="NLM_lpage">24</span><span class="refDoi">Â DOI: 10.1124/mol.113.086595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1124%2Fmol.113.086595" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=314-24&issue=3&author=C.+Pinilla&title=Selective+agonists+and+antagonists+of+formylpeptide+receptors%3A+duplex+flow+cytometry+and+mixture-based+positional+scanning+libraries&doi=10.1124%2Fmol.113.086595"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.086595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.086595%26sid%3Dliteratum%253Aachs%26aulast%3DPinilla%26aufirst%3DC.%26atitle%3DSelective%2520agonists%2520and%2520antagonists%2520of%2520formylpeptide%2520receptors%253A%2520duplex%2520flow%2520cytometry%2520and%2520mixture-based%2520positional%2520scanning%2520libraries%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D84%26issue%3D3%26spage%3D314%26epage%3D24%26doi%3D10.1124%2Fmol.113.086595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Pinilla, C.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Advances in the use of synthetic combinatorial chemistry: mixture-based libraries</i></span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">118</span><span class="NLM_x">â</span> <span class="NLM_lpage">22</span><span class="refDoi">Â DOI: 10.1038/nm0103-118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1038%2Fnm0103-118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=12514724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFKk" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=118-22&issue=1&author=C.+Pinilla&title=Advances+in+the+use+of+synthetic+combinatorial+chemistry%3A+mixture-based+libraries&doi=10.1038%2Fnm0103-118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the use of synthetic combinatorial chemistry: Mixture-based libraries</span></div><div class="casAuthors">Pinilla, Clemencia; Appel, Jon R.; Borras, Eva; Houghten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-122</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mixt.-based combinatorial libraries, large collections of thousands to millions of compds. in systematically arranged mixts., were reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobTCpBOIQ7-rVg90H21EOLACvtfcHk0lh5AUj5qLUz8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFKk&md5=007987b5a17da538f60a4358f9ee834e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnm0103-118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0103-118%26sid%3Dliteratum%253Aachs%26aulast%3DPinilla%26aufirst%3DC.%26atitle%3DAdvances%2520in%2520the%2520use%2520of%2520synthetic%2520combinatorial%2520chemistry%253A%2520mixture-based%2520libraries%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26issue%3D1%26spage%3D118%26epage%3D22%26doi%3D10.1038%2Fnm0103-118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Houghten, R. A.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods</i></span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">19</span><span class="refDoi">Â DOI: 10.1021/cc7001205</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc7001205" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWgurfK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=3-19&issue=1&author=R.+A.+Houghten&title=Strategies+for+the+use+of+mixture-based+synthetic+combinatorial+libraries%3A+scaffold+ranking%2C+direct+testing+in+vivo%2C+and+enhanced+deconvolution+by+computational+methods&doi=10.1021%2Fcc7001205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Use of Mixture-Based Synthetic Combinatorial Libraries: Scaffold Ranking, Direct Testing In Vivo, and Enhanced Deconvolution by Computational Methods</span></div><div class="casAuthors">Houghten, Richard A.; Pinilla, Clemencia; Giulianotti, Marc A.; Appel, Jon R.; Dooley, Colette T.; Nefzi, Adel; Ostresh, John M.; Yu, Yongping; Maggiora, Gerald M.; Medina-Franco, Jose L.; Brunner, Daniela; Schneider, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-19</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHw0Bw1Gl2KLVg90H21EOLACvtfcHk0lh5AUj5qLUz8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWgurfK&md5=9693c04842ee3232043fd2d8a5dabd44</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fcc7001205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc7001205%26sid%3Dliteratum%253Aachs%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26atitle%3DStrategies%2520for%2520the%2520use%2520of%2520mixture-based%2520synthetic%2520combinatorial%2520libraries%253A%2520scaffold%2520ranking%252C%2520direct%2520testing%2520in%2520vivo%252C%2520and%2520enhanced%2520deconvolution%2520by%2520computational%2520methods%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2008%26volume%3D10%26issue%3D1%26spage%3D3%26epage%3D19%26doi%3D10.1021%2Fcc7001205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Zhang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title"><i>A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</i></span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">67</span><span class="NLM_x">â</span> <span class="NLM_lpage">73</span><span class="refDoi">Â DOI: 10.1177/108705719900400206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&issue=2&author=J.+H.+Zhangauthor=T.+D.+Chungauthor=K.+R.+Oldenburg&title=A+Simple+Statistical+Parameter+for+Use+in+Evaluation+and+Validation+of+High+Throughput+Screening+Assays&doi=10.1177%2F108705719900400206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2eYUoK2kIa1rzLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520Simple%2520Statistical%2520Parameter%2520for%2520Use%2520in%2520Evaluation%2520and%2520Validation%2520of%2520High%2520Throughput%2520Screening%2520Assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26issue%3D2%26spage%3D67%26epage%3D73%26doi%3D10.1177%2F108705719900400206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Leister, K. P.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Two High Throughput Screen Assays for Measurement of TNF-alpha in THP-1 Cells</i></span> <span class="citation_source-journal">Curr. Chem. Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span><span class="refDoi">Â DOI: 10.2174/1875397301105010021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.2174%2F1875397301105010021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=21643507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BC3MXms1KgtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=21-9&author=K.+P.+Leister&title=Two+High+Throughput+Screen+Assays+for+Measurement+of+TNF-alpha+in+THP-1+Cells&doi=10.2174%2F1875397301105010021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Two high throughput screen assays for measurement of TNF-Î± in THP-1 cells</span></div><div class="casAuthors">Leister, Kristin P.; Huang, Ruili; Goodwin, Bonnie L.; Chen, Andrew; Austin, Christopher P.; Xia, Menghang</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Genomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">CCGUAQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-3973</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Tumor Necrosis Factor-Î± (TNF-Î±), a secreted cytokine, plays an important role in inflammatory diseases and immune disorders, and is a potential target for drug development.  The traditional assays for detecting TNF-Î±, enzyme linked immunosorbent assay (ELISA) and RIA, are not suitable for the large size compd. screens.  Both assays suffer from a complicated protocol, multiple plate wash steps and/or excessive radioactive waste.  A simple and quick measurement of TNF-Î± prodn. in a cell based assay is needed for high throughput screening to identify the lead compds. from the compd. library.  We have developed and optimized two homogeneous TNF-Î± assays using the HTRF (homogeneous time resolved fluorescence) and AlphaLISA assay formats.  We have validated the HTRF based TNF-Î± assay in a 1536-well plate format by screening a library of 1280 pharmacol. active compds.  The active compds. identified from the screen were confirmed in the AlphaLISA TNF-Î± assay using a bead-based technol.  These compds. were also confirmed in a traditional ELISA assay.  From this study, several beta adrenergic agonists have been identified as TNF-Î± inhibitors.  We also identified several novel inhibitors of TNF-Î±, such as BTO-1, CCG-2046, ellipticine, and PD 169316.  The results demonstrated that both homogeneous TNF-Î± assays are robust and suitable for high throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQz3I9GaaciLVg90H21EOLACvtfcHk0lhKScbDoMKOvQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXms1KgtLs%253D&md5=5b132f9fbbe2577774018f0e750df4d7</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F1875397301105010021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1875397301105010021%26sid%3Dliteratum%253Aachs%26aulast%3DLeister%26aufirst%3DK.%2BP.%26atitle%3DTwo%2520High%2520Throughput%2520Screen%2520Assays%2520for%2520Measurement%2520of%2520TNF-alpha%2520in%2520THP-1%2520Cells%26jtitle%3DCurr.%2520Chem.%2520Genomics%26date%3D2011%26volume%3D5%26spage%3D21%26epage%3D9%26doi%3D10.2174%2F1875397301105010021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Ludwig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hundhausen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadway, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leesnitzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becherer, J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules</i></span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">161</span><span class="NLM_x">â</span> <span class="NLM_lpage">171</span><span class="refDoi">Â DOI: 10.2174/1386207053258488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.2174%2F1386207053258488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=15777180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVGgurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=161-171&issue=2&author=A.+Ludwigauthor=C.+Hundhausenauthor=M.+Lambertauthor=N.+Broadwayauthor=R.+Andrewsauthor=D.+Bickettauthor=M.+Leesnitzerauthor=J.+Becherer&title=Metalloproteinase+inhibitors+for+the+disintegrin-like+metalloproteinases+ADAM10+and+ADAM17+that+differentially+block+constitutive+and+phorbol+ester-inducible+shedding+of+cell+surface+molecules&doi=10.2174%2F1386207053258488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules</span></div><div class="casAuthors">Ludwig, Andreas; Hundhausen, Christian; Lambert, Millard H.; Broadway, Neil; Andrews, Robert C.; Bickett, D. Mark; Leesnitzer, M. Anthony; Becherer, J. David</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-171</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The transmembrane metzinkin-proteases of the ADAM (a disintegrin and a metalloproteinase)-family ADAM10 and ADAM 17 are both implicated in the ectodomain shedding of various cell surface mols. including the IL6-receptor and the transmembrane chemokines CX3CL1 and CXCL16.  These mols. are constitutively released from cultured cells, a process that can be rapidly enhanced by cell stimulation with phorbol esters such as PMA.  Recent research supports the view that the constitutive cleavage predominantly involves ADAM10 while the inducible one is mediated to a large extent by ADAM17.  We here describe the discovery of hydroxamate compds. with different potency against ADAM10 and ADAM17 and different ability to block constitutive and inducible cleavage of IL6R, CX3CL1 and CXCL16 by the two proteases.  By screening a no. of hydroxamate inhibitors for the inhibition of recombinant metalloproteinases, a compd. was found inhibiting ADAM10 with more than 100-fold higher potency than ADAM17, which may be explained by an improved fit of the compd. to the S1' specificity pocket of ADAM10 as compared to that of ADAM17.  In cell-based cleavage expts. this compd. (GI254023X) potently blocked the constitutive release of IL6R, CX3CL1 and CXCL16, which was in line with the reported involvement of ADAM10 but not ADAM17 in this process.  By contrast, the compd. did not affect the PMA-induced shedding, which was only blocked by GW280264X, a potent inhibitor of ADAM17.  As expected, GI254023X did not further decrease the residual release of CX3CL1 and CXCL16 in ADAM10-deficient cells verifying that the compd.'s effect on the constitutive shedding of these mols. was exclusively due to the inhibition of ADAM10.  Thus, GI254023X may by of use as a preferential inhibitor of constitutive shedding events without effecting the inducible shedding in response to agonists acting similar to PMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyuZAUznlqdbVg90H21EOLACvtfcHk0lhKScbDoMKOvQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVGgurk%253D&md5=8c474e5cc77e96573d90a18ab9768d7b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.2174%2F1386207053258488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207053258488%26sid%3Dliteratum%253Aachs%26aulast%3DLudwig%26aufirst%3DA.%26aulast%3DHundhausen%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DM.%26aulast%3DBroadway%26aufirst%3DN.%26aulast%3DAndrews%26aufirst%3DR.%26aulast%3DBickett%26aufirst%3DD.%26aulast%3DLeesnitzer%26aufirst%3DM.%26aulast%3DBecherer%26aufirst%3DJ.%26atitle%3DMetalloproteinase%2520inhibitors%2520for%2520the%2520disintegrin-like%2520metalloproteinases%2520ADAM10%2520and%2520ADAM17%2520that%2520differentially%2520block%2520constitutive%2520and%2520phorbol%2520ester-inducible%2520shedding%2520of%2520cell%2520surface%2520molecules%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2005%26volume%3D8%26issue%3D2%26spage%3D161%26epage%3D171%26doi%3D10.2174%2F1386207053258488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Golubkov, V. S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells</i></span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">10460</span><span class="NLM_x">â</span> <span class="NLM_lpage">5</span><span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-06-2997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1158%2F0008-5472.CAN-06-2997" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=10460-5&issue=21&author=V.+S.+Golubkov&title=Membrane+type-1+matrix+metalloproteinase+confers+aneuploidy+and+tumorigenicity+on+mammary+epithelial+cells&doi=10.1158%2F0008-5472.CAN-06-2997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-2997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-2997%26sid%3Dliteratum%253Aachs%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26atitle%3DMembrane%2520type-1%2520matrix%2520metalloproteinase%2520confers%2520aneuploidy%2520and%2520tumorigenicity%2520on%2520mammary%2520epithelial%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D21%26spage%3D10460%26epage%3D5%26doi%3D10.1158%2F0008-5472.CAN-06-2997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Kuruppu, S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title"><i>Production of soluble Neprilysin by endothelial cells</i></span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">423</span><span class="NLM_x">â</span> <span class="NLM_lpage">7</span><span class="refDoi">Â DOI: 10.1016/j.bbrc.2014.01.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;key=10.1016%2Fj.bbrc.2014.01.158" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2014&pages=423-7&issue=2&author=S.+Kuruppu&title=Production+of+soluble+Neprilysin+by+endothelial+cells&doi=10.1016%2Fj.bbrc.2014.01.158"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.01.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.01.158%26sid%3Dliteratum%253Aachs%26aulast%3DKuruppu%26aufirst%3DS.%26atitle%3DProduction%2520of%2520soluble%2520Neprilysin%2520by%2520endothelial%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D446%26issue%3D2%26spage%3D423%26epage%3D7%26doi%3D10.1016%2Fj.bbrc.2014.01.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00354">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_00834"></div></div></div></div></div><hr /></hr><p class="last">Molecular formula strings (CSV). The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00354">10.1021/acs.jmedchem.5b00354</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00354/suppl_file/jm5b00354_si_001.csv">jm5b00354_si_001.csv (2.67 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00354&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00354%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-15" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00354" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799bf1acc883c46","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
